- HIPO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
Hippo (HIPO) S-1IPO registration
Filed: 24 Aug 21, 4:33pm
Delaware | 6770 | 32- 0662604 | ||
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Title of each class of securities to be registered | Amount to be registered | Proposed maximum offering price per security | Proposed maximum aggregate offering price | Amount of registration fee | ||||
Common stock (1)(2) | 386,233,06 5 | $4.20 (3) | $1,624,110,038 (3) | $177,190.40 | ||||
Warrants (1) | 4,400,000 | $— (4) | $— (4) | $— | ||||
Common stock (1)(5) | 5,037,463 | $11.50 (6) | $57,930,824.50 (6) | $6,320.25 | ||||
Total | $ | $183,510.65 | ||||||
(1) | Pursuant to Rule 416(a) of the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(2) | The number of shares of common stock being registered represents the sum of (a) 316,640,538 shares of common stock issued in connection with the Merger (as defined below), (b) 55,000,000 shares of common stock issued to certain qualified institutional buyers and accredited investors in private placements consummated in connection with the Business Combination (as defined below) and (c) 14,592,527 shares of common stock reserved for issuance upon the exercise of options to purchase common stock. |
(3) | Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the common stock of Hippo Holdings on the New York Stock Exchange (the “NYSE”) on August 20, 2021 (such date being within five business days of the date that this registration statement was first filed with the SEC). This calculation is in accordance with Rule 457(c) of the Securities Act. |
(4) | In accordance with Rule 457(g), the entire registration fee for the warrants is allocated to the shares of common stock underlying the warrants, and no separate fee is payable for the warrants. |
(5) | Reflects the shares of common stock that may be issued upon exercise of outstanding warrants, with each warrant exercisable for one share of common stock, subject to adjustment, for an exercise price of $11.50 per share. |
(6) | Calculated pursuant to Rule 457(g) under the Securities Act, based on the exercise price of the warrants. |
Page | ||||
ii | ||||
v | ||||
1 | ||||
6 | ||||
49 | ||||
50 | ||||
51 | ||||
65 | ||||
85 | ||||
121 | ||||
127 | ||||
131 | ||||
139 | ||||
141 | ||||
154 | ||||
164 | ||||
175 | ||||
176 | ||||
179 | ||||
179 | ||||
179 | ||||
F-1 |
• | “Business Combination” are to the Domestication together with the Merger; |
• | “Bylaws” are to our bylaws dated as of July 30, 2021; |
• | “Cayman Constitutional Documents” are to RTPZ’s Amended and Restated Memorandum of Association under Cayman Islands Companies Law and RTPZ’s Articles of Association, each as amended from time to time; |
• | “Cayman Islands Companies Law” are to the Cayman Islands Companies Act (As Revised); |
• | “Certificate of Incorporation” are our certificate of incorporation dated as of July 30, 2021; |
• | “Closing” are to the closing of the Business Combination; |
• | “Continental” are to Continental Stock Transfer & Trust Company; |
• | “DGCL” are to the General Corporation Law of the State of Delaware; |
• | “Domestication” are to the domestication of RTPZ as a corporation incorporated in the State of Delaware; |
• | “Effective Time” are to the effective time of the Merger; |
• | “ESPP” are to the Hippo Holdings Inc. 2021 Employee Stock Purchase Plan; |
• | “Exchange Act” are to the Securities Exchange Act of 1934, as amended; |
• | “Exchange Ratio” are to the quotient obtained by dividing (i) the Aggregate Merger Consideration by (ii) the aggregate fully-diluted number of shares of Hippo common stock issued and outstanding immediately prior to the First Merger; |
• | “GAAP” are to accounting principles generally accepted in the United States of America; |
• | “Hippo” are to Hippo Holdings Inc. and its consolidated subsidiaries and businesses, including Spinnaker Insurance Company, after the Business Combination; |
• | “Hippo Holdings common stock” are to shares of Hippo Holdings common stock, par value $0.0001 per share; |
• | “Hippo Holdings Inc.” or “Hippo Holdings” are to RTPZ after the Domestication and its name change from Reinvent Technology Partners Z to Hippo Holdings Inc.; |
• | “Hippo Holdings options” are to options to purchase shares of Hippo Holdings common stock; |
• | “Hippo notes” are to the convertible promissory notes issued by Hippo and convertible into shares of Hippo common stock; |
• | “Incentive Award Plan” are to the Hippo Holdings Inc. 2021 Incentive Award Plan; |
• | “initial public offering” are to RTPZ’s initial public offering that was consummated on November 23, 2020; |
• | “IPO registration statement” are to the Registration Statement on Form S-1 (333-249799) filed by RTPZ in connection with its initial public offering, which became effective on November 18, 2020; |
• | “IRS” are to the U.S. Internal Revenue Service; |
• | “JOBS Act” are to the Jumpstart Our Business Startups Act of 2012; |
• | “Merger” are to the merger of Merger Sub with and into Old Hippo, with Old Hippo surviving the merger as a wholly owned subsidiary of Hippo Holdings; |
• | “Merger Sub” means RTPZ Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of RTPZ prior to the Business Combination, which, as a result of the Merger, merged into Old Hippo; |
• | “NYSE” are to the New York Stock Exchange; |
• | “Old Hippo” are to Hippo Enterprises Inc. prior to the Business Combination, which became a wholly owned subsidiary of Hippo Holdings and later merged into Hippo Holdings as a result of the Business Combination; |
• | “Old Hippo capital stock” are to shares of Old Hippo common stock and Old Hippo preferred stock. |
• | “Old Hippo common stock” are to shares of Old Hippo common stock, par value $0.00001 per share; |
• | “Old Hippo options” are to options to purchase shares of Old Hippo common stock; |
• | “Old Hippo warrants” are to the warrants to purchase shares of Hippo capital stock outstanding prior to the Effective Time; |
• | “Old Hippo preferred stock” are to the Series A-1 preferred stock, Series A-2 preferred stock, Series B preferred stock, Series C-1 preferred stock, Series C preferred stock, Series D preferred stock and Series E preferred stock of Old Hippo; |
• | “Organizational Documents” are to the Certificate of Incorporation and the Bylaws; |
• | “PIPE Investment” are to the purchase of shares of Hippo Holdings common stock pursuant to the Subscription Agreements; |
• | “PIPE Investors” are to those certain investors participating in the PIPE Investment pursuant to the Subscription Agreements; |
• | “private placement warrants” are to the RTPZ private placement warrants outstanding as of the date of this prospectus and the warrants of Hippo Holdings issued as a matter of law upon the conversion thereof at the time of the Domestication; |
• | “pro forma” are to giving pro forma effect to the Business Combination; |
• | “public shareholders” are to holders of public shares, whether acquired in RTPZ’s initial public offering or acquired in the secondary market; |
• | “public shares” are to the RTPZ Class A ordinary shares (including those that underlie the units of RTPZ) that were offered and sold by RTPZ in its initial public offering and registered pursuant to the IPO registration statement and the shares of Hippo Holdings common stock issued as a matter of law upon the conversion thereof on the effective date of the Domestication. |
• | “public warrants” are to the redeemable warrants (including those that underlie the units of RTPZ) that were offered and sold by RTPZ in its initial public offering and registered pursuant to the IPO registration statement or the redeemable warrants of Hippo Holdings issued as a matter of law upon the conversion thereof at the time of the Domestication; |
• | “redemption” are to each redemption of public shares for cash pursuant to the Cayman Constitutional Documents and the Organizational Documents; |
• | “Registration Rights Agreement” are to the Registration Rights Agreement entered into by and among Hippo Holdings, the Sponsor and the other holders of RTPZ Class B ordinary shares, certain former stockholders of Hippo, and Reinvent Capital Fund LP, as amended and modified from time to time; |
• | “RTPZ” are to Reinvent Technology Partners Z prior to its domestication as a corporation in the State of Delaware; |
• | “RTPZ Class A ordinary shares” are to RTPZ’s Class A ordinary shares, par value $0.0001 per share; |
• | “RTPZ Class B ordinary shares” are to RTPZ’s Class B ordinary shares, par value $0.0001 per share; |
• | “RTPZ founder shares” are to the 5,750,000 RTPZ Class B ordinary shares purchased by the Sponsor in a private placement prior to the initial public offering for an aggregate purchase price of $25,000 (or approximately $0.004 per share), and the RTPZ Class A ordinary shares that will be issued upon the conversion thereof; |
• | “Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002; |
• | “SEC” are to the United States Securities and Exchange Commission; |
• | “Securities Act” are to the Securities Act of 1933, as amended; |
• | “Selling Securityholder” are to the selling securityholders named in this prospectus; |
• | “Sponsor” are to Reinvent Sponsor Z LLC, a Cayman Islands limited liability company; |
• | “Sponsor Agreement” are to that certain Sponsor Agreement, dated March 3, 2021, by and between RTPZ and Hippo, as amended and modified from time to time; |
• | “Subscription Agreement” are to that certain Sponsor Agreement, dated March 3, 2021, by and between RTPZ and Hippo, as amended and modified from time to time; |
• | “Sponsor Shares” are to the RTPZ founder shares that were beneficially owned by the Sponsor as of the Domestication. |
• | “Third Party PIPE Investor” are to any PIPE Investor who is not (i) Reinvent Capital Fund LP, (ii) the Sponsor, or (iii) a Hippo PIPE Investor; |
• | “Transaction” are to Old Hippo becoming a wholly owned subsidiary of Hippo Holdings as a result of Merger Sub, a direct wholly owned subsidiary of RTPZ, merging with and into Old Hippo, with Old Hippo surviving as a wholly owned subsidiary of Hippo Holdings; |
• | “trust account” are to the trust account established at the consummation of RTPZ’s initial public offering at JPMorgan Chase Bank, N.A. and maintained by Continental, acting as trustee; |
• | “Warrant Agreement” is to the Warrant Agreement, dated as of November 18, 2020, by and between RTPZ and Continental, as warrant agent, as amended; and |
• | “warrants” are to the public warrants and the private placement warrants. |
• | our public securities’ liquidity and trading; |
• | our future capital needs following the Business Combination; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following the completion of the Business Combination; |
• | our future results of operations and financial positions; |
• | our ability to attract, retain, and expand our customer base; |
• | our ability to maintain and enhance our brand and reputation; |
• | our lack of operating history and ability to attain profitability; |
• | our ability to effectively manage the growth of our business; |
• | the effects of seasonal trends on our results of operation; |
• | our ability to attain greater value from each customer; |
• | our ability to compete effectively in our industry; |
• | our ability to maintain reinsurance contracts; |
• | our ability to utilize our proprietary technology; |
• | our ability to underwrite risks accurately and charge profitable rates; |
• | our ability to protect our intellectual property; |
• | our ability to expand our product offerings or improve existing ones; |
• | our ability to attract and retain personnel; |
• | potential harm caused by misappropriation of our data and compromises in cybersecurity; |
• | potential harm caused by changes in internet search engines’ methodologies; |
• | our ability to raise additional capital; |
• | fluctuations in our results of operation and operating metrics; |
• | our ability to receive, process, store, use and share data, and compliance with laws and regulations related to data privacy and data security; |
• | our ability to stay in compliance with laws and regulation that currently apply, or become applicable, to our business both in the United States and internationally; |
• | our inability to predict the lasting impacts of COVID-19 to our business in particular, and the global economy generally; |
• | our expected uses of the cash on our balance sheet following the Business Combination; and |
• | other factors detailed under the section entitled “ Risk Factors. |
• | Hippo Holdings makes policies fast and easy to buy. |
• | Hippo Holdings’ policies are designed for the modern homeowner. |
• | Hippo Holdings has designed a proactive, human approach to claims, enabled by technology. |
• | Hippo Holdings has pioneered what it believes is the most widely adopted Smart Home program in the U.S. industry. |
• | Hippo Holdings proactively helps its customers maintain and protect their homes |
(1) | Spinnaker and North American Advantage Insurance Services LLC (“NAAIS”) are presented on a pro forma basis as of January 1, 2018. For more information please see “ Recent Acquisition: Spinnaker Insurance Company |
(2) | Frequency defined as number of claims divided by the total number of units of exposure, where a unit of exposure is defined as one policy year earned. For example, one policy in force written 24 months ago, represents 2x units of exposure. The cohorts are 12-month cohorts starting on 8/1 of each calendar year. |
• | We have a history of net losses and we may not achieve or maintain profitability in the future. |
• | Our success and ability to grow our business depend on retaining and expanding our customer base. If we fail to add new customers or retain current customers, our business, revenue, operating results and financial condition could be harmed. |
• | The “Hippo” brand may not become as widely known as incumbents’ or other competitors’ brands or the brand may become tarnished. |
• | Denial of claims or our failure to accurately and timely pay claims could materially and adversely affect our business, financial condition, results of operations and prospects. |
• | Our limited operating history makes it difficult to evaluate our current business performance, implementation of our business model and our future prospects. |
• | We may not be able to manage our growth effectively. |
• | Intense competition in the segments of the insurance industry in which we operate could negatively affect our ability to attain or increase profitability. |
• | Reinsurance may be unavailable at current coverage, limits or pricing, which may limit our ability to write new or renew existing business. Furthermore, reinsurance subjects our insurance company subsidiaries to counterparty credit and performance risk and may not be adequate to protect us against losses, which could have a material effect on our results of operations and financial condition. |
• | Failure to maintain our risk-based capital at the required levels could adversely affect the ability of our insurance subsidiaries to maintain regulatory authority to conduct our business. |
• | Failure to maintain our financial strength ratings could adversely affect the ability of our insurance company subsidiaries to conduct our business as currently conducted. |
• | If we are unable to expand our product offerings, our prospects for future growth may be adversely affected. |
• | Our proprietary technology, which relies on third party data, may not operate properly or as we expect it to. |
• | Our technology platform may not operate properly or as we expect it to operate. |
• | Our future success depends on our ability to continue to develop and implement our technology, and to maintain the confidentiality of this technology. |
• | we fail to effectively use search engines, social media platforms, content-based online advertising, and other online sources for generating traffic to our website; |
• | potential customers in a particular marketplace or more generally do not meet our underwriting guidelines; |
• | our products are not competitive in terms of customer experience, pricing, or insurance coverage options; |
• | our competitors mimic our digital platform or develop other innovative services, causing current and potential customers to purchase their insurance products instead of our products; |
• | we lose customers to new market entrants and/or existing competitors; |
• | we do not obtain regulatory approvals necessary for expansion into new markets or in relation to our products (such as line, form, underwriting and rating approvals) or such approvals contain conditions that impose restrictions on our operations (such as limitations on growth); |
• | our digital platform experiences disruptions; |
• | we suffer reputational harm to our brand resulting from negative publicity, whether accurate or inaccurate; |
• | we fail to expand geographically; |
• | we fail to offer new and competitive products, to provide effective updates to our existing products or to keep pace with technological improvements in our industry; |
• | we are unable to maintain traditional retail agent relationships; |
• | customers have difficulty installing, updating or otherwise accessing our website on mobile devices or web browsers as a result of actions by us or third parties; |
• | customers are unable or unwilling to adopt or embrace new technology; |
• | technical or other problems frustrate the customer experience, particularly if those problems prevent us from generating quotes or paying claims in a fast and reliable manner; or |
• | we are unable to address customer concerns regarding the content, data privacy, and security generally or for our digital platform specifically. |
• | changes in the financial profile of one of our insurance companies; |
• | changes in a rating agency’s determination of the amount of capital required to maintain a particular rating; or |
• | increases in the perceived risk of our investment portfolio, a reduced confidence in management or our business strategy, or other considerations that may or may not be under our control. |
• | collect and properly and accurately analyze a substantial volume of data from our customers; |
• | develop, test and apply appropriate actuarial projections and rating formulas; |
• | review and evaluate competitive product offerings and pricing dynamics; |
• | closely monitor and timely recognize changes in trends; and |
• | project both frequency and severity of our customers’ losses with reasonable accuracy. |
• | insufficient, inaccurate or unreliable data; |
• | incorrect or incomplete analysis of available data; |
• | uncertainties generally inherent in estimates and assumptions; |
• | our failure to implement appropriate actuarial projections and rating formulas or other pricing methodologies; |
• | incorrect or incomplete analysis of the competitive environment; |
• | regulatory constraints on rate increases or coverage limitations; |
• | our failure to accurately estimate investment yields and the duration of our liability for loss and loss adjustment expenses; and |
• | unanticipated litigation, court decisions, and legislative or regulatory actions or changes to the existing regulatory landscape. |
• | failure to identify, attract, reward and retain people in leadership positions in our organization who share and further our culture, values and mission; |
• | the increasing size and geographic diversity of our workforce, and our ability to promote a uniform and consistent culture across all our offices and employees; |
• | competitive pressures to move in directions that may divert us from our mission, vision and values; |
• | the continued challenges of a rapidly evolving industry; and |
• | the increasing need to develop expertise in new areas of business that affect us. |
• | intense competition for suitable acquisition targets, which could increase prices and adversely affect our ability to consummate deals on favorable or acceptable terms; |
• | failure or material delay in closing a transaction, including as a result of regulatory review and approvals; |
• | inadequacy of reserves for losses and loss expenses; |
• | quality of their data and underwriting processes; |
• | conditions imposed by regulatory agencies that make the realization of cost-savings through integration of operations more difficult; |
• | difficulties in obtaining regulatory approvals on our ability to be an acquirer; |
• | a need for additional capital that was not anticipated at the time of the acquisition; |
• | transaction-related lawsuits or claims; |
• | difficulties in integrating the technologies, operations, existing contracts and personnel of an acquired company; |
• | difficulties in retaining key employees or business partners of an acquired company; |
• | diversion of financial and management resources from existing operations or alternative acquisition opportunities; |
• | failure to realize the anticipated benefits or synergies of a transaction; |
• | failure to identify the problems, liabilities or other shortcomings or challenges of an acquired company or technology, including issues related to intellectual property, regulatory compliance practices, litigation, accounting practices, or employee or user issues; |
• | risks that regulatory bodies may enact new laws or promulgate new regulations that are adverse to an acquired company or business; |
• | theft of our trade secrets or confidential information that we share with potential acquisition candidates; |
• | risk that an acquired company or investment in new offerings cannibalizes a portion of our existing business; |
• | adverse market reaction to an acquisition; |
• | significant attention from management and disruption to our business; and |
• | potential dilution in value to our stockholders. |
• | barriers to obtaining the required government approvals, licenses or other authorizations, including seasoning or other limitations imposed by a state; |
• | failures in identifying and entering into joint ventures with strategic partners or entering into joint ventures that do not produce the desired results; |
• | challenges in, and the cost of, complying with various laws and regulatory standards, including with respect to the insurance business and insurance distribution, capital and outsourcing requirements, data privacy, tax and regulatory restrictions; |
• | competition from incumbents that already own market share, better understand the market, may market and operate more effectively and may enjoy greater affinity or awareness; and |
• | differing demand dynamics, which may make our product offerings less successful. |
• | the occurrence of severe weather conditions and other catastrophes; |
• | our operating and financial performance, quarterly or annual earnings relative to similar companies; |
• | publication of research reports or news stories about us, our competitors or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts; |
• | the public’s reaction to our press releases, our other public announcements and our filings with the SEC; |
• | announcements by us or our competitors of acquisitions, business plans or commercial relationships; |
• | any major change in our board of directors or senior management, including the departure of our founder; |
• | sales of our common stock by us, our directors, executive officers, principal shareholders, our founder and/or the PIPE Investors, or expectations of such sales given the release of shares from applicable lock-ups over time; |
• | adverse market reaction to any indebtedness we may incur or securities we may issue in the future; |
• | short sales, hedging and other derivative transactions in our common stock; |
• | exposure to capital market risks related to changes in interest rates, realized investment losses, credit spreads, equity prices, foreign exchange rates and performance of insurance-linked investments; |
• | our creditworthiness, financial condition, performance, and prospects; |
• | changes in the fair values of our financial instruments (including certain warrants assumed in connection with the Business Combination); |
• | our dividend policy and whether dividends on our common stock have been, and are likely to be, declared and paid from time to time; |
• | perceptions of the investment opportunity associated with our common stock relative to other investment alternatives; |
• | regulatory or legal developments; |
• | changes in general market, economic and political conditions; |
• | conditions or trends in our industry, geographies or customers; |
• | changes in accounting standards, policies, guidance, interpretations or principles; |
• | the impact of the COVID-19 pandemic on Hippo Holdings’ management, employees, partners, customers and operating results; and |
• | threatened or actual litigation or government investigations. |
• | our board of directors is classified into three classes of directors with staggered three-year terms, and directors are only able to be removed from office for cause; |
• | nothing in our Certificate of Incorporation precludes future issuances without stockholder approval of the authorized but unissued shares of our common stock; |
• | advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders; |
• | our stockholders are only be able to take action at a meeting of stockholders and not by written consent; |
• | only our chairman of the board of directors, our chief executive officer, our president, or a majority of the board of directors are authorized to call a special meeting of stockholders; |
• | no provision in our Organizational Documents provides for cumulative voting, which limits the ability of minority stockholders to elect director candidates; |
• | certain amendments to our Certificate of Incorporation requires the approval of two-thirds of the then outstanding voting power of our capital stock; |
• | our Bylaws provide that the affirmative vote of two-thirds of the then-outstanding voting power of our capital stock, voting as a single class, is required for stockholders to amend or adopt any provision of our Bylaws; |
• | our Certificate of Incorporation authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued, without the approval of the holders of our capital stock; and |
• | certain litigation against us can only be brought in Delaware. |
• | the business combination or transaction which resulted in the stockholder becoming an interested stockholder was approved by the board of directors prior to the time that the stockholder became an interested stockholder; |
• | upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by directors who are also officers of the corporation and shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or |
• | at or subsequent to the time the stockholder became an interested stockholder, the business combination was approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder. |
• | any breach of the director’s duty of loyalty to the corporation or its stockholders; |
• | any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | unlawful payments of dividends or unlawful stock repurchases or redemptions; or |
• | any transaction from which the director derived an improper personal benefit. |
• | be required to have only two years of audited financial statements and only two years of related selected financial data and Management’s Discussion and Analysis of Financial Condition and Results of Operations disclosure; |
• | be exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that its independent registered public accounting firm provide an attestation report on the effectiveness of its internal control over financial reporting; |
• | be exempt from the “say on pay” and “say on golden parachute” advisory vote requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”); and |
• | be exempt from certain disclosure requirements of the Dodd-Frank Act relating to compensation of its executive officers and be permitted to omit the detailed compensation discussion and analysis from proxy statements and reports filed under the Exchange Act; |
• | our employees may experience uncertainty about their future roles, which might adversely affect our ability to retain and hire key personnel and other employees; |
• | customers, suppliers, business partners and other parties with which we maintain business relationships may experience uncertainty about our future and seek alternative relationships with third parties, seek to alter their business relationships with us or fail to extend an existing relationship with us; and |
• | we have expended and will continue to expend significant costs, fees and expenses for professional services and transaction costs in connection with the Business Combination. |
• | The reverse recapitalization of Hippo Enterprises Inc. (“Old Hippo”), referred to herein as the “Business Combination,” and the issuance of Hippo Holdings common stock in the PIPE Investment; |
• | The acquisition of Spinnaker Insurance Company (“Spinnaker”) by Hippo on August 31, 2020 (“Spinnaker Transaction”) |
• | the accompanying Notes to the unaudited pro forma condensed combined financial statements; |
• | the historical unaudited financial statements of RTPZ as of and for the six months ended June 30, 2021 included in RTPZ’s Quarterly Report on Form 10-Q filed with the SEC on August 16, 2021 incorporated herein by reference and the historical audited financial statements of RTPZ as of the year ended December 31, 2020 and for the period from October 2, 2020 (inception) through December 31, on Form10-K/A filed with the SEC on May 11, 2021 incorporated herein by reference; |
• | the historical unaudited condensed consolidated financial statements of Old Hippo as of and for the six months ended June 30, 2021 and the historical audited consolidated financial statements of Old Hippo as of and for the year ended December 31, 2020, which are included as exhibits to this prospectus; |
• | the historical audited financial statements of Spinnaker, as of, and for the year ended, December 31, 2019, included in this prospectus incorporated herein by reference; |
• | the historical unaudited financial information of Spinnaker, as of, and for the period ended, June 30, 2020, included in this prospectus incorporated herein by reference; and |
• | other information relating to RTPZ and Old Hippo included in this prospectus incorporated herein by reference, including the Merger Agreement and the description of certain terms thereof set forth under the section titled “The Business Combination”. |
As of June 30, 2021 | As of June 30, 2021 | |||||||||||||||||||
Hippo (Historical) | RTPZ (Historical) | Pro Forma Transaction Accounting Adjustments | Pro Forma Combined | |||||||||||||||||
Assets | ||||||||||||||||||||
Investments: | ||||||||||||||||||||
Fixed maturities available-for-sale, | $ | 56.6 | $ | — | $ | — | $ | 56.6 | ||||||||||||
Total Investments | 56.6 | — | — | 56.6 | ||||||||||||||||
Cash and cash equivalents | 364.1 | 0.1 | 230.0 | 6(a) | 819.5 | |||||||||||||||
(1.4 | ) | 6(b) | ||||||||||||||||||
(8.1 | ) | 6(d) | ||||||||||||||||||
550.0 | 6(e) | |||||||||||||||||||
(27.6 | ) | 6(f) | ||||||||||||||||||
(95.0 | ) | 6(j) | ||||||||||||||||||
(192.6 | ) | 6(k) | ||||||||||||||||||
Restricted cash | 46.1 | — | 46.1 | |||||||||||||||||
Accounts receivable, net | 54.0 | — | 54.0 | |||||||||||||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 242.8 | — | 242.8 | |||||||||||||||||
Deferred policy acquisition costs | — | — | — | |||||||||||||||||
Ceding commissions receivable | 34.2 | — | 34.2 | |||||||||||||||||
Prepaid reinsurance premiums | 195.3 | — | 195.3 | |||||||||||||||||
Prepaid expenses | — | 0.8 | (0.6 | ) | 6(f) | 0.2 | ||||||||||||||
Investments and cash held in Trust Account | — | 230.0 | (230.0 | ) | 6(a) | — | ||||||||||||||
Property and equipment | — | — | — | |||||||||||||||||
Capitalized internal use software, net | 18.7 | — | 18.7 | |||||||||||||||||
Goodwill | 48.2 | — | 48.2 | |||||||||||||||||
Intangible assets, net | 34.6 | — | 34.6 | |||||||||||||||||
Other assets | 27.2 | — | (5.2 | ) | 6(f) | 22.0 | ||||||||||||||
Total Assets | $ | 1,121.8 | $ | 230.9 | $ | 219.5 | $ | 1,572.2 | ||||||||||||
Liabilities, convertible preferred stock, and stockholders’ equity (deficit) | ||||||||||||||||||||
Liabilities | ||||||||||||||||||||
Loss and loss adjustment expense reserve | 195.2 | — | 195.2 | |||||||||||||||||
Unearned premiums | 216.5 | — | 216.5 | |||||||||||||||||
Reinsurance premiums payable | 137.0 | — | 137.0 | |||||||||||||||||
Provision for commission | 13.0 | — | 13.0 | |||||||||||||||||
Fiduciary liabilities | 28.2 | — | 28.2 | |||||||||||||||||
Convertible promissory notes | 299.0 | — | (299.0 | ) | 6(c) | — | ||||||||||||||
Derivative liability on notes | 162.6 | — | (162.6 | ) | 6(c) | — | ||||||||||||||
Contingent consideration liability | 11.6 | — | 11.6 | |||||||||||||||||
Preferred stock warrant liabilities | 137.5 | — | (137.5 | ) | 6(g) | — | ||||||||||||||
Due to related party | — | 0.3 | (0.3 | ) | 6(b) | — | ||||||||||||||
Deferred legal fees | — | 0.2 | (0.2 | ) | 6(b) | — | ||||||||||||||
Deferred underwriting comissions | — | 8.1 | (8.1 | ) | 6(d) | — | ||||||||||||||
Accrued expenses and other current liabilities | 46.0 | 0.9 | (0.9 | ) | 6(b) | 44.0 | ||||||||||||||
(0.9 | ) | 6(c) | ||||||||||||||||||
(1.1 | ) | 6(f) | ||||||||||||||||||
Derivative warrant liabilities | — | 16.6 | — | 16.6 | ||||||||||||||||
Total liabilities | 1,246.6 | 26.1 | (610.6 | ) | 662.1 |
Commitments and Contingencies | ||||||||||||||||||||
Class A ordinary shares, subject to possible redemption | — | 199.8 | (199.8 | ) | 6(h) | — | ||||||||||||||
Preferred stock | 344.8 | — | (344.8 | ) | 6(i) | — | ||||||||||||||
Stockholders’ equity (deficit) | ||||||||||||||||||||
Class A ordinary shares | — | — | — | 6(i) | — | |||||||||||||||
Class B ordinary shares | — | — | — | 6(i) | — | |||||||||||||||
Hippo common stock | — | — | — | 6(i) | — | |||||||||||||||
Hippo Holdings common stock | — | 6(c) | — | |||||||||||||||||
— | 6(e) | |||||||||||||||||||
— | 6(g) | |||||||||||||||||||
— | 6(i) | |||||||||||||||||||
Additional paid-in capital | 65.8 | 11.6 | 199.8 | 6(h) | 1,445.5 | |||||||||||||||
344.8 | 6(i) | |||||||||||||||||||
462.5 | 6(c) | |||||||||||||||||||
137.5 | 6(g) | |||||||||||||||||||
(14.4 | ) | 6(i) | ||||||||||||||||||
550.0 | 6(e) | |||||||||||||||||||
(24.5 | ) | 6(f) | ||||||||||||||||||
(95.0 | ) | 6(j) | ||||||||||||||||||
(192.6 | ) | 6(k) | ||||||||||||||||||
Accumulated other comprehensive income | (0.3 | ) | — | — | 6(c) | (0.3 | ) | |||||||||||||
Accumulated deficit | (536.4 | ) | (6.6 | ) | 14.4 | 6(i) | (536.4 | ) | ||||||||||||
(7.8 | ) | 6(f) | ||||||||||||||||||
Total stockholders’ equity (deficit) | (470.9 | ) | 5.0 | 1,374.7 | 908.8 | |||||||||||||||
Noncontrolling interest | 1.3 | — | — | 1.3 | ||||||||||||||||
Total stockholders’ equity (deficit) | (469.6 | ) | 5.0 | 1,374.7 | 910.1 | |||||||||||||||
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit) | $ | 1,121.8 | $ | 230.9 | $ | 219.5 | $ | 1,572.2 | ||||||||||||
For the Six Months Ended June 30, 2021 | For the Six Months Ended June 30, 2021 | |||||||||||||||||||
Hippo (Historical) | RTPZ (Historical) | Pro Forma Transactions Accounting Adjustment | Pro Forma Combined | |||||||||||||||||
Revenue: | ||||||||||||||||||||
Net earned premium | $ | 19.0 | $ | — | $ | — | $ | 19.0 | ||||||||||||
Commission income, net | 11.6 | — | — | 11.6 | ||||||||||||||||
Service and fee income | 7.1 | — | — | 7.1 | ||||||||||||||||
Net investment income | 0.2 | — | — | 0.2 | ||||||||||||||||
Net realized capital gain on investments | — | — | — | — | ||||||||||||||||
Other income | — | — | — | — | ||||||||||||||||
Total revenue | 37.9 | — | — | 37.9 | ||||||||||||||||
Expenses: | ||||||||||||||||||||
Losses and loss adjustment expenses | 38.7 | — | — | 38.7 | ||||||||||||||||
Insurance related expenses | 16.0 | — | — | 16.0 | ||||||||||||||||
Technology and development | 14.5 | — | — | 14.5 | ||||||||||||||||
Sales and marketing | 46.9 | — | — | 46.9 | ||||||||||||||||
General and administrative | 17.1 | 2.0 | (1.7 | ) | 7(bb) | 17.4 | ||||||||||||||
Interest and other expense | 183.1 | — | (183.0 | ) | 7(aa) | 0.1 | ||||||||||||||
Commission Expense | — | — | — | — | ||||||||||||||||
Total expenses | 316.3 | 2.0 | (184.7 | ) | 133.6 | |||||||||||||||
Income (loss) from operations | (278.4 | ) | (2.0 | ) | 184.7 | (95.7 | ) | |||||||||||||
Other income (expense) | ||||||||||||||||||||
Unrealized gain on investment held in Trust Account | — | — | — | — | ||||||||||||||||
Change in fair value of derivative warrant liabilities | — | (3.1 | ) | — | (3.1 | ) | ||||||||||||||
Total other income (expense) | — | (3.1 | ) | — | (3.1 | ) | ||||||||||||||
Income (loss) before income taxes | (278.4 | ) | (5.1 | ) | 184.7 | (98.8 | ) | |||||||||||||
Income taxes (benefit) expense | 0.3 | — | — | 0.3 | ||||||||||||||||
Net income (loss) | (278.7 | ) | (5.1 | ) | 184.7 | (99.1 | ) | |||||||||||||
Net income (loss) attributable to noncontrolling interests, net of tax | 1.1 | — | — | 1.1 | ||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (279.8) | $ | (5.1) | $ | 184.7 | $ | (100.2) | ||||||||||||
Weighted-average shares used in computing net loss per share attributable to Hippo — basic and diluted | 13,968,160 | |||||||||||||||||||
Net loss per share attributable to Hippo — basic and diluted | $ | (20.03 | ) | |||||||||||||||||
Weighted average shares outstanding — Class A ordinary shares | 23,000,000 | |||||||||||||||||||
Class A ordinary shares — basic and diluted | $ | — | ||||||||||||||||||
Weighted average shares outstanding — Class B ordinary shares | 5,750,000 | |||||||||||||||||||
Class B ordinary shares — basic and diluted | $ | (0.89 | ) | |||||||||||||||||
Weighted average shares outstanding — Hippo Holdings Common stock | 559,731,226 | |||||||||||||||||||
Hippo Holdings common stock — basic and diluted | $ | (0.18 | ) |
For the Year Ended December 31, 2020 | For the period from January 1, 2020 to August 31, 2020 | For the period from inception October 2, 2020 (date of inception) to December 31, 2020 | For the Year ended December 31, 2020 | |||||||||||||||||||||||||||||||||||||
Hippo (Historical) | Spinnaker (Historical) | Spinnaker PPA Transaction Accounting Adjustments | Hippo and Spinnaker Combined (Historical) | RTPZ (Historical) | Pro Forma Transactions Accounting Adjustment | Pro Forma Combined | ||||||||||||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||||||||||||||||
Net earned premium | $ | 17.1 | $ | 5.6 | $ | — | $ | 22.7 | $ | — | $ | — | $ | 22.7 | ||||||||||||||||||||||||||
Commission income, net | 27.1 | — | (7.8 | ) | 7(aa) | 19.3 | — | — | 19.3 | |||||||||||||||||||||||||||||||
Service and fee income | 6.3 | — | — | 6.3 | — | — | 6.3 | |||||||||||||||||||||||||||||||||
Net investment income | 1.1 | 0.7 | — | 1.8 | — | — | 1.8 | |||||||||||||||||||||||||||||||||
Total revenue | 51.6 | 6.3 | (7.8 | ) | 50.1 | — | — | 50.1 | ||||||||||||||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||||||||||||||||
Losses and loss adjustment expenses | 25.3 | 5.0 | (0.9 | ) | 7(aa) | 29.4 | — | — | 29.4 | |||||||||||||||||||||||||||||||
Insurance related expenses | 19.3 | — | (0.5 | ) | 7(aa) | 18.8 | — | — | 18.8 | |||||||||||||||||||||||||||||||
Technology and development | 18.0 | — | 0.4 | 7(bb) | 18.4 | — | — | 18.4 | ||||||||||||||||||||||||||||||||
Sales and marketing | 69.4 | — | (14.6 | ) | 7(aa) | 54.8 | — | — | 54.8 | |||||||||||||||||||||||||||||||
General and administrative | 36.8 | 7.4 | — | 44.2 | 0.3 | 8.9 | 7(ee) | 53.4 | ||||||||||||||||||||||||||||||||
Interest and other expense | 26.0 | — | — | 26.0 | — | (25.8 | ) | 7(cc) | 0.2 | |||||||||||||||||||||||||||||||
Commission Expense | — | (11.3 | ) | 11.3 | 7(aa) | — | — | — | — | |||||||||||||||||||||||||||||||
Total expenses | 194.8 | 1.1 | (4.3 | ) | 191.6 | 0.3 | (16.9 | ) | 175.0 | |||||||||||||||||||||||||||||||
Income (loss) from operations | (143.2 | ) | 5.2 | (3.5 | ) | (141.5 | ) | (0.3 | ) | 16.9 | (124.9 | ) | ||||||||||||||||||||||||||||
Other income (expense) | ||||||||||||||||||||||||||||||||||||||||
Financing costs — derivative warrant liabilities | — | — | — | — | (0.4 | ) | (0.7 | ) | 7(ff) | (1.1 | ) | |||||||||||||||||||||||||||||
Change in fair value of derivative warrant liabilities | — | — | — | — | (0.8 | ) | — | (0.8 | ) | |||||||||||||||||||||||||||||||
Total other income (expense) | — | — | — | — | (1.2 | ) | (0.7 | ) | (1.9 | ) | ||||||||||||||||||||||||||||||
Income (loss) before income taxes | (143.2 | ) | 5.2 | (3.5 | ) | (141.5 | ) | (1.5 | ) | 16.2 | (126.8 | ) | ||||||||||||||||||||||||||||
Income taxes (benefit) expense | (1.8 | ) | 1.1 | (1.1 | ) | 7(dd) | (1.8 | ) | — | 7(dd) | — | 7(dd) | (1.8 | ) | ||||||||||||||||||||||||||
Net income (loss) | (141.4 | ) | 4.1 | (2.4 | ) | (139.7 | ) | (1.5 | ) | 16.2 | (125.0 | ) | ||||||||||||||||||||||||||||
Net income (loss) attributable to noncontrolling interests, net of tax | 0.1 | — | — | 0.1 | — | — | 0.1 | |||||||||||||||||||||||||||||||||
Net income (loss) attributable to common stockholders | $ | (141.5 | ) | $ | 4.1 | $ | (2.4 | ) | $ | (139.8 | ) | $ | (1.5 | ) | $ | 16.2 | $ | (125.1 | ) | |||||||||||||||||||||
Weighted-average shares used in computing net loss per share attributable to Hippo — basic and diluted | 12,495,509 | |||||||||||||||||||||||||||||||||||||||
Net loss per share attributable to Hippo — basic and diluted | $ | (11.32 | ) | |||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding — Class A ordinary shares | 23,000,000 | |||||||||||||||||||||||||||||||||||||||
Class A ordinary shares — basic and diluted | $ | — | ||||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding — Class B ordinary shares | 5,750,000 | |||||||||||||||||||||||||||||||||||||||
Class B ordinary shares — basic and diluted | $ | (0.26 | ) | |||||||||||||||||||||||||||||||||||||
Weighted average shares outstanding — Hippo | 559,731,226 | |||||||||||||||||||||||||||||||||||||||
Holdings Common stock | ||||||||||||||||||||||||||||||||||||||||
Hippo Holdings common stock — basic and diluted | $ | (0.22 | ) |
• | the issued and outstanding shares of Old Hippo preferred stock was canceled and converted into shares of Old Hippo common stock at the then-effective conversion rate as calculated pursuant to Hippo’s Amended and Restated Certificate of Incorporation; |
• | the Old Hippo warrants were exercised in full on a cash or cashless basis or terminated without exercise, as applicable, in accordance with their respective terms; |
• | the Old Hippo notes were automatically converted into shares of Old Hippo common stock in accordance with their respective terms; |
• | the issued and outstanding share of Old Hippo common stock (including the Old Hippo common stock referred to in the above points) as of immediately prior to the Effective Time, was canceled in exchange for the right to receive a number of shares of Hippo Holdings common stock equal to the Exchange Ratio; and |
• | the outstanding vested and unvested Old Hippo options as of immediately prior to the Effective Time, was converted into Hippo Holdings options with the same terms except for the number of shares exercisable and the exercise price, each of which was adjusted using the Exchange Ratio. |
• | Pursuant to the terms of the Sponsor Agreement, the Sponsor subjected the 5,630,000 Sponsor Shares to the following (a) price-based vesting terms over a ten-year period following the Closing and(b) lock-ups. |
• | Tranche 1 |
• | Price-Based Vesting Trigger |
• | Lockup |
• | Tranche 2 |
• | Price-Based Vesting Trigger |
• | Lockup |
• | Tranche 3 |
• | Price-Based Vesting Trigger |
• | Lockup |
• | Tranche 4 |
• | Price-Based Vesting Trigger |
• | Lockup |
• | After ten years, any Sponsor Shares that have not yet met the applicable price-based vesting trigger shall automatically vest. |
• | If, after Closing, Hippo Holdings completes a transaction that results in a change of control, the Sponsor Shares are released from the vesting and lock-up restrictions immediately prior to such change of control. As RTPZ legally owns the shares and is subject only to transfer restrictions that lapse upon the earlier of (1) meeting one or more specific conditions described above or (2) a stated date, such Sponsor Shares are considered to be outstanding shares of stock. |
• | Pursuant to the terms of the Sponsor Agreement, the Sponsor agreed, in addition to the existing exercise provisions in the Warrant Agreement, to the mandatory exercise of the private placement warrants if, during the exercise period, (a) Hippo Holdings elects to redeem the public warrants, (b) the last reported sales price of Hippo Holdings common stock for any 20 trading days within a period of 30 consecutive trading days exceeds $25.00 per share, and (c) there is an effective registration statement covering the issuance of shares of Hippo Holdings common stock issuable upon exercise of the private placement warrants, and a current prospectus relating thereto, available at the time of such exercise. |
• | Following the Closing, Hippo Holdings used $95,000,000 to acquire 9,500,000 shares of Hippo Holdings common stock from certain stockholders of Old Hippo prior to the Business Combination. |
Shares (4) | % Ownership | |||||||
Hippo stockholders (1) (2) | 547,974,660 | 89.5 | % | |||||
PIPE Investors — Existing Hippo stockholders | 9,900,000 | 1.6 | % | |||||
PIPE Investors (3)(5) | 45,100,000 | 7.4 | % | |||||
Class A ordinary shares | 3,738,620 | 0.6 | % | |||||
Class B ordinary shares (5) | 5,750,000 | 0.9 | % | |||||
Pro Forma common stock at the Closing | 612,463,280 | 100 | % | |||||
(1) | Includes approximately 52.7 million shares of Old Hippo common stock underlying rollover options that do not represent legally outstanding shares of Old Hippo common stock at the Closing. |
(2) | Includes redemption by Old Hippo of 9.5 million shares whereby, at the Closing, Hippo Holdings used $95.0 million to repurchase 9.5 million shares of Hippo Holdings common stock from certain stockholders of Old Hippo. |
(3) | Includes $10.0 million of investment from Reinvent Capital Fund and remaining $441.0 million from Third Party PIPE investors. |
(4) | Excludes the outstanding RTPZ warrants issued in connection with its initial public offering as such securities are not exercisable until 30 days after the Closing. |
(5) | Through the Class B ordinary shares, the Sponsor and its related entities owned 1.027% of Hippo Holdings common stock outstanding immediately following the Closing. |
Hippo Common Stock outstanding prior to the Closing | 15,940,879 | |||
Exchange Ratio | 6.95433 | |||
110,858,175 | ||||
Less: Redemption of Hippo Holdings common stock immediately after the Closing | (9,500,000 | ) | ||
101,358,175 | ||||
Hippo convertible preferred stock outstanding prior to the Closing | 43,985,178 | |||
Exchange Ratio | 6.95433 | |||
305,887,553 | ||||
Hippo convertible promissory note (including accrued interest) outstanding prior to the Closing | 6,247,807 | |||
Exchange Ratio | 6.95433 | |||
43,449,329 | ||||
Hippo’s common and preferred warrants which converted prior to the Closing | 6,405,726 | |||
Exchange Ratio | 6.95433 | |||
44,547,549 | ||||
Shares of RTPZ Common Stock issued to Hippo Stockholders upon the Closing | 495,242,606 | |||
Rollover of Hippo’s options to Hippo Holding’s options | 7,582,619 | |||
Exchange Ratio | 6.95433 | |||
52,732,054 | ||||
Total Aggregate Merger Consideration, including rollover options | 547,974,660 | |||
(a) | Reflects the release of $230.0 million of investments held in the trust account that become available upon the Closing. |
(b) | Reflects the settlement of RTPZ’s historical liabilities that were settled upon the Closing. |
(c) | Reflects the automatic conversion of Hippo notes into shares of Hippo common stock as per the original terms of the Hippo notes, and subsequent conversion into Hippo Holdings common stock. Upon the conversion, the carrying value of the debt of $299.0 million, including unamortized debt discount, accrued interest of $0.9 million recorded in accrued liability, and the related derivative liability of $162.6 million were derecognized. The Hippo Holdings shares issued in exchange for the Hippo notes were recorded at fair value to Hippo Holdings common stock in amount of $0 and additional paid in capital in amount of $462.5 million. |
(d) | Reflects the payment of approximately $8.1 million of deferred underwriters’ fees incurred during RTPZ’s initial public offering and due upon the Closing. |
(e) | Reflects the proceeds of $550.0 million from the issuance and sale of 55.0 million shares of Hippo Holdings common stock at $10.00 per share pursuant to the Subscription Agreements entered into with the PIPE Investors in connection with the PIPE Investment. |
(f) | Reflects recording of Old Hippo’s transaction costs of $25.2 million. These expected transaction costs are in connection with the Closing and related transactions and are deemed to be direct and incremental costs of the Business Combination, $24.5 million of which have been allocable to common stock issued and recorded as a reduction to additional paid-in capital and the remaining $0.7 million allocable to issued warrants classified as liabilities have been charged to the unaudited pro forma condensed combined statement of operations. Necessary adjustments have been made to other assets for deferred offering cost of $5.2 million, accrued liabilities for $1.1 million for unpaid Old Hippo transaction costs, and cash and cash equivalents for $21.1 million for Old Hippo’s transaction costs. In addition, an adjustment of $7.1 million has been made to accumulated deficit with an offset to cash and cash equivalents and prepaid expenses to reflect RTPZ’s transaction costs in the nature of advisory, legal, accounting and auditing fees and other professional fees pertaining to the Business Combination and related transactions. |
(g) | Reflects the reclassification of Old Hippo’s convertible preferred stock warrant liability to additional paid in capital as a result of Old Hippo warrants being converted into Hippo Holdings common stock. |
(h) | Reflects the reclassification of Class A ordinary shares of $199.8 million to permanent equity immediately prior to the Closing. |
(i) | Reflects the recapitalization of Old Hippo through the contribution of all outstanding Old Hippo common stock and Old Hippo preferred stock to RTPZ and the issuance of 494.7 million shares of Hippo Holdings common stock and the elimination of the accumulated deficit of RTPZ, the accounting acquiree. As a result of the recapitalization, the carrying value of Old Hippo’s convertible preferred stock of $344.8 million, common stock of $0, and RTPZ’s accumulated deficit of $14.4 million were derecognized. The shares of Hippo Holdings common stock issued in exchange for Old Hippo’s capital were recorded to Hippo Holdings common stock in the amount of $0 and additional paid in capital in amount of $344.8 million. The Transaction Accounting Adjustment also includes conversion of outstanding RTPZ Class A and Class B ordinary shares into Hippo Holdings common stock concurrent with the Closing. |
(j) | Reflects the redemption of Hippo Holdings common stock amounting to $95.0 million at $10.00 per share, following the Closing. |
(k) | Reflects the cash disbursed to redeem 19.3 million Class A ordinary shares for $192.6 million allocated to Hippo Holdings common stock and APIC, using a par value of $0.0001 per share at a redemption price of approximately $10.00 per share. |
(aa) | Reflects reversal of $68.4 million interest expense and change in fair value of embedded derivative pertaining to convertible promissory notes. The adjustment also reflects reversal of $114.6 million for changes in fair value of Old Hippo warrants to purchase Old Hippo preferred stock. |
(bb) | Reflects reversal of $1.7 million of RTPZ’s transaction costs that were recorded during the six months ended June 30, 2021 as such costs pertain to the Business Combination. These costs have been shown as a proforma adjustment within the unaudited pro forma condensed combined statement of operations for the year ended December 31,2020. |
(aa) | Reflects adjustment to eliminate pre-existing relationship and fair value between Spinnaker and Old Hippo and fair value adjustments as described below: |
(bb) | Reflects incremental expense pertaining to amortization of intangibles (including value of business acquired) amounting to $0.4 million. |
(cc) | Reflects reversal of $9.6 million interest expense and change in fair value of embedded derivative pertaining to convertible promissory notes. The Transaction Accounting Adjustment also includes reversal of $16.2 million for changes in fair value of Old Hippo warrants to purchase Old Hippo preferred stock. |
(dd) | The unaudited pro forma condensed combined statement of operations of Old Hippo for the year ended December 31, 2020 takes into consideration if recognition of deferred tax assets is appropriate when realization of these assets is more likely than not. Based upon weight of all available evidence, with primary focus on the Old Hippo’s history of recent losses, Old Hippo has concluded that it is not more likely than not that the recorded deferred tax assets will be realized. As a result, the tax effect of the Transactions is recorded at no tax expense or benefit to Old Hippo. The pro forma combined provision for income taxes does not necessarily reflect the amounts that would have resulted had RTPZ and Old Hippo filed consolidated income tax returns during the period presented. |
(ee) | Reflects RTPZ’s transaction cost of $8.9 million as part of the Business Combination and related transactions. |
(ff) | Reflects the transaction costs allocable to RTPZ liability classified warrants. Refer to Note 2 for further details. |
(in millions, except share and per share data) | For the Six Months Ended June 30, 2021 | For the Year Ended December 31, 2020 | ||||||
Pro forma net loss | $ | (100.2 | ) | $ | (125.1 | ) | ||
Weighted average shares outstanding of Hippo Holdings common stock | 559,731,226 | 559,731,226 | ||||||
Net loss per share (Basic and Diluted) attributable to Hippo Holdings common stockholders | $ | (0.18 | ) | $ | (0.22 | ) | ||
Weighted average shares outstanding — basic and diluted | ||||||||
Former Hippo stockholders | 495,242,606 | 495,242,606 | ||||||
RTPZ Class A stockholders | 3,738,620 | 3,738,620 | ||||||
RTPZ Class B stockholders | 5,750,000 | 5,750,000 | ||||||
PIPE Transaction | 55,000,000 | 55,000,000 | ||||||
Total | 559,731,226 | 559,731,226 | ||||||
For the Six Months Ended June 30, 2021 | For the Year Ended December 31, 2020 | |||||||
Hippo Holdings Stock Options | 52,732,054 | 52,732,054 | ||||||
Hippo Holdings Common stock subject to repurchase | 12,003,665 | 12,003,665 | ||||||
RTPZ — public and private placement warrants | 9,000,000 | 9,000,000 |
• | Equally weigh Insurance and Technology: Insurance Technology. |
• | Be thorough, don’t seek silver bullets: |
• | Grow from success as well as failure: |
• | Embrace regulation: |
• | The best claims experience is the one that never happens. |
• | Add real value and deliver on our promise to customers: |
expectations with a white glove approach that leverages humans for empathy and technology for ease, efficiency, and accuracy. In addition, our coverages have been crafted around their value to the customer, not only on their profitability to us. |
• | We make Hippo policies fast and easy to buy. |
• | Our policies are designed for the modern homeowner. |
• | We have designed a proactive, human approach to claims, enabled by technology. |
• | We have pioneered what we believe is the most widely adopted Smart Home program in the industry. |
• | We proactively help our customers maintain and protect their homes. |
(1) | Spinnaker and North American Advantage Insurance Services LLC (“NAAIS”) are presented on a pro forma basis as of January 1, 2018. For more information please see “ Recent Acquisition: Spinnaker Insurance Company |
(2) | Frequency defined as number of claims divided by the total number of units of exposure, where a unit of exposure is defined as one policy year earned. For example, one policy in force written 24 months ago, represents 2x units of exposure. The cohorts are 12-month cohorts starting on 8/1 of each calendar year. |
• | Significant initial capital requirements to support insurance risk, challenges finding cost-effective reinsurance without an underwriting track record, expensive off-the-shelf |
• | Complicated and fragmented regulatory landscape with a unique set of rules from each state |
• | Significant resource investment in tech and infrastructure to access, collect and validate insurance-related data, in addition to the development of multiple customized APIs |
• | Difficulty accessing distribution networks, built upon a legacy, agent-based distribution, or resource-intensive process of creating and scaling new, alternative customer acquisition channels |
• | We made insurance easy to buy: |
• | We designed our policies for the modern homeowner: |
• | We crafted a proactive, tech-enabled claims experience, focused on a live, white-glove approach: |
• | Proactive technology-enabled approach : We aspire to be there for our customers as soon as the need arises, if possible before they even reach out to us for support. We use live data to help identify major events like fires or storms. When we suspect that our customers’ home may be impacted, our Claims Concierge team reaches out proactively to help ensure the safety of our customer, their families and their homes. We firmly believe in prioritizing the well-being of our customers and addressing damage to the home quickly, hopefully before things deteriorate or repair costs escalate. If we are effective, customers benefit from superior service in resolving claims, and we gain from better insurance outcomes by mitigating costs and increased customer loyalty. |
• | Human attention from live Claims Concierges : We believe that a customer calling about damage to their home, often a very complicated and stressful situation, needs to speak to a human who can be relied upon for help. Our Claims Concierge team eliminates the often inefficient use of bots or automation, as well as other burdensome processes. Our claims professionals are experienced in both claims handling and customer service. Once a claim is submitted, a Claims Concierge is assigned to the claim and focuses first on ensuring customer safety and alleviating stress. We seek to have the same Claims Concierge remain the key point of contact for the customer throughout the life of the claim. Hippo uniquely measures customer satisfaction, or Claims NPS, specifically for our claims operations. Our claims team is able to achieve a90-day Claims NPS of 60, according to our survey (compared to an average Claims NPS of negative 49 for typical carriers using the same survey methodology, according to a 2014 Morgan Stanley Research and Boston Consulting Group report), in spite of the complicated nature of a home insurance claim. |
• | We employ continuous risk reevaluation and underwriting: |
• | We deploy what we believe is the most widely adopted Smart Home program in the U.S. home insurance space: |
• | We help customers maintain their homes: in-home services. Moreover, Hippo Home Care has been building a proactive home maintenance offering: homeowners can sign up for annual checkups by home professionals that inspect key systems around the home and perform routine maintenance tasks. Hippo Home Care has delivered thousands of checkups to date and performed over 11,000 preventive actions in customers’ homes. |
• | Direct to consumer: |
• | Insurance partners (agents / producers): producer portal direct-to-consumer |
• | Non-insurance partners: |
• | Home builders — we developed an insurance policy for new home construction, as well as a technology product that integrates with builders’ sales systems. These integrations allow us to provide the builder’s customers a simple, personalized insurance offer precisely when their customers are in the market for a policy. These policies are heavily tailored to the customer’s property and can be easily purchased online or through our partner agency. Through these partnerships we are able to access positively selected customers with a fundamentally better risk profile than those associated with existing homes. The result is a potentially smoother home purchase experience and higher customer satisfaction for our builder partners. |
• | Smart home providers — we have been developing proprietary integration with the leading providers of smart home and security systems to offer their customers better home insurance coverage with meaningful premium discounts. Moreover, these benefits are also available to our partners’ customers if they purchase insurance from Hippo. |
• | Offering a fast and accurate online purchase flow that meets modern consumers’ expectations |
• | Integrating smart home activation status into our policy management system |
• | Quickly deploying rate changes in any state or region upon regulatory approval |
• | Creating sophisticated feedback loops between internal teams to ensure cross-pollination (for example, fast underwriting improvements based on claims insights) |
• | Developing proprietary, channel-specific technology to integrate Hippo’s offerings into partners’ platforms and streamlining their go-to-market |
• | Approximately 70% of eligible customers opt into the program |
• | Approximately 70% of the customers opting into the program activate their kits |
• | Customers who keep their kits active receive meaningful premium discounts |
• | Rapid growth across diverse channels. |
• | Risk prevention and proactive home protection. |
• | Better experiences throughout the customer journey. |
• | Our agile development teams are able to design, deliver and iterate to build product features our customers and partners desire. We have built a flexible and adaptable software architecture and |
engineering teams to effectively innovate and implement new ideas. This is combined with an agile iterative approach to experimentation and analytics, working to make sure that we continuously improve our knowledge of what customers want. |
• | Our underlying software architecture and platform are designed to support future expansion and growth. We are creating data models, algorithms, learning engines, knowledge graphs and cloud platforms that are all intended to support a future set of goals — more ambitious partnerships, wider distribution channels, scaled number of customers. By anticipating future growth with a blueprint of technology capabilities and technical platforms in advance, we are proactively preparing for the next step-change in our company’s growth trajectory. |
• | We are keeping the pace of innovation high by investing in research and development of underlying technologies and capabilities that seek to change how the market operates in protecting homeowners. We launch tests with partners, look at new and proprietary data sources, offer additional virtual and in-home services, expand the boundaries of expectations on preventative measures, and try out new techniques for customer support and service. All of these are part of our innovation culture and supported by the technology infrastructure to build / experiment / measure / iterate. |
• | We write and place home insurance and other insurance products from our agencies that have so far been largely unaffected by COVID-19. |
• | Our systems are entirely cloud based and accessible to our teams from any browser anywhere in the world. Customers’ phone calls are routed to our team’s laptops and answered and logged from wherever they happen to be. Internal communication has been via email, Slack and Zoom since our founding. Our teams are able to access systems, support customers and collaborate with each other from anywhere, much as they did before the pandemic. |
• | Our customers’ experience has also been largely unaffected by the turmoil; |
• | We have initiated virtual inspections for our underwriting requirements and claims processing to keep our employees, agents, policy holders and potential policy holders safe. |
• | Our growth strategy is centered around accelerating our existing position in markets that we already serve by increasing our direct-to-consumer |
• | In addition to efforts in states where we are currently selling insurance, we also expect to drive growth by expanding into new markets across the United States and by continuing to develop new strategic partnerships with key players involved in the real estate transaction ecosystem. |
• | Finally, we plan to deepen our relationships with our customers by offering value-added services, both directly and through partners, that are not specifically insurance products like home maintenance, home monitoring, and home appliance warranties. |
1. | MGA |
2. | Agency |
3. | Insurance as a Service |
4. | Risk Retention |
1. | Substantive: We are retaining more risk on our balance sheet and accordingly both our net earned premium and our Loss and Loss Adjustment Expenses are expected to be higher. |
2. | Financial presentation: The direct acquisition costs associated with the premium written on our carrier will shift from sales and marketing to insurance related expense and will be offset by the corresponding ceding commission and amortized over the lifetime of the policy. Only the excess of ceding commission over our direct acquisition costs will be recognized as revenue. All else being equal, for the exact same amount of premium we expect: |
a. | our ceding commission will be lower |
b. | our sales and marketing expense will be lower |
c. | our bottom line results will be unchanged |
• | Premium for the risk retained by us is recognized on a pro-rata basis over the policy period. |
• | Ceding commission on premium ceded to third party reinsurers is deferred as a liability and recognized on a pro-rata basis over the term of the policy, net of acquisition costs. To the extent ceding commission received exceeds direct acquisition costs, the excess is presented as revenue in the Commission income, Net line on our statements of operations and comprehensive loss. The consolidated company (Hippo and Spinnaker) began to earn ceding commission on premium ceded to third party reinsurers in September 2020 and the ceding commission is recognized net of acquisition costs, on apro-rata basis over the term of the policy. |
Six Months Ended June 30, | Year Ended December 31 | |||||||||||||||
2021 | 2020 | 2020 (1) | 2019 | |||||||||||||
($ in millions) | ||||||||||||||||
Total Generated Premium | $ | 281.9 | $ | 144.4 | $ | 333.6 | $ | 196.3 | ||||||||
Total Revenue | 37.9 | 22.2 | 51.6 | 34.7 | ||||||||||||
Net Loss attributable to Hippo | (279.8 | ) | (48.7 | ) | (141.5 | ) | (83.1 | ) | ||||||||
Adjusted EBITDA | (78.0 | ) | (40.4 | ) | (89.9 | ) | (56.5 | ) | ||||||||
Gross Loss Ratio | 177 | % | 108 | % | 109 | % | 0 | % | ||||||||
Net Loss Ratio | 204 | % | 130 | % | 148 | % | 0 | % |
(1) | Excludes Spinnaker results from the period of January 1, 2020 to August 31, 2020, including $71.8 million of non-Hippo program written premium. |
i) | Gross written premium (“GWP”) — a GAAP measure defined below; and |
ii) | Gross placed premium — premium of policies placed with third-party insurance companies, for which we do not retain insurance risk and for which we earn a commission payment, and policy fees charged by us to the policyholders on the effective date of the policy. |
Six Months Ended June 30, | Year Ended December 31 | |||||||||||||||||||||||
2021 | 2020 | Change | 2020 | 2019 | Change | |||||||||||||||||||
Gross Written Premium | $ | 227.7 | $ | 14.7 | $ | 213.0 | $ | 116.1 | $ | 0.0 | $ | 116.1 | ||||||||||||
Gross Placed Premium | 54.2 | 129.7 | (75.5 | ) | 217.5 | 196.3 | 21.1 | |||||||||||||||||
Total Generated Premium | $ | 281.9 | $ | 144.4 | $ | 137.5 | $ | 333.6 | $ | 196.3 | $ | 137.3 |
Six Months Ended June 30, | Year Ended December 31, | |||||||||||||||
2021 | 2020 | 2020 | 2019 | |||||||||||||
Net loss attributable to Hippo | $ | (279.8 | ) | $ | (48.7 | ) | $ | (141.5 | ) | $ | (83.1 | ) | ||||
Adjustments: | ||||||||||||||||
Net investment income | (0.2 | ) | (0.6 | ) | (1.1 | ) | (2.2 | ) | ||||||||
Depreciation and amortization | 5.1 | 3.0 | 6.7 | 2.9 | ||||||||||||
Interest expense | 21.9 | — | 3.5 | — | ||||||||||||
Stock-based compensation | 5.3 | 1.8 | 17.7 | 21.9 | ||||||||||||
Fair value adjustments | 161.1 | 4.1 | 22.4 | 2.0 | ||||||||||||
Contingent consideration charge | 1.3 | — | 3.4 | 1.9 | ||||||||||||
Other one-off transactions | 7.0 | — | 0.8 | — | ||||||||||||
Income taxes (benefit) expense | 0.3 | — | (1.8 | ) | 0.1 | |||||||||||
Adjusted EBITDA (1) | $ | (78.0 | ) | $ | (40.4 | ) | $ | (89.9 | ) | $ | (56.5 | ) | ||||
(1) | In previous disclosures our Adjusted EBITDA calculation included an adjustment for capitalization of internal use software costs. We no longer include this adjustment as we believe the current presentation is more relevant and in-line with our peers and relevant comparable companies. We have adjusted the historical periods accordingly. |
Six Months Ended June 30 | Year Ended December 31 | |||||||||||||||
2021 | 2020 | 2020 | 2019 | |||||||||||||
Gross losses and LAE | $ | 286.2 | $ | 5.2 | $ | 106.9 | $ | 0.0 | ||||||||
Gross earned premium | 161.5 | 4.8 | 98.0 | 0.0 | ||||||||||||
Gross loss ratio | 177 | % | 108 | % | 109 | % | 0 | % |
Six Months Ended June 30 | Year Ended December 31 | |||||||||||||||
2021 | 2020 | 2020 | 2019 | |||||||||||||
Net Losses and LAE | $ | 38.7 | $ | 5.2 | $ | 25.3 | $ | 0.0 | ||||||||
Net Earned Premium | 19.0 | 4.0 | 17.1 | 0.0 | ||||||||||||
Net Loss Ratio | 204 | % | 130 | % | 148 | % | 0 | % |
• | New business submissions; |
• | Binding of new business submissions into policies; |
• | Bound policies going effective; |
• | Renewals of existing policies; and |
• | Average size and premium rate of bound policies. |
a. | MGA Commission |
sheet. Rather, we work with carrier platforms and a diversified panel of highly rated reinsurance companies who pay us commission in exchange for the opportunity to take that risk on their balance sheets. Our performance obligation associated with these contracts is the placement of the policy, which is met on the effective date. Upon issuance of a new policy, we charge policy fees and inspection fees (see Service and Fee Income |
b. | Agency Commission non-Hippo policies. For these policies, we earn a recurring agency commission from the carriers whose policies we sell, which is recorded in the commission income, net line on our statements of operations and comprehensive loss. Similar to the MGA businesses, the performance obligation from the agency contracts is placement of the insurance policies. |
c. | Ceding Commission pro-rata basis over the terms of the policies reinsured. We record the portion of ceding commission income which represents reimbursement of successful direct acquisition costs related to the underlying policies as an offset to the applicable direct acquisition costs. |
d. | Carrier Fronting Fees insurance-as-a-service pro-rata basis over the terms of the policies. This revenue is included in the Commission income, net line on our statements of operations and comprehensive loss. |
e. | Claim Processing Fees |
Six Months Ended June 30 | Year Ended December 31 | |||||||||||||||||||||||||||||||
2021 | 2020 | Change | % Change | 2020 | 2019 | Change | % Change | |||||||||||||||||||||||||
Revenue: | ||||||||||||||||||||||||||||||||
Net earned premium | $ | 19.0 | $ | 4.0 | $ | 15.0 | 375 | % | $ | 17.1 | $ | — | $ | 17.1 | N/A | |||||||||||||||||
Commission income, net. | 11.6 | 15.5 | (3.9 | ) | (25 | )% | 27.1 | 28.9 | (1.8 | ) | (6 | )% | ||||||||||||||||||||
Service and fee income | 7.1 | 2.1 | 5.0 | 238 | % | 6.3 | 3.6 | 2.7 | 75 | % | ||||||||||||||||||||||
Net investment income | 0.2 | 0.6 | (0.4 | ) | (67 | )% | 1.1 | 2.2 | (1.1 | ) | (50 | )% | ||||||||||||||||||||
Total revenue. | 37.9 | 22.2 | 15.7 | 71 | % | 51.6 | 34.7 | 16.9 | 49 | % | ||||||||||||||||||||||
Expenses: | ||||||||||||||||||||||||||||||||
Loss and Loss Adjustment Expenses | 38.7 | 5.2 | 33.5 | 644 | % | 25.3 | — | 25.3 | N/A | |||||||||||||||||||||||
Insurance related expenses | 16.0 | 8.0 | 8.0 | 100 | % | 19.3 | 7.1 | 12.2 | 172 | % | ||||||||||||||||||||||
Technology and development | 14.5 | 7.3 | 7.2 | 99 | % | 18.0 | 7.7 | 10.3 | 134 | % | ||||||||||||||||||||||
Sales and marketing | 46.9 | 35.3 | 11.6 | 33 | % | 69.4 | 66.3 | 3.1 | 5 | % | ||||||||||||||||||||||
General and administrative | 17.1 | 11.1 | 6.0 | 54 | % | 36.8 | 34.6 | 2.2 | 6 | % | ||||||||||||||||||||||
Interest and other expense | 183.1 | 4.0 | 179.1 | 4478 | % | 26.0 | 2.0 | 24.0 | 1200 | % | ||||||||||||||||||||||
Total expenses | 316.3 | 70.9 | 245.4 | 346 | % | 194.8 | 117.7 | 77.1 | 66 | % | ||||||||||||||||||||||
Loss before income taxes | (278.4 | ) | (48.7 | ) | (229.7 | ) | 472 | % | (143.2 | ) | (83.0 | ) | (60.2 | ) | 73 | % | ||||||||||||||||
Income taxes (benefit) expense | 0.3 | — | 0.3 | N/A | (1.8 | ) | 0.1 | (1.9 | ) | (1900 | )% | |||||||||||||||||||||
Net loss | (278.7 | ) | (48.7 | ) | (230.0 | ) | 472 | % | (141.4 | ) | (83.1 | ) | (58.3 | ) | 70 | % | ||||||||||||||||
Net income attributable to noncontrolling interests, net of tax | 1.1 | — | 1.1 | N/A | 0.1 | — | 0.1 | N/A | ||||||||||||||||||||||||
Net loss attributable to Hippo | $ | (279.8 | ) | $ | (48.7 | ) | $ | (231.1 | ) | 475 | % | $ | (141.5 | ) | $ | (83.1 | ) | $ | (58.4 | ) | 70 | % | ||||||||||
Other comprehensive income: | ||||||||||||||||||||||||||||||||
Change in net unrealized gain on available-for-sale | (0.3 | ) | — | (0.3 | ) | N/A | — | 0.1 | (0.1 | ) | (100 | )% | ||||||||||||||||||||
Comprehensive loss attributable to Hippo | $ | (280.1 | ) | $ | (48.7 | ) | $ | (231.4 | ) | 475 | % | $ | (141.5 | ) | $ | (83.0 | ) | $ | (58.5 | ) | 70 | % | ||||||||||
Six Months Ended June 30, | ||||||||||||
2021 | 2020 | Change | ||||||||||
Gross written premium | 227.7 | 14.7 | 213.0 | |||||||||
Ceded written premium | 208.4 | 2.0 | 206.4 | |||||||||
Net written premium | 19.3 | 12.7 | 6.6 | |||||||||
Change in unearned premium | (0.3 | ) | (8.7 | ) | 8.4 | |||||||
Net earned premium | $ | 19.0 | $ | 4.0 | $ | 15.0 |
Year Ended December 31 | ||||||||||||
2020 | 2019 | Change | ||||||||||
Gross Written Premium | 116.1 | — | 116.1 | |||||||||
Ceded written premium | 78.4 | — | 78.4 | |||||||||
Net Written Premium | 37.7 | — | 37.7 | |||||||||
Change in unearned premium | 20.6 | — | 20.6 | |||||||||
Net Earned Premium | $ | 17.1 | $ | — | $ | 17.1 |
1. | Lower effective commission rate in FY 2020: Assuming similar blended net commission rate of FY 2019 in FY 2020, our commission income, net would have been higher by $15.1 million. However, in FY 2020, our blended commission rate decreased by 5 percentage points compared to FY 2019, due to a larger commission slide, resulting in offsetting potential increase in our commission income to only $1.2 million. |
2. | Impact of acquisition of Spinnaker on revenue recognition for the policies written by Spinnaker: |
Six Months Ended June 30, | Year Ended December 31 | |||||||||||||||
2021 | 2020 | 2020 | 2019 | |||||||||||||
Net cash provided by (used in): | ||||||||||||||||
Operating activities | $ | (69.2 | ) | $ | (22.9 | ) | $ | (65.4 | ) | $ | (29.1 | ) | ||||
Investing activities | $ | (10.2 | ) | $ | 64.8 | $ | (2.3 | ) | $ | (72.3 | ) | |||||
Financing activities | $ | (2.8 | ) | $ | 3.0 | $ | 518.1 | $ | 101.4 |
Payments Due by Period | ||||||||||||||||||||||||
Total | Less Than 1 Year | 2 Years | 3 Years | 4 Years | 5 or More Years | |||||||||||||||||||
Purchase commitments | $ | 19.8 | $ | 13.8 | $ | 6.0 | $ | — | $ | — | $ | — | ||||||||||||
Operating lease obligations (1) | 25.1 | 2.9 | 4.0 | 3.5 | 3.5 | 11.2 | ||||||||||||||||||
Unpaid Loss and Loss Adjustment Expense (2) | 105.1 | 105.1 | — | — | — | — | ||||||||||||||||||
Total contractual obligations | $ | 150.0 | $ | 121.8 | $ | 10.0 | $ | 3.5 | $ | 3.5 | $ | 11.2 | ||||||||||||
(1) | Represents minimum rental payments for operating leases having initial or remaining non-cancelable lease terms primarily related to our office space. Included in the lease obligations is a $11.4 million lease agreements that we have entered into but has not yet commenced as of December 31, 2020. |
(2) | The reserve for Loss and Loss Adjustment Expenses represent management’s estimate of the ultimate cost of settling losses. As more fully discussed in “— Critical Accounting Policies — Unpaid Loss and Loss Adjustment Expenses”, the estimation of the unpaid Loss and Loss Adjustment Expenses is based on various complex and subjective judgments. Actual losses paid may differ, perhaps significantly, from the reserve estimates reflected in our consolidated financial statements. Similarly, the timing of payment of our estimated losses is not fixed and there may be significant changes in actual payment activity. The assumptions used in estimating the likely payments due by period are based on our historical claims payment experience and industry payment patterns, but due to the inherent uncertainty in the process of estimating the timing of such payments, there is a risk that the amounts paid can be significantly different from the amounts disclosed. |
1- | Loss and loss adjustment expense paid for an accident period as of a given evaluation date |
2- | Case reserves for loss and loss adjustment expense for losses for an accident period that have been reported but not yet paid as of a given evaluation date |
3- | Incurred But Not Reported (“IBNR”) amounts for loss and loss adjustment expense for an accident period are the costs of events or conditions that have not been reported to or specifically identified by the Company as of a given date, but have occurred during the period. |
• | Reported and/or Paid Loss and Claim Count Development Methods |
• | Reported Bornhuetter-Ferguson Method; |
• | Paid Bornhuetter-Ferguson Method: |
• | Frequency Severity Method: |
1. | the information developed from internal and independent external sources such as cost trends, litigation and regulatory trends, legislative activity, climate change, social and economic patterns and claim assumptions are used to develop meaningful estimates of the likely future performance of business bound by the Company; |
2. | the estimates of the effective impact of rate changes which includes pricing changes and changes in the underlying amounts of total insured values; |
3. | our historical loss development and trend experience that is assumed to be indicative of future loss development and trends. |
December 31, 2020 | ||||||||
Gross | Net | |||||||
Loss and loss adjustment reserves | ||||||||
Total reserves | $ | 105.1 | $ | 13.0 | ||||
10% increase in ultimate loss and loss adjustment expenses, net | 10% decrease in ultimate loss and loss adjustment expenses, net | |||||||
($ in millions) | ||||||||
Impact on: | ||||||||
Loss and loss adjustment expense reserves, net | $ | 14.9 | $ | 4.7 |
• | paid and unpaid amounts recoverable; |
• | any balances in dispute or subject to legal collection; |
• | the financial wellbeing of a reinsurer (i.e. insolvent, liquidated, in receivership or otherwise subject to formal or informal regulatory restriction); |
• | the likelihood of collection of the reinsurance recovery considering factors such as, amounts outstanding, length of collection periods, disputes, any collateral or letters of credit held and other relevant factors. |
• | relevant precedent transactions involving our capital stock; |
• | the liquidation preferences, rights, preferences, and privileges of our redeemable convertible preferred stock relative to the common stock; |
• | our actual operating and financial performance; |
• | current business conditions and projections; |
• | our stage of development; |
• | the likelihood and timing of achieving a liquidity event for the shares of common stock underlying the stock options, such as an initial public offering, given prevailing market conditions; |
• | any adjustment necessary to recognize a lack of marketability of the common stock underlying the granted options; |
• | recent secondary stock sales and tender offers; |
• | the market performance of comparable publicly traded companies; and |
• | U.S. and global capital market conditions. |
Name | Age | Position(s) | ||
Executive Officers | ||||
Assaf Wand | 46 | Chief Executive Officer, Co-Founder and Director | ||
Richard McCathron | 50 | President and Director | ||
Stewart Ellis | 45 | Chief Financial Officer | ||
Ran Harpaz | 47 | Chief Technology Officer | ||
Simon Fleming-Wood | 52 | Chief Marketing Officer | ||
Aviad Pinkovezky | 40 | Chief Product Officer | ||
Non-Employee Directors | ||||
Amy Errett (3) | 63 | Director | ||
Eric Feder (2) | 51 | Director | ||
Lori Dickerson Fouché (3) | 51 | Director | ||
Hugh R. Frater (1) | 65 | Director | ||
Noah Knauf (1)(2) | 41 | Director | ||
Sam Landman (2)(3) | 41 | Director | ||
Sandra Wijnberg (3) | 64 | Director |
(1) | Member of the audit, risk and compliance committee (the “Audit Committee”). |
(2) | Member of the compensation committee. |
(3) | Member of the nominating and corporate governance committee. |
• | the Class I directors are Eric Feder, Noah Knauf and Sam Landman, and their terms will expire at our 2022 annual meeting of stockholders; |
• | the Class II directors are Richard McCathron, Lori Dickerson Fouché and Hugh R. Frater, and their terms will expire at our 2023 annual meeting of stockholders; and |
• | the Class III directors are Assaf Wand, Sandra Wijnberg and Amy Errett, and their terms will expire at the 2024 annual meeting of stockholders. |
• | appointing, compensating, retaining, evaluating, terminating and overseeing Hippo Holdings’ independent registered public accounting firm; |
• | discussing with Hippo Holdings’ independent registered public accounting firm their independence from management; |
• | reviewing with Hippo Holdings’ independent registered public accounting firm the scope and results of their audit; |
• | pre-approving all audit and permissiblenon-audit services to be performed by Hippo Holdings’ independent registered public accounting firm; |
• | setting clear hiring policies for employees or former employees of Hippo Holdings’ independent registered public accounting firm; |
• | overseeing the financial reporting process and discussing with management and Hippo Holdings’ independent registered public accounting firm the interim and annual financial statements that Hippo Holdings files with the SEC; |
• | overseeing Hippo Holdings’ internal audit process and function; |
• | overseeing Hippo Holdings’ risk assessment and risk management, including with respect to the underwriting and pricing of insurable risks, the settlement of claims, the appropriate levels of retained risk and other insurance-related matters; |
• | establishing procedures for the receipt, retention and treatment of complaints received by Hippo Holdings regarding accounting, internal accounting controls or auditing matters; |
• | reporting regularly to the Hippo Holdings board of directors regarding the activities of the Audit Committee; |
• | reviewing and monitoring Hippo Holdings’ earnings releases, accounting principles, accounting policies, financial and accounting controls and compliance with legal and regulatory requirements; and |
• | periodically reviewing and reassessing the Audit Committee Charter. |
• | reviewing and approving corporate goals and objectives relevant to the compensation of Hippo Holdings’ Chief Executive Officer, evaluating the performance of Hippo Holdings’ Chief Executive Officer in light of these goals and objectives and setting or making recommendations to Hippo Holdings’ board of directors regarding the compensation of Hippo Holdings’ Chief Executive Officer; |
• | reviewing and setting or making recommendations to Hippo Holdings’ board of directors regarding the compensation of Hippo Holdings’ other executive officers; |
• | making recommendations to Hippo Holdings’ board of directors regarding the compensation of Hippo Holdings’ directors; |
• | reviewing and approving or making recommendations to Hippo Holdings’ board of directors regarding Hippo Holdings’ incentive compensation and equity-based plans and arrangements; and |
• | appointing and overseeing any compensation consultants. We believe that the composition and functioning of Hippo Holdings’ compensation committee meets the requirements for independence under the current NYSE listing standards. |
• | identifying individuals qualified to become members of Hippo Holdings’ board of directors, consistent with criteria approved by Hippo Holdings’ board of directors; |
• | recommending to Hippo Holdings’ board of directors the nominees for election to Hippo Holdings’ board of directors at annual meetings of Hippo Holdings’ stockholders; |
• | overseeing an evaluation of Hippo Holdings’ board of directors and its committees; and |
• | developing and recommending to Hippo Holdings’ board of directors a set of corporate governance guidelines. We believe that the composition and functioning of Hippo Holdings’ nominating and corporate governance committee meets the requirements for independence under the current NYSE listing standards. |
• | Assaf Wand, Hippo’s Chief Executive Officer; |
• | Richard McCathron, Hippo’s President; and |
• | Simon Fleming-Wood, Hippo’s Chief Marketing Officer. |
Name and Principal Position | Year | Salary ($) | Option Awards ($) (1) | All Other Compensation ($) (2) | Total ($) | |||||||||||||||
Assaf Wand | 2020 | 258,333 | — | — | 258,3333 | |||||||||||||||
Chief Executive Officer | ||||||||||||||||||||
Richard McCathron | 2020 | 300,000 | 1,369,065 | 31,222 | 1,700,287 | |||||||||||||||
President | ||||||||||||||||||||
Simon Fleming-Wood | 2020 | 64,962 | 2,319,000 | — | 2,383,692 | |||||||||||||||
Chief Marketing Officer |
(1) | Amounts reported represent the aggregate grant date fair value of stock options granted to the NEOs during 2020 computed in accordance with FASB ASC Topic 718. Assumptions used in the calculation of this amount are included in Note 17 to the audited consolidated financial statements included in this prospectus. |
(2) | Amounts reported represents travel and lodging expenses in connection with Mr. McCathron’s travel from his home office in Austin, Texas to Hippo’s offices in the Bay Area, California. |
Option awards | Stock awards | |||||||||||||||||||||||||||
Name | Vesting commencement date | Number of securities underlying unexercised options (#) exercisable | Number of securities underlying unexercised options (#) unexercisable | Option exercise price ($) | Option expiration date | Number of shares that have not vested (#) | Market value of shares that have not vested ($) (7) | |||||||||||||||||||||
Assaf Wand | 10/15/2019 | (1) | 329,273 | 989,172 | 5.60 | 10/14/2029 | — | — | ||||||||||||||||||||
01/23/2019 | (2) | 256,819 | 19,266,561 | |||||||||||||||||||||||||
Richard McCathron | 12/01/2020 | (3) | 150,000 | 10,497,000 | ||||||||||||||||||||||||
08/27/2020 | (4) | 8,333 | 91,667 | 7.36 | 09/27/2030 | |||||||||||||||||||||||
05/13/2019 | (4) | 49,479 | 75,521 | 2.32 | 05/12/2029 | — | — | |||||||||||||||||||||
01/23/2019 | (4) | 37,500 | 52,084 | 2.32 | 01/22/2029 | |||||||||||||||||||||||
01/23/2018 | (5) | 31,086 | 23,438 | 1.09 | 01/23/2028 | |||||||||||||||||||||||
02/06/2017 | (1) | 75,000 | 12,500 | 0.30 | 02/28/2027 | |||||||||||||||||||||||
Simon Fleming-Wood | 10/26/2020 | (6) | 300,000 | — | 7.36 | 12/03/2030 | — | — |
(1) | 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date, and 1/16th of the shares subject to the option vest on each quarterly anniversary thereafter, subject to continued service with Hippo Holdings through the applicable vesting date. If the NEO’s employment with Hippo Holdings is terminated without cause or the NEO’s employment is constructively terminated in connection with a change of control, 50% of the shares subject to the option will vest and become exercisable on the date of termination. |
(2) | Mr. Wand purchased 493,091 shares upon early exercise of his option prior to vesting. The unvested shares are subject to repurchase by Hippo Holdings at the original exercise price of $2.32 per share upon a termination of Mr. Wand’s service. The shares vest as to 1/48th of the shares on each monthly anniversary of the vesting commencement date, subject to continued service with Hippo Holdings through the applicable vesting date. Notwithstanding the foregoing, 100% of the unvested shares will vest upon a change in control. |
(3) | Mr. McCathron purchased 150,000 shares upon early exercise of an option prior to vesting. The unvested shares are subject to repurchase by Hippo Holdings at the original exercise price of $7.36 per share upon a termination of Mr. McCathron’s service. The shares vest as to 1/48th of the shares vest on each monthly anniversary of the vesting commencement date, subject to continued service with Hippo Holdings through the applicable vesting date. |
(4) | 1/48th of the shares subject to the option vest on each monthly anniversary of the vesting commencement date, subject to continued service with Hippo Holdings through the applicable vesting date. |
(5) | 1/16th of the shares subject to the option vest on each quarterly anniversary of the vesting commencement date, subject to continued service with Hippo Holdings through the applicable vesting date. |
(6) | 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date, and 1/16th of the shares subject to the option vest quarterly thereafter, subject to continued service with us through the applicable vesting date. If the NEO’s employment with Hippo Holdings is terminated without cause or the NEO’s employment is constructively terminated in connection with a change in control, 100% of the shares subject to the option will vest and become exercisable on the date of termination. |
(7) | Amount calculated by subtracting the amount paid for the shares from $77.34 per share, which was determined by multiplying the closing trading price of the RTPZ Class A ordinary shares on January 11, 2021, $11.50, times 6.72479, which is the currently assumed exchange ratio for the transaction. RTPZ Class A ordinary shares did not start trading until such date, which is the closest date to December 31, 2020. |
Name | Cash ($) | Equity ($) (1) | Perquisites/ Benefits ($) (2) | Total ($) | ||||||||||||
Assaf Wand | — | 30,000,000 | 1,192,298 | 31,192,298 | ||||||||||||
Richard McCathron | — | 5,000,000 | — | 5,000,000 | ||||||||||||
Simon Fleming-Wood | — | — | — | — |
(1) | The amounts represent the aggregate dollar value payable to the NEOs related to the number of shares of Hippo Holdings common stock Hippo Holdings redeemed upon the consummation of the Business Combination, at a purchase price of $10.00 per share, from each of the following NEOs: 3,000,000 shares from Mr. Wand and 500,000 shares from Mr. McCathron. These payments are not compensatory in nature to the NEOs and will not be treated as compensation to the NEOs. |
(2) | The amount for Mr. Wand represents the aggregate dollar value of the forgiveness of Mr. Wand’s loan extended pursuant to that certain Secured Partial Recourse Promissory Note and Stock Pledge Agreement by and between Hippo and Mr. Wand and all interest accrued thereon has been forgiven upon the consummation of the Business Combination. |
Name | Fees Earned or Paid in Cash ($) | Option Awards ($) (1) | All Other Compensation ($) | Total ($) | ||||||||||||
Sandra Wijnberg | — | 73,121 | — | 73,121 | ||||||||||||
All Other Non-Employee Directors(2) | — | — | — | — |
(1) | Amounts reported represent the aggregate fair value of options granted to Ms. Wijnberg computed in accordance with FASB ASC Topic 718 in fiscal year 2020. Assumptions used in the calculation of these amounts are included in Note 17 to our audited consolidated financial statements included in this prospectus. As of December 31, 2020, Ms. Wijnberg held an aggregate of options to purchase 35,000 shares Hippo common stock. No options or other equity awards were held by our other non-employee directors as of December 31, 2020. |
(2) | All Other Non-Employee Directors include Eric Feder, Sam Landman, Hugh Frater, Lori Dickerson Fouche, Amy Errett and Noah Knauf. |
• | Each non-employee director will receive an annual cash retainer in the amount of $35,000 per year. Thenon-executive chairperson of the board will receive an additional annual cash compensation in the amount of $22,500 per year for such chairperson’s service on the board. |
• | The chairperson of the audit committee will receive additional annual cash compensation in the amount of $20,000 per year for such chairperson’s service on the audit committee. Each non-chairperson member of the audit committee will receive additional annual cash compensation in the amount of $10,000 per year for such member’s service on the audit committee. |
• | The chairperson of the compensation committee will receive additional annual cash compensation in the amount of $12,000 per year for such chairperson’s service on the compensation committee. Each non-chairperson member of the compensation committee will receive additional annual cash compensation in the amount of $6,000 per year for such member’s service on the compensation committee. |
• | The chairperson of the nominating and corporate governance committee will receive additional annual cash compensation in the amount of $8,000 per year for such chairperson’s service on the nominating and corporate governance committee. Each non-chairperson member of the nominating and corporate governance committee will receive additional annual cash compensation in the amount of $4,000 per year for such member’s service on the nominating and corporate governance committee. |
• | to the extent that an award terminates, expires or lapses for any reason or an award is settled in cash without the delivery of shares, any shares subject to the award at such time will be available for future grants under the Incentive Award Plan; |
• | to the extent shares are tendered or withheld to satisfy the grant, exercise price or tax withholding obligation with respect to any award under the Incentive Award Plan, such tendered or withheld shares will be available for future grants under the Incentive Award Plan; |
• | to the extent shares subject to stock appreciation rights are not issued in connection with the stock settlement of stock appreciation rights on exercise thereof, such shares will be available for future grants under the Incentive Award Plan; |
• | the payment of dividend equivalents in cash in conjunction with any outstanding awards will not be counted against the shares available for issuance under the Incentive Award Plan; and |
• | to the extent permitted by applicable law or any exchange rule, shares issued in assumption of, or in substitution for, any outstanding awards of any entity acquired in any form of combination by us or any of our subsidiaries will not be counted against the shares available for issuance under the Incentive Award Plan. |
• | Nonstatutory Stock Options |
• | Incentive Stock Options |
• | Restricted Stock |
• | Restricted Stock Units |
• | Stock Appreciation Rights |
• | Performance Bonus Awards and Performance Stock Units |
• | Other Stock or Cash Based Awards |
awards, which may include vesting conditions based on continued service, performance and/or other conditions. |
• | Dividend Equivalents |
• | each person who is known to be the beneficial owner of more than 5% of shares of Hippo Holdings common stock; |
• | each of Hippo Holdings’ current named executive officers and directors; and |
• | all current executive officers and directors of Hippo Holdings as a group. |
Number of Shares of Hippo Holdings Common Stock | +60 Days Vested | Number of Shares Beneficially Owned | % | |||||||||||||
Name and Address of Beneficial Owner (1)(2) | ||||||||||||||||
Five Percent Holders: | ||||||||||||||||
Fifth Wall Ventures, L.P. and affiliates (3) | 74,168,521 | — | 74,168,521 | 13.2 | % | |||||||||||
LEN FW INVESTOR, LLC and affiliates (4) | 80,786,369 | — | 80,786,369 | 14.4 | % | |||||||||||
Mitsui Sumitomo Insurance Co., Ltd. (5) | 39,555,425 | — | 39,555,425 | 7.0 | % | |||||||||||
Bond Capital Fund, LP and affiliate (6) | 30,003,193 | — | 30,003,193 | 5.3 | % | |||||||||||
RPM Ventures III, L.P. (7) | 30,644,982 | — | 30,644,982 | 5.4 | % | |||||||||||
Directors and Executive Officers of Post-Business Combination: | ||||||||||||||||
Assaf Wand (8) | 32,320,815 | 4,586,013 | 36,906,828 | 6.5 | % | |||||||||||
Richard McCathron (9) | 2,508,501 | 667,633 | 3,176,134 | * | ||||||||||||
Eric Feder | — | — | — | — | ||||||||||||
Sam Landman | — | — | — | — | ||||||||||||
Hugh Frater (10) | 1,076,362 | — | 1,076,362 | * | ||||||||||||
Noah Knauf | — | — | — | — | ||||||||||||
Sandra Wijnberg (11) | — | 81,130 | 81,130 | * | ||||||||||||
Simon Fleming-Wood | — | — | — | — | ||||||||||||
Lori Dickerson Fouché | — | — | — | — | ||||||||||||
Amy Errett | — | — | — | — | ||||||||||||
Aviad Pinkovezky (12) | 1,810,001 | 333,229 | 2,143,230 | * | ||||||||||||
Ran Harpaz (13) | 2,104,125 | 36,224 | 2,140,349 | * | ||||||||||||
Stewart Ellis (14) | 3,366,803 | — | 3,366,803 | * | ||||||||||||
All Directors and Executive Officers of the Combined Company as a Group (13 individuals) | 43,186,607 | 5,704,229 | 57,640,054 | 8.65 | % |
* | Less than one percent |
(1) | Unless otherwise noted, the business address of each of those listed in the table above is c/o Hippo Holdings Inc., 150 Forest Avenue, Palo Alto, California 94301. |
(2) | Prior to the Closing, holders of record of RTPZ Class A ordinary shares and RTPZ Class B ordinary shares were entitled to one vote for each share held on all matters to be voted on by RTPZ shareholders and vote together as a single class, except as required by law; provided, that holders of RTPZ Class B ordinary shares |
had the right to elect all of RTPZ’s directors prior to the Closing, and holders of RTPZ’s Class A ordinary shares were not entitled to vote on the election of directors during such time. As a result of and upon the effective time of the Domestication, (a) each of the then issued and outstanding RTPZ Class A ordinary shares converted automatically, on a one-for-one basis, into a share of Hippo Holdings common stock and (b) each of the then issued and outstanding RTPZ Class B ordinary shares converted automatically, on aone-for-one |
(3) | Consists of 74,168,521 shares of Hippo Holdings common stock, of which (i) 51,447,246 are common stock directly held by Fifth Wall Ventures SPV IV L.P., (ii) 458,603 are common stock directly held by Fifth Wall Ventures SPV XVII, L.P. and (iii) 22,262,672 are common stock directly held by Fifth Wall Ventures, L.P. Fifth Wall Ventures, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (i) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. The address of the above persons and entities is 11360 Mindanao Way, Suite 100B, Marina Del Rey, California 90292. |
(4) | Consists of 80,786,369 shares of Hippo Holdings common stock, of which (i) 29,239,123 are common stock held directly by LEN FW Investor, LLC, (ii) 100,000 are PIPE Shares held by LEN FW Investor, LLC and (iii) 51,447,246 are common stock held directly by Fifth Wall Ventures SPV IV L.P. Fifth Wall Ventures, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (iii) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. Eric Feder is currently a member of our board of directors and an officer of the parent of LEN FW Investor, LLC. The address of the above persons and entities is 700 Northwest 107th Avenue, Miami, Florida 33172. |
(5) | Consists of 39,555,425 shares of Hippo Holdings common stock. Mitsui Sumitomo Insurance Co., Ltd.’s address is 9, Kanda-Surugadai 3-chome, Chiyoda-Ku, Tokyo, Japan. |
(6) | Consists of 30,003,193 shares of Hippo Holdings common stock held in the name of BOND Capital Fund, LP, as nominee, for the account of BOND Capital Fund, LP and BOND Capital Founders Fund, LP (together, the “BOND Funds”). Daegwon Chae, Juliet de Baubigny, Noah Knauf, Mary Meeker, Mood Rowghani, Jay Simons, and Paul Vronsky are managing members of BOND Capital Associates, LLC, the general partner of the BOND Funds, and share voting and dispositive power over the shares held for the account of the BOND Funds. The address of each of these entities is 100 The Embarcadero, San Francisco, California 94105. |
(7) | Consists of 30,644,982 shares of Hippo Holdings, of which (i) 26,369,295 are common stock directly held by RPM Ventures III, L.P. and (ii) 4,275,687 are common stock directly held by BGW Ventures II, LP, an affiliate of RPM Ventures III, L.P. The address of the above persons and entities is 320 N. Main Street, Suite 400, Ann Arbor, Michigan 48104. |
(8) | Consists of (i) 36,906,828 shares of Hippo Holdings common stock, of which approximately 17,087,948 shares are held by Mr. Wand and 15,232,867 shares are held by Mr. Wand as trustee of a trust, and (ii) approximately 4,586,013 shares of Hippo Holdings common stock issuable pursuant to Hippo options of which all are held by Mr. Wand and none are held by Mr. Wand as trustee of a trust. |
(9) | Consists of (i) 4,324,332 shares of Hippo Holdings common stock, of which approximately 2,508,501 shares are held by Mr. McCathron and (ii) 667,633 shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(10) | Consists of (i) 1,076,362 shares of Hippo Holdings common stock, all of which are held by Mr. Frater as trustee of a trust and (ii) no shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(11) | Consists of (i) no shares of Hippo Holdings common stock and (ii) 81,130 shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(12) | Consists of (i) 2,143,230 shares of Hippo Holdings common stock, of which 1,670,920 shares are held by Mr. Pinkovezky as trustee of a trust and 139,081 shares are held for the benefit of Mr. Pinkovezky by a separate trust and (ii) 333,229 shares of Hippo Holdings common stock issuable pursuant to Hippo options of which all are held by Mr. Pinkovezky and none are held by Mr. Pinkovezky as trustee of a trust. |
(13) | Consists of (i) 2,277,981 shares of Hippo Holdings common stock, of which approximately 2,104,125 shares are held by Mr. Harpaz and (ii) 36,224 shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(14) | Consists of (i) 3,366,803 shares of Hippo Holdings common stock, 3,108,425 of which are held by Mr. Ellis and 258,378 of which are held for the benefit of Mr. Ellis by a trust and (ii) no shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
• | up to 55,000,000 PIPE Shares; |
• | up to 5,750,000 RTPZ founder shares; |
• | up to 14,592,527 shares of common stock held by Hippo Holdings holders issuable upon the exercise of equity awards; |
• | up to 4,400,000 shares of common stock issuable upon the exercise of private placement warrants; |
• | up to 315,928,001 shares of Hippo Holdings common stock; and |
• | up to 637,463 shares of common stock issuable upon the exercise of Hippo Holdings warrants. |
Shares of Common Stock | ||||||||||||||||
Name | Number Beneficially Owned Prior to Offering (1) | Number Registered for Sale Hereby | Number Beneficially Owned After Offering | Percent Owned After Offering (2) | ||||||||||||
140 Summer Partners Master Fund LP (3) | 500,000 | 500,000 | — | — | ||||||||||||
40 North Latitude Mater Fund Ltd. (4) | 4,000,000 | 4,000,000 | — | — | ||||||||||||
Ally Financial Inc. (5) | 200,000 | 200,000 | — | — | ||||||||||||
Alyeska Master Fund, L.P. (6) | 1,260,000 | 1,260,000 | 260,000 | * | ||||||||||||
Assaf Wand (7) | 36,906,828 | 36,906,828 | 36,906,828 | 6.5 | % | |||||||||||
Baron Real Estate Fund (8) | 1,500,000 | 1,500,000 | — | — | ||||||||||||
Beagle Limited (9) | 25,000 | 25,000 | — | — | ||||||||||||
BHHP LLC (10) | 500,000 | 500,000 | — | — |
Bond Capital Fund, LP (11) | 30,003,193 | 30,003,193 | 30,003,193 | 5.3 | % | |||||||||||
Byron Auguste (12) | 30,000 | 30,000 | 30,000 | * | ||||||||||||
David Mayer de Rothschild (13) | 140,000 | 140,000 | — | — | ||||||||||||
Diameter Master Fund LP (14) | 881,128 | 881,128 | 181,128 | * | ||||||||||||
Dragoneer Global Fund II, L.P. (15) | 3,329,237 | 3,329,237 | 2,829,237 | * | ||||||||||||
EMJ Master Fund LP (16) | 777,750 | 777,750 | 77,750 | * | ||||||||||||
Entities Affiliated with Brosh Capital (17) | 500,000 | 500,000 | — | — | ||||||||||||
Entities advised by Capital Research and Management Company (18) | 3,011,418 | 3,011,418 | 11,418 | * | ||||||||||||
Entities Affiliated with Clal Insurance (19) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Entities Affiliated with Comcast (20) | 26,823,284 | 26,823,284 | 26,823,284 | 4.7 | % | |||||||||||
Entities Affiliated with Corbin Capital (21) | 600,000 | 600,000 | — | — | ||||||||||||
Entities Affiliated with Darlington Partners (22) | 3,000,000 | 3,000,000 | — | — | ||||||||||||
Entities Affiliated with Fifth Wall Ventures (23) | 74,168,521 | 74,168,521 | 74,168,521 | 13.2 | % | |||||||||||
Entities Affiliated with Horizon (24) | 26,872,544 | 26,872,544 | 24,872,544 | 4.4 | % | |||||||||||
Entities Affiliated with Luxor Capital (25) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Entities Affiliated with Millennium (26) | 1,453,733 | 1,453,733 | 253,733 | * | ||||||||||||
Entities Affiliated with Park West (27) | 4,000,000 | 4,000,000 | — | — | ||||||||||||
Entities Affiliated with Saba Capital (28) | 2,000,000 | 2,000,000 | — | — | ||||||||||||
Entities Affiliated with Samlyn Capital (29) | 500,000 | 500,000 | — | — | ||||||||||||
Entities Affiliated with Sentinel Dome (30) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Entities Affiliated with Serengeti (31) | 700,000 | 700,000 | 50,000 | * | ||||||||||||
Entities Affiliated with Suvretta Capital Management LLC (32) | 600,000 | 600,00 | — | — | ||||||||||||
Entities Managed by UBS (33) | 300,000 | 300,000 | — | — | ||||||||||||
Gan Eden Ventures, Inc. (34) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Garden Fund, LLC (35) | 100,000 | 100,000 | — | — | ||||||||||||
Ghisallo Master Fund LP (36) | 500,000 | 500,000 | — | — | ||||||||||||
Gores HP, LLC (37) | 500,000 | 500,000 | — | — | ||||||||||||
The HCG Fund LP (38) | 500,000 | 500,000 | — | — | ||||||||||||
Hound Partners, LLC (39) | 529,682 | 529,682 | 29,682 | * | ||||||||||||
Hugh R. Frater Irrevocable Trust Dtd 12/11/2012 (40) | 1,076,362 | 1,076,362 | 1,076,362 | * | ||||||||||||
Invus Public Equities, L.P. (41) | 600,000 | 600,000 | — | — | ||||||||||||
Jane Street Global Trading, LLC (42) | 438,903 | 438,903 | 38,903 | * | ||||||||||||
Julie Hanna (43) | 30,000 | 30,000 | 30,000 | * | ||||||||||||
Lee Linden (44) | 30,000 | 30,000 | 30,0000 | * | ||||||||||||
Len FW Investor, LLC (45) | 80,786,369 | 80,786,369 | 80,686,369 | 14.4 | % | |||||||||||
Linda Rottenberg (46) | 30,000 | 30,000 | 30,000 | * | ||||||||||||
Linden Capital L.P. (47) | 500,000 | 500,000 | — | — | ||||||||||||
Madison Rock Investments LP (48) | 100,000 | 100,000 | — | — | ||||||||||||
Octahedron Master Fund, L.P. (49) | 250,000 | 250,000 | — | — | ||||||||||||
PBCAY One Limited (50) | 2,000,000 | 2,000,000 | — | — | ||||||||||||
Psagot Provident Funds and Pensions Ltd .(51) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Reinvent Capital Fund LP (52) | 1,000,000 | 1,000,000 | ||||||||||||||
Reinvent Sponsor Z LLC (53) | 5,630,000 | 5,630,000 | — | — | ||||||||||||
Ribbit Capital VI, L.P. (54) | 300,000 | 300,00 | ||||||||||||||
Richard McCathron (55) | 3,176,134 | 3,176,134 | 3,176,134 | * | ||||||||||||
RPM Ventures III, L.P. (56) | 30,644,982 | 30,644,982 | 30,644,982 | 5.4 | % | |||||||||||
Sandra Wijnberg (57) | 81,130 | 81,130 | 81,130 | * | ||||||||||||
Schonfeld Strategic 460 Fund LLC (58) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Senator Global Opportunity Master Fund L.P. (59) | 2,250,000 | 2,250,000 | — | — |
Shapero 2015 Trust (60) | 75,000 | 75,000 | — | — | ||||||||||||
Slate Path Master Fund LP (61) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Smith’s Point Family Partners LLC (62) | 700,000 | 700,000 | — | — | ||||||||||||
Stewart Ellis (63) | 3,366,803 | 3,366,803 | 3,366,803 | * | ||||||||||||
Soroban Opportunities Master Fund LP (64) | 2,000,000 | 2,000,000 | — | — | ||||||||||||
The Adam & Carolyn Nash Family Trust U/D/T January 25, 2021 (65) | 10,000 | 10,000 | — | — | ||||||||||||
Entities Affiliated with Third Point Loan LLC (66) | 1,000,000 | 1,000,000 | — | — | ||||||||||||
Transcend Partners LLC (67) | 200,000 | 200,000 | — | — | ||||||||||||
Weiss Ventures I LLC (68) | 1,200,000 | 1,200,000 | — | — | ||||||||||||
West Coast Equity Partners LLC (69) | 600,000 | 600,000 | — | — | ||||||||||||
XN Exponent Master Fund LP (70) | 4,500,000 | 4,500,000 | — | — |
* | Less than 1% |
(1) | The first table includes PIPE Shares, Sponsor Shares, Hippo Holdings Holder Shares, shares of common stock issuable upon exercise of certain equity awards (including both shares beneficially owned as determined in accordance with Rule 13d-3 of the Exchange Act and additional shares underlying options to purchase common stock which may be exercisable within one year following the Closing), shares of common stock issuable upon exercise of the Old Hippo Warrants and shares of common stock issuable upon exercise of the private placement warrants, and the second table includes the private placement warrants included in this table (collectively, the “Resale Securities”). We do not know when or in what amounts the selling securityholders will offer the Resale Securities for sale, if at all. |
(2) | The percentage of shares to be beneficially owned after completion of the offering is calculated on the basis of 559,731,226 shares of common stock outstanding, assuming the exercise of all currently outstanding warrants and the sale of all Resale Securities by the selling securityholders. |
(3) | Shares offered hereby consist of 500,000 PIPE Shares. The securities to which this filing relates are held directly by 140 Summer Partners Master Fund LP, a Delaware limited partnership (the “Fund”). 140 Summer Partners Fund GP LLC, a Delaware limited liability company, serves as the general partner of 140 Summer Partners Master Fund LP and as such has discretion over the portfolio securities beneficially owned by 140 Summer Partners Master Fund LP. Peter Rosenblum is the managing member of 140 Summer Partners Fund GP LLC and directs 140 Summer Partners Fund GP LLC operations. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. |
(4) | Shares hereby offered consist of 4,000,000 PIPE Shares held by 40 North Latitude Master Fund Ltd. (“Latitude”). David Winter and David Millstone are sole managers of 40 North Management LLC, which holds the sole voting power in Latitude, and 40 North GP III LLC, the General Partner of Latitude. Mr. Winter and Mr. Millstone are sole directors of Latitude. The business address of Latitude is c/o 40 North Management LLC 9 West 57th Street, 46th floor, New York, NY 10019. |
(5) | Shares hereby offered consist of 200,000 PIPE Shares held by Ally Ventures, a business unit of Ally Financial Inc. The business address of Ally Ventures is 300 Park Avenue, 4 th Floor, New York, NY 10022. (6) Shares hereby offered consist of the 1,000,000 PIPE Shares and 260,000 warrants held by Alyeska Master Fund, L.P. Alyeska Investment Group, L.P., the investment manager of Alyeska Master Fund, L.P., has voting and investment control of the shares held by Alyeska Master Fund, L.P. Anand Parekh is the Chief Executive Officer of Alyeska Investment Group, L.P. and may be deemed to be the beneficial owner of such shares. Mr. Parekh, however, disclaims any beneficial ownership of the shares held by Alyeska Master Fund, L.P. The registered address of Alyeska Master Fund, L.P. is at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street George Town, Grand Cayman,KY1-1104, Cayman Islands. Alyeska Investment Group, L.P. is located at 77 W. Wacker, Suite 700, Chicago IL 60601. |
(7) | Consists of (i) 36,906,828 shares of Hippo Holdings common stock, of which approximately 17,087,948 shares are held by Mr. Wand and 15,232,867 shares are held by Mr. Wand as trustee of a trust, |
and (ii) approximately 4,586,013 shares of Hippo Holdings common stock issuable pursuant to Hippo options of which all are held by Mr. Wand and none are held by Mr. Wand as trustee of a trust. |
(8) | Shares hereby offered consist of 1,500,000 PIPE Shares held directly by Baron Real Estate Fund. Baron Real Estate Fund is an investment company registered under the Investment Company Act of 1940. Ronald Baron, the Chief Executive Officer of Baron Select Funds, of which Baron Real Estate Fund is a series, and has voting and/or investment control over the shares held by Baron Real Estate Fund. Mr. Baron disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of Baron Real Estate Fund is 767 Fifth Avenue, 49 th Floor, New York, New York 10153. |
(9) | Shares hereby offered consist of 25,000 PIPE Shares held directly by Beagle Limited. Beagle Limited is a corporation organized under the laws of Bermuda. Giovanni Pigozzi is the beneficial owner of Beagle Limited and has voting and/or investment control over the shares held by Beagle Limited. Mr. Pigozzi disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of Baron Real Estate Fund is 767 Fifth Avenue, 49 th Floor, New York, New York 10153. |
(10) | Shares hereby offered consist of 500,000 PIPE Shares held directly by BHHP LLC. BHHP LLC is a limited partnership organized under Delaware law. Chaim Tvzi Nash and Shmuel Gniwisch are the managers of Kli Capital LLP, a Delaware limited liability company and general partner of BHHP LLC, and have voting and/or investment control over the shares held by BHHP LLC. Mr. Nash and Mr. Gniwisch disclaim beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of BHHP LLC is 1083 Main Street, Champlain, New York 12919. |
(11) | Consists of 30,003,193 shares of Hippo Holdings common stock held in the name of BOND Capital Fund, LP, as nominee, for the account of BOND Capital Fund, LP and BOND Capital Founders Fund, LP (together, the “BOND Funds”). Daegwon Chae, Juliet de Baubigny, Noah Knauf, Mary Meeker, Mood Rowghani, Jay Simons and Paul Vronsky are managing members of BOND Capital Associates, LLC, the general partner of the BOND Funds, and share voting and dispositive power over the shares held for the account of the BOND Funds. The address of each of these entities is 100 The Embarcadero, San Francisco, California 94105. |
(12) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Byron Auguste. |
(13) | Shares hereby offered consist of 140,000 PIPE Shares. |
(14) | Shares hereby offered consist of 700,000 PIPE Shares held directly by Diameter Master Fund LP and 181,128 warrants, of which (i) 140,064 warrants are held by Diameter Master Fund LP, (ii) 16,700 warrants are held by Diameter SPO Master Fund LP and (iii) 24,364 warrants are held by Diameter Dislocation Master Fund LP. Diameter Capital Partners LP is the investment manager of the Diameter Master Fund LP and, therefore, has investment and voting power over these shares. Scott Goodwin and Jonathan Lewinsohn, as the sole managing members of the general partner of the investment manager, make voting and investment decisions on behalf of the investment manager. As a result, the investment manager, Mr. Goodwin and Mr. Lewinsohn may be deemed to be the beneficial owners of these shares. Notwithstanding the foregoing, each of Mr. Goodwin and Mr. Lewinsohn disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of Diameter Master Fund LP is 55 Hudson Yards, 29B, New York, New York 10001. |
(15) | Shares hereby offered consist of 500,000 PIPE Shares held directly by Dragoneer Global Fund II, L.P. and 2,829,237 shares of Hippo Holdings common stock held by Hungry DF Holdings, LP, an affiliate of Dragoneer Global Fund II, L.P. (together, “Dragoneer”). Dragoneer’s registered investment adviser is Dragoneer Investment Group, LLC (“Dragoneer Adviser”). Cardinal DIG CC, LLC (“Cardinal” and together with Dragoneer and Dragoneer Adviser, the “Dragoneer Entities”) is the managing member of Dragoneer Adviser. Marc Stad is the sole member of Cardinal. By virtue of these relationships, Marc Stad and each of the Dragoneer Entities may be deemed to share voting and dispositive power with respect to |
shares held by Dragoneer The business address for Mr. Stad and each of the Dragoneer Entities is 1 Letterman Drive, Building D M-500, San Francisco, CA 94129. |
(16) | Shares hereby offered consist of 700,000 PIPE Shares and 77,750 warrants held directly by EMJ Master Fund LP. EMJ Master Fund LP is a limited partnership organized pursuant to the Exempted Limited Partnership Law, 2018 of the Cayman Islands. Eric M. Jackson is the president and founder of EMJ Capital Ltd, an Ontario corporation which acts as Investment Manager to EMJ Master Fund LP and has voting and/or investment control over the shares held by EMJ Master Fund LP. Mr. Jackson disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The legal address of EMJ Master Fund LP is c/o Waystone Governance Ltd., Suite 5B201, 2nd Floor, One Nexus Way, PO Box 2587, KY1-1103, Cayman Islands and the business address 1370 Don Mills Road, Suite 300, Toronto, Ontario, Canada M3B 3N7. |
(17) | Shares hereby offered consist of 500,000 PIPE Shares, of which (i) 455,000 are held by Brosh Capital Partners L.P., (ii) 22,500 are held by Halman Aldubi on behalf of Roni Biram and (iii) 22,500 are held by Halman Aldubi on behalf of Ester Deutsch. Brosh Capital Partners L.P. is a limited partnership organized under the laws of the Cayman Islands. Amir Efrati is the CEO and Director of Exodus Management Israel Ltd., which is the general partner of Brosh Capital Partners L.P. and has voting and/or investment control over the shares held by Brosh Capital Partners L.P. Mr. Efrati disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for the above-referenced entities is 4 Ariel Sharon Street, Givataim 5320047 Israel. |
(18) | Shares hereby offer consist of 3,011,418 PIPE Shares, which consists of (i) 2,405,228 common shares held by The Growth Fund of America (“GFA”), (ii) 580,847 common shares held by American Funds Insurance Series – Growth Fund (“VIG” and, together with GFA, the “CRMC Stockholders”), and (iii) 25,343 common shares held by Capital Group Growth Fund of America Trust (US) (“TGFA”). Capital Research and Management Company (“CRMC”) is the investment adviser or subadviser for each CRMC Stockholder. Capital Bank and Trust Company (“CB&T”) is the discretionary trustee and investment adviser for TGFA, and CRMC has been retained by CB&T as investment adviser to CB&T. For purposes of the reporting requirements of the Exchange Act, CRMC and Capital International Investors (“CII”) may be deemed to be the beneficial owner of the common shares held by each CRMC Stockholder; however, each of CRMC and CII expressly disclaims that each is, in fact, the beneficial owner of such securities. For purposes of the reporting requirements of the Exchange Act, CB&T, CRMC and CII may be deemed to be the beneficial owner of the common shares held by TGFA; however, each of CB&T, CRMC and CII expressly disclaims that it is, in fact, the beneficial owner of such securities. Christopher D. Buchbinder, Mark L. Casey, Barry S. Crosthwaite, J. Blair Frank, Joanna F. Jonsson, Carl M. Kawaja, Donald D. O’Neal, Anne-Marie Peterson, Alex Popa, Andraz Razen, Martin Romo, Lawrence R. Solomon, and Alan J. Wilson, as portfolio managers, have voting and investment powers over the shares held by GFA. Christopher D. Buchbinder, Mark L. Casey, Barry S. Crosthwaite, J. Blair Frank, Joanna F. Jonsson, Carl M. Kawaja, Donald D. O’Neal, Anne-Marie Peterson, Alex Popa, Andraz Razen, Martin Romo, Lawrence R. Solomon, and Alan J. Wilson, as portfolio managers, have voting and investment powers over the shares held by VIG. Christopher D. Buchbinder, Mark L. Casey, Barry S. Crosthwaite, J. Blair Frank, Joanna F. Jonsson, Carl M. Kawaja, Donald D. O’Neal, Anne-Marie Peterson, Alex Popa, Andraz Razen, Martin Romo, Lawrence R. Solomon, and Alan J. Wilson, as portfolio managers, have voting and investment powers over the shares held by TGFA. The address for each of the CRMC Stockholders and VIG is c/o Capital Research and Management Company, 333 S. Hope St., 50th Floor, Los Angeles, California 90071. Each of the CRMC Stockholders and VIG acquired the securities being registered hereby in the ordinary course of its business. |
(19) | Shares hereby offered consist of 1,000,000 PIPE Shares, of which (i) 430,000 are held by Clal Insurance Company Ltd. and (ii) 570,000 are held by Clal Pension and Provident Funds Ltd. (together, the “Clal Insurance Companies”). The Clal Insurance Companies are insurance companies organized under the laws of Israel. Barak Benksi and Dov Caspi are the chief investment officer and deputy chief investment officer of the Clal Insurance Companies, respectively, and have voting and/or investment control over the shares held by the Clal Insurance Companies. Mr. Benski and Mr. Caspi disclaim beneficial ownership of the |
securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for the above-referenced entities is 4 Ariel Sharon Street, Givataim 5320047 Israel. |
(20) | Consists of 26,823,284 shares of Hippo Holdings common stock, of which (i) 26,388,639 are held by Comcast Ventures, LP and (ii) 434,645 are held by Comcast Warranty and Home Insurance. The business address for Comcast Ventures, LP and Comcast Warranty and Home Insurance is 1701 John F. Kennedy Boulevard, Philadelphia, Pennsylvania 19103. |
(21) | Shares hereby offered consist of 600,000 PIPE Shares, of which (i) 246,000 are held by Pinehurst Partners, L.P., (ii) 108,000 are held by Corbin Opportunity Fund, L.P. and (iii) 246,000 are held by Corbin ERISA Opportunity Fund, Ltd. Corbin Capital Partners, L.P. (“CCP”) is the investment manager of Pinehurst Partners, L.P., Corbin Opportunity Fund, L.P. and Corbin ERISA Opportunity Fund, Ltd. Corbin Capital Partners, L.P. and its general partner, Corbin Capital Partners Group, LLC, may be deemed beneficial owners of the Company securities being registered in the Registration Statement on behalf of Corbin ERISA Opportunity Fund, Ltd., Pinehurst Partners, L.P. and Corbin Opportunity Fund, L.P. Craig Bergstrom is the Chief Investment Officer of Corbin Capital Partners, L.P., the investment manager of Pinehurst Partners, L.P., Corbin Opportunity Fund, L.P. and Corbin ERISA Opportunity Fund, Ltd., and accordingly may be deemed to have voting and dispositive power with respect to shares held by Pinehurst Partners, L.P., Corbin Opportunity Fund, L.P. and Corbin ERISA Opportunity Fund, Ltd. Mr. Bergstrom disclaims beneficial ownership of such shares. The business address of each of the above-mentioned funds is 590 Madison Avenue, 31 st Floor, New York, New York 10022. |
(22) | Shares hereby offered consist of 3,000,000 PIPE Shares, of which (i) 2,655,000 are held by Darlington Partners, LP and (ii) 345,000 are held by Darlington Partners II, LP (together, the “Darlington Funds”). Darlington Partners GP, LLC is the general partner of the Darlington Funds and have voting and/or investment control over the shares held by the Darlington Funds. Darlington Partners GP, LLC disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of the Darlington Funds is 300 Drakes Landing Road, Suite 290, Greenbrae, California 94904. |
(23) | Consists of 74,168,521 shares of Hippo Holdings common stock, of which (i) 51,447,246 are common stock directly held by Fifth Wall Ventures SPV IV L.P., (ii) 458,603 are common stock directly held by Fifth Wall Ventures SPV XVII, L.P. and (iii) 22,262,672 are common stock directly held by Fifth Wall Ventures, L.P. Fifth Wall Ventures, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (i) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. The address of the above persons and entities is 11360 Mindanao Way, Suite 100B, Marina Del Rey, California 90292. |
(24) | Shares hereby offered consist of 24,872,544 shares of Hippo Holdings common stock held by Digital Fortune Limited and 2,000,000 PIPE Shares, of which (i) 24,750 are held by Celestial Ally Limited, (ii) 982,801 are held by Eliot International Limited, (iii) 982,801 are held by Famous Giant Limited and (iv) 9,828 are held by Moon Stream Investments Limited. Kang Tzu Ping is the ultimate beneficial owner of Celestial Ally Limited and as such, Ms. Kang may be deemed to beneficially own the PIPE Shares directly held by Celestial Ally Limited. Chau Hoi Shuen Solina Holly is the ultimate beneficial owner of Eliot International Limited and as such, Ms. Chau may be deemed to beneficially own the PIPE Shares directly held by Eliot International Limited. Li Ka Shing is the ultimate beneficial owner of Famous Giant Limited and as such, Mr. Li may be deemed to beneficially own the PIPE Shares directly held by Famous Giant Limited. The business address of each of the above-mentioned entities is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands. |
(25) | Shares hereby offered consist of (i) 313,079 PIPE Shares, held by Lugard Road Capital Master Fund, LP (“Lugard”) beneficially owned by Luxor Capital Group, LP, the investment manager of Lugard; (ii) 3,544 PIPE Shares held by Luxor Capital Partners Long Offshore Master Fund, LP (“Luxor Long Offshore”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Long Offshore (iii) 10,656 PIPE Shares held by Luxor Capital Partners Long, LP (“Luxor Long”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Long; (iv) 198,491 PIPE Shares held by Luxor Capital |
Partners Offshore Master Fund, LP (“Luxor Offshore”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Offshore; (v) 315,949 PIPE Shares held by Luxor Capital Partners, LP (“Luxor Capital”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Capital; and (vi) 158,281 PIPE Shares held by Luxor Wavefront, LP (“Luxor Wavefront”) beneficially owned by Luxor Capital Group, LP, the investment manager of Luxor Wavefront. Christian Leone, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and investment power with respect to the securities owned by Luxor Long Offshore, Luxor Long, Luxor Offshore, Luxor Capital, and Luxor Wavefront. Jonathan Green, in his position as Portfolio Manager at Luxor Capital Group, LP, may be deemed to have voting and investment power with respect to the securities held by Lugard. Mr. Leone and Mr. Green each disclaims beneficial ownership of any of the PIPE shares over which each exercises voting and investment power. The mailing address of each of the above-mentioned funds is 1114 Avenue of the Americas, 28th Fl New York, NY 10036. |
(26) | Shares hereby offered consist of 1,200,000 PIPE Shares, of which (i) 1,100,000 are held by Integrated Core Strategies (US) LLC (“Integrated Core Strategies”) and (ii) 100,000 are held by ICS Opportunities, Ltd. (“ICS Opportunities”), 28,494 warrants, of which (i) 100 warrants are held by Integrated Core Strategies and (ii) 28,394 warrants are held by ICS Opportunities and 225,239 shares of Hippo Holdings common stock held directly by ICS Opportunities II LLC. Millennium International Management LP, a Delaware limited partnership (“Millennium International Management”), is the investment manager to ICS Opportunities and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities. Millennium Management LLC, a Delaware limited liability company (“Millennium Management”), is the general partner of the managing member of Integrated Core Strategies and may be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Management is also the general partner of the 100% owner of ICS Opportunities and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities. Millennium Group Management LLC, a Delaware limited liability company (“Millennium Group Management”), is the managing member of Millennium Management and may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies. Millennium Group Management is also the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities. The managing member of Millennium Group Management is a trust of which Israel A. Englander, a United States citizen (“Mr. Englander”), currently serves as the sole voting trustee. Therefore, Mr. Englander may also be deemed to have shared voting control and investment discretion over securities owned by Integrated Core Strategies and ICS Opportunities. The business address of the above-referenced entities is c/o Millennium Management LLC 399 Park Avenue, New York, New York 10022. |
(27) | Shares hereby offered consist of 4,000,000 PIPE Shares, of which (i) 3,642,400 are held by Park West Investors Master Fund, Limited and (ii) 357,600 are held by Park West Partners International, Limited (collectively, the “PW Funds”). Park West Asset Management LLC is the investment manager to the PW Funds. Peter S. Park, through one or more affiliated entities, is the controlling manager of Park West Asset Management LLC. The business address for the PW Funds is c/o Park West Asset Management LLC, 900 Larkspur Landing Circle, Suite 165, Larkspur, California 94939. |
(28) | Shares hereby offered consist of 2,000,000 PIPE Shares, of which (i) 488,200 are held by Saba Capital Master Fund, Ltd., (ii) 1,325,600 are held Saba Capital Master Fund II, Ltd. and (iii) 186,200 are held by Saba Capital Master Fund III, L.P. (the “Saba Funds”). Boaz Weinstein is the managing member of the general partner of the Saba Funds investment manager and accordingly may be deemed to have voting and dispositive power with respect to shares held by the Saba Funds. Mr. Boaz disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of the Saba Funds is c/o Saba Capital Management, LP, 405 Lexington Avenue, 58 th Floor, New York, New York 10174. |
(29) | Shares hereby offered consist of 500,000 PIPE Shares, of which (i) 224,631 are held by Samlyn Offshore Master Fund, Ltd., (ii) 180,352 are held Samlyn Net Neutral Master Fund, Ltd., (iii) 89,538 are held by |
Samlyn Onshore Fund, LP and (iv) 5,479 are held by Samlyn Long Alpha Master Fund, Ltd. (the “Samlyn Funds”). The reported securities are directly owned by the Samlyn Funds, and may be deemed to be indirectly beneficially owned by (i) Samlyn Capital, LLC, as the investment manager of the Samlyn Funds, and (ii) Samlyn Partners, LLC (“Samlyn Partners”), as the general partner of the Samlyn Funds. The reported securities may also be deemed to be indirectly beneficially owned by Robert Pohly as the principal of Samlyn Capital and Managing Member of Samlyn Partners. Samlyn Capital, Samlyn Partners and Robert Pohly disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Exchange Act or for any other purpose. The business address of the Samlyn Funds is c/o Samlyn Capital, LLC, 500 Park Avenue, New York, New York 10022. |
(30) | Shares hereby offered consist of 1,000,000 PIPE Shares, of which (i) 565,000 are held by SDP Flagship Master Fund, L.P., (ii) 200,000 are held by NPB Manager Fund, SPC., on behalf of and for the account of Segregated Portfolio 103, (iii) 170,000 are held by SDP Opportunities Master Fund, L.P. and (iv) 65,000 are held by NPB Manager Fund, SPC., on behalf of and for the account of Segregated Portfolio 102 (together, the “Sentinel Entities”). Qazi Munirul Alam is the chief investment officer of Sentinel Dome Partners, LLC, the investment adviser to the Sentinel Entities and has voting and/or investment control over the shares held by the Sentinel Entities. The business address of the Sentinel Entities is 3 Embarcadero Center, Suite 1680, San Francisco, California 94111. |
(31) | Shares hereby offered consist of 650,000 PIPE Shares, of which (i) 250,000 are held by Serengeti Caracal Multi-Series Master LLC — Series AL, (ii) 100,000 are held Serengeti Multi-Series Master LLC — Series C II, (iii) 150,000 are held by Serengeti Multi-Series Master LLC — Series SPC II, (iv) 50,000 are held by Serengetie Multi-Series Master LLC — Series USF and (v) 100,000 are held by Serengeti Opportunities MM LP. Shares hereby offered also consist of 50,000 warrants, of which (i) 30,000 warrants are held by Serengeti Opportunities MM LP and (ii) 20,000 warrants are held by Serengeti Multi-Series Master LLC. Serengeti Asset Management LP is investment adviser for Serengeti Caracal Multi-Series Master LLC — Series AL. J.L. Serengeti Management LLC is the general partner of Serengeti Asset Management LP. Joseph A. LaNasa III is the managing member of J.L. Serengeti Management LLC. In such capacities, each of Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa may be deemed to have voting and dispositive power over the shares held by Serengeti Caracal Multi-Series Master LLC — Series AL. Mr. LaNasa disclaims beneficial ownership of these shares. The address for Serengeti Caracal Multi-Series Master LLC — Series AL, Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa is 632 Broadway, Suite 901, New York, NY 10012. Serengeti Asset Management LP is investment adviser for Serengeti Multi-Series Master LLC — Series C II. J.L. Serengeti Management LLC is the general partner of Serengeti Asset Management LP. Joseph A. LaNasa III is the managing member of J.L. Serengeti Management LLC. In such capacities, each of Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa may be deemed to have voting and dispositive power over the shares held by Serengeti Multi-Series Master LLC — Series C II. Mr. LaNasa disclaims beneficial ownership of these shares. The address for Serengeti Multi-Series Master LLC — Series C II, Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa is 632 Broadway, Suite 901, New York, NY 10012. Serengeti Asset Management LP is investment adviser for Serengeti Multi-Series Master LLC — Series SPC II. J.L. Serengeti Management LLC is the general partner of Serengeti Asset Management LP. Joseph A. LaNasa III is the managing member of J.L. Serengeti Management LLC. In such capacities, each of Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa may be deemed to have voting and dispositive power over the shares held by Serengeti Multi- Series Master LLC — Series SPC II. Mr. LaNasa disclaims beneficial ownership of these shares. The address for Serengeti Multi-Series Master LLC — Series SPC II, Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa is 632 Broadway, Suite 901, New York, NY 10012. Serengeti Asset Management LP is investment adviser for Serengeti Multi-Series Master LLC — Series USF. J.L. Serengeti Management LLC is the general partner of Serengeti Asset Management LP. Joseph A. LaNasa III is the managing member of J.L. Serengeti Management LLC. In such capacities, each of Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa may be deemed to have voting and |
dispositive power over the shares held by Serengeti Multi-Series Master LLC — Series USF. Mr. LaNasa disclaims beneficial ownership of these shares. The address for Serengeti Multi-Series Master LLC — Series USF, Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa is 632 Broadway, Suite 901, New York, NY 10012. Serengeti Asset Management LP is investment adviser for Serengeti Opportunities MM LP. J.L. Serengeti Management LLC is the general partner of Serengeti Asset Management LP. Joseph A. LaNasa III is the managing member of J.L. Serengeti Management LLC. In such capacities, each of Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa may be deemed to have voting and dispositive power over the shares held by Serengeti Opportunities MM LP. Mr. LaNasa disclaims beneficial ownership of these shares. The address for Serengeti Opportunities MM LP, Serengeti Asset Management LP, J.L. Serengeti Management LLC and Mr. LaNasa is 632 Broadway, Suite 901, New York, NY 10012. |
(32) | Shares hereby offered consist of 600,000 PIPE Shares, of which (i) 595,000 are held by Suvretta Master Fund, Ltd. and (ii) 5,000 are held by Suvretta Long Master Fund, Ltd. (together, the “Suvretta Funds”). The Suvretta Funds are exempt companies organized under the laws of the Cayman Islands. Aaron Cowen is the control person of Suvretta Capital Management, LLC, the investment manager of the Suvretta Funds and has voting and/or investment control over the shares held by the Suvretta Funds. The business address for the Suvretta Funds is 540 Madison Avenue, 7 th Floor, New York, New York 10022. |
(33) | Shares hereby offered consist of 300,000 PIPE Shares, of which (i) 137,970 are held by Nineteen77 Global Multi-Strategy Alpha Master Limited, (ii) 137,970 are held by Nineteen77 Global Merger Arbitrage Master Limited, (ii) 23,040 are held by Nineteen77 Global Merger Arbitrage Opportunity Fund and (iv) 1,020 are held by IAM Investments ICAV – O’Connor Event Driven UCITS Fund (together, the “UBS Entities”). Kevin Russell, the chief investment officer of UBS O’Connor LLC, the investment manager of the UBS Entities, has voting and/or investment control over the shares held by the UBS Entities. Mr. Russell disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for the UBS Entities is c/o UBS O’Connor LLC, One North Wacker Drive, 31 st Floor, Chicago, Illinois 60606. |
(34) | Shares offered hereby consist of 1,000,000 PIPE Shares held directly by Gan Eden Ventures, Inc. Gan Eden Ventures, Inc. is a corporation organized under Canadian law. Mark Chess and Edward Weisz are the directors of Gan Eden Ventures, Inc. and have voting and/or investment control over the shares held by Gan Eden Ventures, Inc. The business address of Gan Eden Ventures, Inc. is 1 Herons Will Way, Toronto, Ontario, Canada M2J O2G. |
(35) | Shares offered hereby consist of 100,000 PIPE Shares held directly by Garden Fund, LLC. Garden Fund, LLC is a limited liability company organized under California law. The business address of Garden Fund, LLC is 1 Sansome Street, Suite 3500, San Francisco, California 94104. |
(36) | Shares hereby offered consist of 500,000 PIPE Shares held directly by Ghisallo Master Fund LP. Michael Germino is a control person for Ghisallo Master Fund LP. The address for Ghisallo Master Fund LP is 190 Elgin Avenue, George Town, Grand Cayman, Cayman Islands KY 1-9008. |
(37) | Shares hereby offered consist of 500,000 PIPE Shares held directly by Gores HP, LLC. Gores HP, LLC is a partnership organized under the laws of Delaware. The business address of Gores HP, LLC is 6260 Lookout Road, Boulder, Colorado 80301. |
(38) | Shares hereby offered consist of 500,000 PIPE Shares held in trust by Gundy Co for The HCG Fund LP. The HCG Fund LP is a limited partnership organized under the laws of Canada. Sean Kallir is the chief executive officer and primary manager of HCG Investment Management Inc., the investment manager of The HCG Fund LP and has voting and/or investment control over the shares held by The HCG Fund LP. The business address of The HCG Fund LP is 366 Adelaide St W, Suite 601, Toronto, ON, M5V 1R9. |
(39) | Shares hereby offered consist of 500,000 PIPE Shares and 29,682 warrants held by clients of Hound Partners, LLC. Hound Partners, LLC is a limited liability company organized under the laws of Delaware. Jonathan Auerbach is the portfolio manager of Hound Partners, LLC and has voting and/or investment control over the shares held by such clients. The business address of Hound Partners, LLC is 101 Park Avenue, 48th Floor, New York, New York 10178. |
(40) | Consists of 1,076,362 shares of Hippo Holdings common stock, all of which are held by Mr. Frater as trustee of a trust. |
(41) | Shares hereby offered consist of 600,000 PIPE Shares held directly by Invus Public Equities, L.P. Invus Public Equities Advisors, LLC (“Invus PE Advisors”) controls Invus PE, as its general partner and accordingly, may be deemed to beneficially own the shares held by Invus PE. Artal Treasury Limited (“Artal Treasury”) controls Invus PE Advisors, as its managing member and accordingly, may be deemed to beneficially own the shares held by Invus PE. Artal International S.C.A. (“Artal International”) through its Geneva branch, is the sole stockholder of Artal Treasury and may be deemed to beneficially own the 600,000 shares that Artal Treasury may be deemed to beneficially own. Artal International Management S.A. (“Artal International Management”), as the managing partner of Artal International, controls Artal International and accordingly, may be deemed to beneficially own the shares that Artal International may be deemed to beneficially own. Artal Group S.A., as the sole stockholder of Artal International Management, controls Artal International Management and accordingly, may be deemed to beneficially own the shares that Artal International Management may be deemed to beneficially own. Westend S.A. (“Westend”), as the parent company of Artal Group S.A. (“Artal Group”), controls Artal Group and accordingly, may be deemed to beneficially own the shares that Artal Group may be deemed to beneficially own. Stichting Administratiekantoor Westend (the “Stichting”), as majority shareholder of Westend, controls Westend and accordingly, may be deemed to beneficially own the shares that Westend may be deemed to beneficially own. As of August 17,2021 Mr. Amaury Wittouck, as the sole member of the board of the Stichting, controls the Stichting and accordingly, may be deemed to beneficially own the shares that the Stichting may be deemed to beneficially own. The business address of Invus Public Equities, L.P. is 750 Lexington Avenue, 30 th Floor, New York, New York 10022. |
(42) | Shares hereby offered consist of 400,000 PIPE Shares held directly by Jane Street Global Trading, LLC and 38,903 warrants. Jane Street Global Trading, LLC is a wholly owned subsidiary of Jane Street Group, LLC. Michael A. Jenkins and Robert. A. Granieri are the members of the Operating Committee of Jane Street Group, LLC and have voting and/or investment control over the shares held by Jane Street Global Trading, LLC. The business address of Jane Street Global Trading LLC is 250 Vesey Street, 3 rd Floor, New York, New York 10281. |
(43) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Julie Hanna. |
(44) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Lee Linden. |
(45) | Shares hereby offered consist of 100,000 PIPE Shares owned directly by LEN FW Investor, LLC and 80,686,369 shares of Hippo Holdings common stock, of which (i) 51,447,246 are common stock directly held by Fifth Wall Ventures SPV IV L.P., and (ii) 29,239,123 are common stock directly held by LEN FW Investor, LLC. Fifth Wall Ventures, L.P. has granted LEN FW Investor, LLC an irrevocable voting proxy in respect of the shares referred to in clause (i) herein, which are held directly by Fifth Wall Ventures SPV IV L.P. The address of the above persons and entities is 11360 Mindanao Way, Suite 100B, Marina Del Rey, California 90292. |
(46) | Consists of 30,000 shares of Hippo Holdings common stock held directly by Linda Rottenberg. |
(47) | Shares hereby offered consist of 500,000 PIPE Shares held directly by Linden Capital L.P. The securities held by Linden Capital L.P. are indirectly held by Linden Advisors LP (the investment manager of Linden Capital L.P.), Linden GP LLC (the general partner of Linden Capital L.P.), and Mr. Siu Min (Joe) Wong (the principal owner and the controlling person of Linden Advisors LP and Linden GP LLC). Linden Capital L.P., Linden Advisors LP, Linden GP LLC and Mr. Wong share voting and dispositive power with respect to the securities held by Linden Capital L.P. The business address of Linden Capital L.P. is c/o Linden Advisors LP, 590 Madison Avenue, 15 th Floor, New York, New York 10022. |
(48) | Shares hereby offered consist of 100,000 PIPE Shares held directly by Madison Rock Investments LP. Madison Rock Investments LP is a partnership organized under the laws of Delaware. The business address of Madison Rock Investments LP is 630 Fifth Avenue, New York, New York 10111. |
(49) | Shares hereby offered consist of 250,000 PIPE Shares held directly by Octahedron Master Fund, L.P. Octahedron Master Fund, L.P. is a limited partnership organized under the laws of the Cayman Islands. Octahedron Fund GP LLC is the general partner of Octahedron Master Fund, L.P. Rajaraman Parameswaram is the managing member of Octahedron Fund GP LLC and has voting and/or investment |
control over the shares held by Octahedron Master Fund L.P. Mr. Parameswaram disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for Octahedron Mater Fund, L.P. is 4126 17 th Street, Suite #2, San Francisco, California 94114. |
(50) | Shares hereby offered consist of 2,000,000 PIPE Shares held directly by PBCAY One Limited. PBCAY One Limited is a company organized under the laws of the Cayman Islands. The business address of PBCAY One Limited is 201 The Exchange Building, DIFC, PO Box 116020, Dubai, U.A.E. |
(51) | Shares hereby offered consist of 1,000,000 PIPE Shares held directly by Psagot Provident Funds and Pensions Ltd. Psagot Provident Funds and Pensions Ltd is a management company organized under the laws of Israel. The business address for Psagot Provident Funds and Pensions Ltd is 14 Ahad Ha’am Street, Tel Aviv, Israel 6514211. |
(52) | Shares hereby offered consist of 1,000,000 PIPE Shares held directly by Reinvent Capital Fund LP. Reinvent Capital Fund GP LLC is the general partner of Reinvent Capital Fund LP. Due to its relationship with Reinvent Capital Fund LP, Reinvent Capital Fund GP LLC may be deemed to beneficially own the PIPE Shares directly held by Reinvent Capital Fund LP. Mark Pincus and Michael Thompson are the managing members of Reinvent Capital Fund GP LLC and may therefore be deemed to beneficially own the PIPE Shares held directly by Reinvent Capital Fund LP. Mr. Pincus and Mr. Thompson each disclaim beneficial ownership of the PIPE Shares held directly by Reinvent Capital Fund LP except to the extent of their pecuniary interest therein. The business address of Reinvent Capital Fund LP is 215 Park Avenue S, 11th Floor, New York, New York 10023. |
(53) | Shares offered hereby consist of (i) 5,630,000 shares of Hippo Holdings common stock held directly by the Sponsor and (ii) 4,400,000 shares of Hippo Holdings common stock issuable upon exercise of the private placement warrants. Each of Reid Hoffman, Mark Pincus, Michael Thompson, David Cohen, and Lee Linden (who are each former directors and/or officers of RTPZ), or entities related thereto, among others, are members of the Sponsor. Messrs. Hoffman and Pincus may be deemed to beneficially own shares held by the Sponsor by virtue of their shared control over the Sponsor. Other than Messrs. Hoffman and Pincus, no member of the Sponsor exercises voting or dispositive control over any of the shares held by the Sponsor. Each of Messrs. Hoffman and Pincus disclaims beneficial ownership of the ordinary shares held by the Sponsor, except to the extent of his pecuniary interest therein. The 4,400,000 private placement warrants offered hereby are held directly by the Sponsor. These securities are subject to a contractual lock-up as described under “Certain Relationships and Related Party Transactions — Old Hippo — Lockup Agreements. Certain Relationships and Related Party Transactions — Old Hippo — Registration Rights Agreement |
(54) | Shares hereby offered consist of 300,000 PIPE Shares held directly by Ribbit Capital VI, L.P. Ribbit Capital VI, L.P. is an exempt limited partnership organized under the laws of the Cayman Islands. Ribbit Capital GP VI, Ltd. is the general partner of Ribbit Capital VI, L.P. Meyer Malka is the director of Ribbit Capital GP VI, Ltd. and has voting and/or investment control over the shares held by Ribbit Capital VI, L.P. The business address for Ribbit Capital VI, L.P. is 362 University Avenue, Palo Alto, California 94301. |
(55) | Consists of (i) 4,324,332 shares of Hippo Holdings common stock, of which approximately 2,508,501 shares are held by Mr. McCathron and (ii) 667,633 shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(56) | Consists of 30,644,982 shares of Hippo Holdings, of which (i) 26,369,086 are common stock directly held by RPM Ventures III, L.P. and (ii) 4,275,687 are common stock directly held by BGW Ventures II, LP, an affiliate of RPM Ventures III, L.P. The address of the above persons and entities is 320 N. Main Street, Suite 400, Ann Arbor, Michigan 48104. |
(57) | Consists of (i) no shares of Hippo Holdings common stock and (ii) 81,130 shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(58) | Shares hereby offered consist of 1,000,000 PIPE Shares held directly by Schonfeld Strategic 460 Fund LLC. Schonfeld Strategic 460 Fund LLC is a limited liability company organized under the laws of Delaware. The |
business address of Schonfeld Strategic 460 Fund LLC is 460 Park Avenue, 19 th Floor, New York, New York 10022. |
(59) | Shares hereby offered consist of 2,250,000 PIPE Shares held directly by Senator Global Opportunity Master Fund L.P. Senator Global Opportunity Master Fund L.P. is a limited partnership organized under the laws of the Cayman Islands. Senator Investment Group LP (“Senator”) is investment manager of Senator Global Opportunity Master Fund L.P. and may be deemed to have voting and dispositive power with respect to the shares. The general partner of Senator is Senator Management LLC (the “Senator GP”). Douglas Silverman controls Senator GP, and, accordingly, may be deemed to have voting and dispositive power with respect to the shares held by this selling security holder. Mr. Silverman disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for Senator Global Opportunity Master Fund L.P. is 510 Madison Avenue, 28 th Floor, New York, New York 10022. |
(60) | Shares hereby offered consist of 75,000 PIPE Shares held directly by Shapero 2015 Trust. Daniel Shapero is the trustee for Shapero 2015 Trust and has voting and/or investment control over the shares held by Shapero 2015 Trust. The business address of Shapero 2015 Trust is 920 Hamilton Avenue, Palo Alto, California 94301. |
(61) | Shares hereby offered consist of 1,000,000 PIPE Shares held directly by Slate Path Master Fund LP. Slate Path Master Fund LP is an exempted limited partnership organized under the laws of the Cayman Islands. Slate Path Capital GP LLC is the general partner of Slate Path Master Fund LP. David Greenspan is the managing member of Slate Path Capital GP LLC and has voting and/or investment control over the shares held by Slate Path Master Fund LP. Mr. Greenspan disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address for Slate Path Master Fund LP is 717 Fifth Avenue, 16 th Floor, New York, New York 10022. |
(62) | Shares hereby offered consist of 700,000 PIPE Shares held directly by Smith’s Point Family Partners LLC. Smith’s Point Family Partners LLC is a limited liability company organized under the laws of Pennsylvania. The business address of Smith’s Point Family Partners LLC is PO Box 500, Gladwyne, Pennsylvania 19035. |
(63) | Consists of (i) 3,366,803 shares of Hippo Holdings common stock, 3,108,425 of which are held by Mr. Ellis and 258,378 of which are held for the benefit of Mr. Ellis by a trust and (ii) no shares of Hippo Holdings common stock issuable pursuant to Hippo options. |
(64) | Shares hereby offered consist of 2,000,000 PIPE Shares held directly by Soroban Opportunities Master Fund LP. Soroban Opportunities Master Fund LP is an exempted limited partnership organized under the laws of the Cayman Islands. Soroban Capital GP LLC may be deemed to beneficially own the shares by virtue of its role as general partner of Soroban Opportunities Master Fund LP. Soroban Capital Partners LP may be deemed to beneficially own the shares by virtue of its role as investment manager of Soroban Opportunities Master Fund LP. Soroban Capital Partners GP LLC may be deemed to beneficially own the shares by virtue of its role as general partner of Soroban Capital Partners LP. Eric W. Mandelblatt may be deemed to beneficially own the shares by virtue of his role as Managing Partner of Soroban Capital Partners GP LLC. Each of Soroban Capital GP LLC, Soroban Capital Partners LP, Soroban Capital Partners GP LLC and Eric W. Mandelblatt disclaim beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein. The business address of Soroban Opportunities Master Fund LP is c/o Soroban Capital Partners LP, 55 W 46 th Street, 32nd Floor, New York, New York 10036. |
(65) | Shares hereby offered consist of 10,000 PIPE Shares held directly by Adam Nash and Carolyn Nash as trustees of The Adam & Carolyn Nash Family Trust, U/D/T January 25, 2012. The business address of The Adam & Carolyn Nash Family Trust, U/D/T January 25, 2012 is 300 3rd Street, Suite 7, Los Altos, California 94022. |
(66) | Shares hereby offered consist of 1,000,000 PIPE Shares held by Third Point Loan LLC. (“TP Loan”). TP Loan holds the securities listed herein as nominee for funds managed and/or advised by Third Point LLC (“Third Point”) and not in its individual capacity. Daniel S. Loeb is the Chief Executive Officer of Third Point. By reason of the provisions of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Third Point and Mr. Loeb may be deemed to be the beneficial owners of the securities beneficially owned |
by TP Loan. Third Point and Mr. Loeb hereby disclaim beneficial ownership of all such securities, except to the extent of any indirect pecuniary interest therein. The business address for Mr. Loeb and the entities identified in this footnote is c/o Third Point LLC, 55 Hudson Yards, 51st Floor, New York, NY 10001. |
(67) | Shares hereby offered consist of 200,000 PIPE Shares held directly by Transcend Partners LLC. Transcend Partners LLC is a limited liability company organized under the laws of Delaware. Malcolm Fairbairn and Emily Fairbairn are members of Transcend Partners LLC and have voting and/or investment control over the shares held by Transcend Partners LLC. The business address of Transcend Partners LLC is 10 Orginda View, Orinda, California 94563. |
(68) | Shares hereby offered consist of 1,200,000 PIPE Shares held directly by Weiss Ventures I LLC. Weiss Ventures I LLC is a Delaware limited liability company wholly-owned by Brookdale Aggregate Holdings LLC (“BAH”), a private investment fund. BAH is a subsidiary owned by Brookdale International Partners, L.P. (“BIP”) and Brookdale Global Opportunity Fund (“BGO”). BIP and BGO are both private investment funds. Weiss Asset Management LP (“WAM”), a U.S.-based, SEC-registered investment adviser, is the investment manager of BIP and BGO. BIP GP LLC (“BIP GP”) is the general partner of BIP. WAM is the manager of Weiss Ventures I LLC and BAH. WAM GP is the general partner of WAM and the manager of BIP GP. Andrew Weiss is the managing member of WAM GP. Each of Andrew Weiss, BIP GP, WAM and WAM GP disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein. The business address of Weiss Ventures I LLC is 222 Berkeley Street, 16th Floor, Boston, Massachusetts 02116. |
(69) | Shares hereby offered consist of 600,000 PIPE Shares held directly by West Coast Equity Partners LLC. WCEP Management LLC is the managing company of West Coast Equity Partners LLC. Alexander Lazovsky, Anton Baranchuk and Sergey Yushin are the management members of WCEP Management LLC and have voting and/or investment control over the shares held by West Coast Equity Partners LLC. Mr. Lazovsky, Mr. Baranchuck and Mr. Yushin disclaim beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except as to such extent of such reporting person’s pecuniary interest in the securities. The business address of West Coast Equity Partners LLC is 703 Crestview Drive, San Carlos, California 94070. |
(70) | Shares hereby offered consist of 4,500,000 PIPE Shares held directly by XN Exponent Master Fund LP. XN Exponent Master Fund LP is a limited partnership organized under the laws of the Cayman Islands. XN Exponent Advisors LLC serves as investment manager to XN Exponent Master Fund LP (the “Fund”) and has discretionary authority to make investment decisions and determine how to vote any securities held by the Fund. XN Exponent Advisors LLC is wholly owned by XN LP, a registered investment advisor. The general partner of XN LP is XN Management GP LLC, which is indirectly controlled by Gaurav Kapadia. The principal business address of the entities referenced herein is 412 West 15th Street, 13th Floor, New York, New York. |
• | we have been or are to be a participant; |
• | the amount involved exceeds or will exceed $120,000; and |
• | any of our directors, executive officers or beneficial holders of more than 5% of our capital stock, or any immediate family member of, or person sharing the household with, any of these individuals (other than tenants or employees), had or will have a direct or indirect material interest. |
Name | Note Principal ($) | Number of Shares of Common Stock | ||||||
Mitsui Sumitomo Insurance Co., Ltd. (1) | 350,000,000 | 39,396,604 |
(1) | Mitsui Sumitomo Insurance Co., Ltd. will beneficially own (in the aggregate) more than 5% of outstanding Hippo capital stock upon conversion of the Hippo notes. |
Name | Number of Shares of Series E Preferred Stock | Aggregate Purchase Price ($) | ||||||
Bond Capital Fund, LP (1) | 915,369 | 17,999,999.09 | ||||||
Comcast Ventures, LP (2) | 50,853 | 999,983.57 | ||||||
Fifth Wall Ventures, L.P. (3) | 66,109 | 1,299,980.60 | ||||||
LEN FW Investor, LLC (4) | 381,403 | 7,499,984.88 | ||||||
RPM Ventures III, L.P. (5) | 50,853 | 999,983.57 |
(1) | Bond Capital Fund, LP and its affiliated funds beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series E preferred stock financing. Noah Knauf is currently, and was at the time of the Series E preferred stock financing, a member of the Old Hippo board of directors and a Member of the General Partner of Bond Capital Fund, LP. |
(2) | Comcast Ventures, LP and its affiliates beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series E preferred stock financing. Sam Landman is currently, and was at the time of the Series E preferred stock financing, a member of the Hippo board of directors and is no longer currently, but was at the time, a Managing Director of Comcast Ventures, LP. |
(3) | Fifth Wall Ventures, L.P. and their affiliated funds beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series E preferred stock financing. |
(4) | LEN FW Investor, LLC beneficially owned more than 5% of the Hippo capital stock outstanding at the time of the Series E preferred financing. Eric Feder is an officer of the parent of LEN FW Investor, LLC and is currently, and was at the time of the Series E preferred stock financing, a member of Hippo’s board of directors. |
(5) | RPM Ventures III, L.P. and its affiliates beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series E preferred stock financing. |
Name | Number of Shares of Series D Preferred Stock | Aggregate Purchase Price ($) | ||||||
Comcast Ventures, LP (1) | 131,937 | 2,000,719.06 | ||||||
RPM Ventures III, LP (2) | 294,304 | 4,462,884.72 | ||||||
Fifth Wall Ventures (3) | 198,713 | 3,013,323.67 | ||||||
LEN FW Investor, LLC (4) | 65,945 | 1,000,003.17 | ||||||
Fifth Wall Ventures SPV XVII, L.P. (3) | 65,945 | 1,000,003.17 |
(1) | Comcast Ventures, LP and its affiliates beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series D preferred stock financing. Sam Landman is currently, and was at the time of the Series D preferred stock financing, a member of Hippo’s board of directors and is no longer currently, but was at the time, a Managing Director of Comcast Ventures, LP. |
(2) | RPM Ventures III, L.P. and its affiliates beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series D preferred stock financing. |
(3) | Fifth Wall Ventures, L.P., Fifth Wall Ventures SPV XVII, L.P. and their affiliated funds beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series D preferred stock financing. |
(4) | LEN FW Investor, LLC beneficially owned more than 5% of the Hippo capital stock outstanding at the time of the Series D preferred financing. Eric Feder is an officer of the parent of LEN FW Investor, LLC and is currently, and was at the time of the Series E preferred stock financing, a member of Hippo’s board of directors. |
Name | Number of Shares of Series C Preferred Stock | Aggregate Purchase Price ($) | ||||||
BGW Ventures II, LP (1) | 654,949 | 4,613,928.40 | ||||||
RPM Ventures III, L.P. (1) | 310,314 | 2,186,073.39 | ||||||
Fifth Wall Ventures, L.P. (2) | 851,702 | 5,999,997.02 | ||||||
Fifth Wall Ventures SPV IV, L.P. (2)(3) | 3,548,760 | 24,999,999.32 | ||||||
Comcast Ventures, LP (4) | 1,119,705 | 7,888,001.51 |
(1) | RPM Ventures III, L.P., BGW Ventures II, LP and its affiliates beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series C preferred stock financing. |
(2) | Fifth Wall Ventures, L.P., Fifth Wall Ventures SPV XVII, L.P. and their affiliated funds beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series C preferred stock financing. |
(3) | LEN FW Investor, LLC may be deemed to beneficially own the Series C preferred stock directly owned by Fifth Wall Ventures SPV IV, L.P., and therefore may be deemed to have beneficially owned more than 5% of the Hippo capital stock outstanding at the time of the Series C preferred stock financing. Eric Feder is an officer of the parent of LEN FW Investor, LLC and is currently, and was at the time of the Series C preferred stock financing, a member of Hippo’s board of directors. |
(4) | Comcast Ventures, LP and its affiliates beneficially owned (in the aggregate) more than 5% of the Hippo capital stock outstanding at the time of the Series C preferred stock financing. Sam Landman is currently, and was at the time of the Series C preferred stock financing, a member of Old Hippo’s board of directors and is no longer currently, but was at the time, a Managing Director of Comcast Ventures, LP. |
• | Stock Transfer Agreement by and between Assaf Wand and ICONIQ Strategic Partners IV, L.P. dated July 17, 2019. |
• | Stock Transfer Agreement by and between Assaf Wand and FinTLV Ventures dated July 24, 2019. |
• | Stock Transfer Agreement by and between Assaf Wand and HH SUM-II Holdings Limited, LP dated July 24, 2019. |
• | Stock Transfer Agreement by and between Assaf Wand and ICONIQ Strategic Partners IV, L.P. dated July 24, 2019. |
• | Stock Transfer Agreement by and between Assaf Wand and Hut 8 Ventures Hunter I, L.P. dated August 21, 2019. |
• | Stock Transfer Agreement by and between Assaf Wand and the Wand Family Delaware Trust dated May 13, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and Bond Capital Fund, LP dated July 20, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and NPC Opportunity Fund dated July 20, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and Innovius Capital Canopus I, L.P. dated July 21, 2020. |
• | Stock Transfer Agreement by and between the Wand Family Delaware Trust and Celestial Ally Limited dated July 27, 2020. |
• | Stock Transfer Agreement by and between Ran Harpaz and Innovius Capital Canopus I, L.P. dated July 21, 2020. |
• | Stock Transfer Agreement by and between Ran Harpaz and Eric Reiner dated July 23, 2020. |
• | Stock Transfer Agreement by and between Stewart Ellis and Innovius Capital Canopus I, L.P. dated July 21, 2020. |
• | Stock Transfer Agreement by and between Aviad Pinkovezky and Innovius Capital Canopus I, L.P. dated July 21, 2020. |
• | any person who is, or at any time since the beginning of Hippo Holdings’ last fiscal year was, a director or executive officer of Hippo Holdings or a nominee to become a director of Hippo Holdings; |
• | any person who is known to be the beneficial owner of more than 5% of any class of Hippo Holdings voting securities; |
• | any immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, in-law orsister-in-law |
• | any firm, corporation or other entity in which any of the foregoing persons is a partner or principal, or in a similar position, or in which such person has a 5% or greater beneficial ownership interest; and |
• | any firm, corporation or other entity in which any director, executive officer, nominee or more than 5% beneficial owner is employed (whether or not as an executive officer). |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of the Hippo Holdings common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which Hippo Holdings send the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Anti-dilution Adjustments |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” (as defined below) of Hippo Holdings common stock except as otherwise described below; |
• | if, and only if, the Reference Value (as defined above under “— Redemption of warrants when the price per share of Hippo Holdings common stock equals or exceeds $18.00”) equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Anti-dilution Adjustments”); and |
• | if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
Redemption Date (period to expiration of warrants) | Fair Market Value of Hippo Holdings Common Stock | |||||||||||||||||||||||||||||||||||
£ 10.00 | 11.00 | 12.00 | 13.00 | 14.00 | 15.00 | 16.00 | 17.00 | ³ 18.00 | ||||||||||||||||||||||||||||
60 months | 0.261 | 0.281 | 0.297 | 0.311 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
57 months | 0.257 | 0.277 | 0.294 | 0.310 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
54 months | 0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.361 | |||||||||||||||||||||||||||
51 months | 0.246 | 0.268 | 0.287 | 0.304 | 0.320 | 0.333 | 0.346 | 0.357 | 0.361 | |||||||||||||||||||||||||||
48 months | 0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.361 | |||||||||||||||||||||||||||
45 months | 0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.330 | 0.343 | 0.356 | 0.361 | |||||||||||||||||||||||||||
42 months | 0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.361 | |||||||||||||||||||||||||||
39 months | 0.221 | 0.246 | 0.269 | 0.290 | 0.309 | 0.325 | 0.340 | 0.354 | 0.361 | |||||||||||||||||||||||||||
36 months | 0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.361 | |||||||||||||||||||||||||||
33 months | 0.205 | 0.232 | 0.257 | 0.280 | 0.301 | 0.320 | 0.337 | 0.352 | 0.361 | |||||||||||||||||||||||||||
30 months | 0.196 | 0.224 | 0.250 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.361 | |||||||||||||||||||||||||||
27 months | 0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.350 | 0.361 | |||||||||||||||||||||||||||
24 months | 0.173 | 0.204 | 0.233 | 0.260 | 0.285 | 0.308 | 0.329 | 0.348 | 0.361 | |||||||||||||||||||||||||||
21 months | 0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.361 | |||||||||||||||||||||||||||
18 months | 0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.361 | |||||||||||||||||||||||||||
15 months | 0.130 | 0.164 | 0.197 | 0.230 | 0.262 | 0.291 | 0.317 | 0.342 | 0.361 | |||||||||||||||||||||||||||
12 months | 0.111 | 0.146 | 0.181 | 0.216 | 0.250 | 0.282 | 0.312 | 0.339 | 0.361 | |||||||||||||||||||||||||||
9 months | 0.090 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.361 | |||||||||||||||||||||||||||
6 months | 0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.361 | |||||||||||||||||||||||||||
3 months | 0.034 | 0.065 | 0.104 | 0.150 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months | — | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
• | 1% of the total number of Hippo Holdings common stock then outstanding; or |
• | the average weekly reported trading volume of Hippo Holdings’ common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
• | ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
• | one or more underwritten offerings; |
• | block trades in which the broker-dealer will attempt to sell the shares of common stock or warrants as agent, but may position and resell a portion of the block as principal to facilitate the transaction; |
• | purchases by a broker-dealer as principal and resale by the broker-dealer for its accounts; |
• | an exchange distribution in accordance with the rules of the applicable exchange; |
• | privately negotiated transactions; |
• | distributions to their members, partners or shareholders; |
• | short sales effected after the date of the registration statement of which this prospectus is a part is declared effective by the SEC; |
• | through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; |
• | in market transactions, including transactions on a national securities exchange or quotations service or over-the-counter |
• | directly to one or more purchasers; |
• | through agents; |
• | broker-dealers may agree with the Selling Securityholders to sell a specified number of such shares of common stock or warrants at a stipulated price per share or warrant; and |
• | a combination of any such methods of sale. |
Page | ||||
Financial Statements (Audited) for the period from October 2, 2020 (inception) to December 31, 2020 | ||||
F-3 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
F-7 | ||||
F-8 | ||||
Financial Statements (Unaudited) for the three and six months ended June 30, 2021 | ||||
F-26 | ||||
F-27 | ||||
F-28 | ||||
F-29 | ||||
F-30 |
Page | ||||
F-47 | ||||
F-48 | ||||
F-49 | ||||
F-50 | ||||
F-51 | ||||
F-52 | ||||
F-92 | ||||
F-96 |
Page | ||||
F-97 | ||||
F-98 | ||||
F-99 | ||||
F-100 | ||||
F-101 |
Page | ||||
F-120 | ||||
F-121 | ||||
F-122 | ||||
F-123 | ||||
F-124 | ||||
F-125 |
Page | ||||
F-139 | ||||
F-140 | ||||
F-141 | ||||
F-142 | ||||
F-143 |
Assets: | ||||
Current assets | ||||
Cash | $ | 622,985 | ||
Prepaid expenses | 1,074,689 | |||
Total Current Assets | 1,697,674 | |||
Cash and investments held in Trust Account | 230,018,693 | |||
Total Assets | $ | 231,716,367 | ||
Liabilities and Shareholders’ Equity: | ||||
Current liabilities: | ||||
Accrued expenses | $ | 139,684 | ||
Due to related party | 11,560 | |||
Total current liabilities | 151,244 | |||
Deferred legal fees | 200,000 | |||
Deferred underwriting commissions | 8,050,000 | |||
Derivative warrant liabilities | 13,467,630 | |||
Total Liabilities | 21,868,874 | |||
Commitments and Contingencies | ||||
Class A ordinary shares, $0.0001 par value; 20,484,749 shares subject to possible redemption at $10.00 per share | 204,847,490 | |||
Shareholders’ Equity: | ||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; NaNissued and outstanding | 0 | |||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,515,251 shares issued and outstanding (excluding 20,484,749 shares subject to possible redemption) | 252 | |||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding | 575 | |||
Additional paid-in capital | 6,471,389 | |||
Accumulated deficit | (1,472,213 | ) | ||
Total shareholders’ equity | 5,000,003 | |||
Total Liabilities and Shareholders’ Equity | $ | 231,716,367 | ||
General and administrative expenses | $ | 250,366 | ||
Loss from operations | (250,366 | ) | ||
Other income (expense) | ||||
Unrealized gain on investments held in Trust Account | 18,693 | |||
Financing costs — derivative warrant liabilities | (374,490 | ) | ||
Change in fair value of derivative warrant liabilities | (866,050 | ) | ||
Total other income (expense) | (1,221,847 | ) | ||
Net loss | $ | (1,472,213 | ) | |
Basic and diluted weighted average shares outstanding of Class A ordinary shares | 23,000,000 | |||
Basic and diluted net loss per ordinary share | $ | 0 | ||
Basic and diluted weighted average shares outstanding of Class B ordinary shares | 5,750,000 | |||
Basic and diluted net loss per ordinary share | $ | (0.26 | ) | |
Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total Shareholders’ Equity | |||||||||||||||||||||||||
Class A | Class B | |||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||
Balance — October 2, 2020 (inception) | 0 | $ | 0 | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||||||
Issuance of Class B ordinary shares to Sponsor | — | — | 5,750,000 | 575 | 24,425 | — | 25,000 | |||||||||||||||||||||
Sale of units in initial public offering less fair value of public warrants | 23,000,000 | 2,300 | — | — | 223,608,210 | — | 223,610,510 | |||||||||||||||||||||
Offering costs | — | — | — | — | (12,703,714 | ) | — | (12,703,714 | ) | |||||||||||||||||||
Excess cash received over fair value of private placement warrants | — | — | — | — | 387,910 | — | 387,910 | |||||||||||||||||||||
Shares subject to possible redemption | (20,484,749 | ) | (2,048 | ) | — | — | (204,845,442 | ) | — | (204,847,490 | ) | |||||||||||||||||
Net loss | — | — | — | — | — | (1,472,213 | ) | (1,472,213 | ) | |||||||||||||||||||
Balance — December 31, 2020 | 2,515,251 | $ | 252 | 5,750,000 | $ | 575 | $ | 6,471,389 | $ | (1,472,213 | ) | $ | 5,000,003 | |||||||||||||||
Cash Flows from Operating Activities: | ||||
Net loss | $ | (1,472,213 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares | 25,000 | |||
Unrealized gain on investments held in Trust Account | (18,693 | ) | ||
Change in fair value of derivative warrant liabilities | 866,050 | |||
Financing costs — derivative warrant liabilities | 374,490 | |||
Changes in operating assets and liabilities: | ||||
Prepaid expenses | (1,074,689 | ) | ||
Accrued expenses | 54,684 | |||
Due to related party | 11,560 | |||
Net cash used in operating activities | (1,233,811 | ) | ||
Cash Flows from Investing Activities | ||||
Cash deposited in Trust Account | (230,000,000 | ) | ||
Net cash used in investing activities | (230,000,000 | ) | ||
Cash Flows from Financing Activities: | ||||
Repayment of note payable to related party | (60,093 | ) | ||
Proceeds received from initial public offering, gross | 230,000,000 | |||
Proceeds received from private placement | 6,600,000 | |||
Offering costs paid | (4,683,111 | ) | ||
Net cash provided by financing activities | 231,856,796 | |||
Net increase in cash | 622,985 | |||
Cash — beginning of the period | 0 | |||
Cash — end of the period | $ | 622,985 | ||
Supplemental disclosure of noncash activities: | ||||
Offering costs included in accrued expenses | $ | 85,000 | ||
Offering costs paid through note payable — related party | $ | 60,093 | ||
Deferred legal fees | $ | 200,000 | ||
Deferred underwriting commissions in connection with the initial public offering | $ | 8,050,000 | ||
Initial value of common stock subject to possible redemption | $ | 205,911,610 | ||
Change in value of common stock subject to possible redemption | $ | (1,064,120 | ) |
As of December 31, 2020 | ||||||||||||
As Previously Reported | Restatement Adjustment | As Restated | ||||||||||
Balance Sheet | ||||||||||||
Total assets | $ | 231,716,367 | $ | — | $ | 231,716,367 | ||||||
Liabilities and shareholders’ equity | ||||||||||||
Total current liabilities | $ | 151,244 | $ | — | $ | 151,244 | ||||||
Deferred legal fees | 200,000 | — | 200,000 | |||||||||
Deferred underwriting commissions | 8,050,000 | 8,050,000 | ||||||||||
Derivative warrant liabilities | 0 | 13,467,630 | 13,467,630 | |||||||||
Total liabilities | 8,401,244 | 13,467,630 | 21,868,874 | |||||||||
Class A common stock, $0.0001 par value; shares subject to possible redemption | 218,315,120 | (13,467,630 | ) | 204,847,490 | ||||||||
Shareholders’ equity | ||||||||||||
Preferred stock — $0.0001 par value | 0 | — | 0 | |||||||||
Class A common stock — $0.0001 par value | 117 | 135 | 252 | |||||||||
Class B common stock — $0.0001 par value | 575 | — | 575 | |||||||||
Additional paid-in-capital | 5,230,984 | 1,240,405 | 6,471,389 | |||||||||
Accumulated deficit | (231,673 | ) | (1,240,540 | ) | (1,472,213 | ) | ||||||
Total shareholders’ equity | 5,000,003 | — | 5,000,003 | |||||||||
Total liabilities and shareholders’ equity | $ | 231,716,367 | $ | — | $ | 231,716,367 | ||||||
Period From October 2, 2020 (Inception) Through December 31, 2020 | ||||||||||||
As Previously Reported | Restatement Adjustment | As Restated | ||||||||||
Statement of Operations | ||||||||||||
Loss from operations | $ | (250,366 | ) | $ | — | $ | (250,366 | ) | ||||
Other (expense) income: | ||||||||||||
Change in fair value of warrant liabilities | — | (866,050 | ) | (866,050 | ) | |||||||
Financing costs | — | (374,490 | ) | (374,490 | ) | |||||||
Unrealized gain on investments held in Trust Account | 18,693 | — | 18,693 | |||||||||
Total other (expense) income | 18,693 | (1,240,540 | ) | (1,221,847 | ) | |||||||
Net loss | $ | (231,673 | ) | $ | (1,240,540 | ) | $ | (1,472,213 | ) | |||
Basic and Diluted weighted-average Class A common stock outstanding | 23,000,000 | 23,000,000 | ||||||||||
Basic and Diluted net loss per Class A common shares | $ | 0.00 | $ | 0 | ||||||||
Basic and Diluted weighted-average Class B common stock outstanding | 5,750,000 | 5,750,000 | ||||||||||
Basic and Diluted net loss per Class B common shares | $ | (0.06 | ) | $ | (0.26 | ) | ||||||
Period From October 2, 2020 (Inception) Through December 31, 2020 | ||||||||||||
As Previously Reported | Restatement Adjustment | As Restated | ||||||||||
Statement of Cash Flows | ||||||||||||
Net loss | $ | (231,673 | ) | $ | (1,240,540 | ) | $ | (1,472,213 | ) | |||
Adjustments to reconcile net loss to net cash used in operating activities | 6,307 | 1,240,540 | 1,246,847 | |||||||||
Net cash used in operating activities | (1,233,811 | ) | — | (1,233,811 | ) | |||||||
Net cash used in investing activities | (230,000,000 | ) | — | (230,000,000 | ) | |||||||
Net cash provided by financing activities | 231,856,796 | — | 231,856,796 | |||||||||
Net change in cash | $ | 622,985 | $ | — | $ | 622,985 | ||||||
As of November 23, 2020 | ||||||||||||
As Previously Reported | Restatement Adjustment | As Restated | ||||||||||
Unaudited Condensed Balance Sheet | ||||||||||||
Total assets | $ | 233,001,707 | $ | — | $ | 233,001,707 | ||||||
Liabilities and shareholders’ equity | ||||||||||||
Total current liabilities | $ | 1,438,508 | $ | — | $ | 1,438,508 | ||||||
Deferred underwriting commissions | 8,050,000 | — | 8,050,000 | |||||||||
Derivative warrant liabilities | — | 12,601,580 | 12,601,580 | |||||||||
Total liabilities | 9,488,508 | 12,601,580 | 22,090,088 | |||||||||
Class A common stock, $0.0001 par value; shares subject to possible redemption | 218,513,190 | (12,601,580 | ) | 205,911,610 | ||||||||
Shareholders’ equity | ||||||||||||
Preferred stock - $0.0001 par value | — | — | — | |||||||||
Class A common stock - $0.0001 par value | 115 | 126 | 241 | |||||||||
Class B common stock - $0.0001 par value | 575 | — | 575 | |||||||||
Additional paid-in-capital | 5,032,916 | 374,364 | 5,407,280 | |||||||||
Accumulated deficit | (33,597 | ) | (374,490 | ) | (408,087 | ) | ||||||
Total shareholders’ equity | 5,000,009 | — | 5,000,009 | |||||||||
Total liabilities and shareholders’ equity | $ | 233,001,707 | $ | — | $ | 233,001,707 | ||||||
• | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted). |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; |
• | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and |
• | if the Reference Value is less than $ 18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Description | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||
Assets: | ||||||||||||
Investments held in Trust Account | $ | 230,017,782 | $ | 0 | $ | 0 | ||||||
Liabilities: | ||||||||||||
Derivative warrant liabilities — Public Warrants | $ | 0 | $ | 0 | $ | 6,762,630 | ||||||
Derivative warrant liabilities — Private Warrants | $ | 0 | $ | 0 | $ | 6,705,000 |
As of November 18, 2020 | As of December 31, 2020 | |||||||
Stock price | $ | 9.72 | $ | 9.98 | ||||
Volatility | 23.20 | % | 23.50 | % | ||||
Expected life of the options to convert | 5.6 | 5.5 | ||||||
Risk-free rate | 0.47 | % | 0.43 | % | ||||
Dividend yield | 0 | 0 |
June 30, 2021 | December 31, 2020 | |||||||
(unaudited) | ||||||||
Assets: | ||||||||
Current assets: | ||||||||
Cash | $ | 101,045 | $ | 622,985 | ||||
Prepaid expenses | 800,310 | 1,074,689 | ||||||
Total current assets | 901,355 | 1,697,674 | ||||||
Cash and investments held in Trust Account | 230,004,108 | 230,018,693 | ||||||
Total Assets | $ | 230,905,463 | $ | 231,716,367 | ||||
Liabilities and Shareholders’ Equity: | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 89,189 | $ | 0 | ||||
Accrued expenses | 874,866 | 139,684 | ||||||
Due to related party | 334,663 | 11,560 | ||||||
Total current liabilities | 1,298,718 | 151,244 | ||||||
Deferred legal fees | 200,000 | 200,000 | ||||||
Deferred underwriting commissions | 8,050,000 | 8,050,000 | ||||||
Derivative warrant liabilities | 16,603,180 | 13,467,630 | ||||||
Total liabilities | 26,151,898 | 21,868,874 | ||||||
Commitments and Contingencies | 0 | 0 | ||||||
Class A ordinary shares; 19,975,356 and 20,484,749 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively | 199,753,560 | 204,847,490 | ||||||
Shareholders’ Equity: | ||||||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; NaN issued and outstanding | 0 | 0 | ||||||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 3,024,644 and 2,515,251 shares issued and outstanding (excluding 19,975,356 and 20,484,749 shares subject to possible redemption) at June 30, 2021 and December 31, 2020, respectively | 303 | 252 | ||||||
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding at June 30, 2021 and December 31, 2020 | 575 | 575 | ||||||
Additional paid-in capital | 11,565,268 | 6,471,389 | ||||||
Accumulated deficit | (6,566,141 | ) | (1,472,213 | ) | ||||
Total shareholders’ equity | 5,000,005 | 5,000,003 | ||||||
Total Liabilities and Shareholders’ Equity | $ | 230,905,463 | $ | 231,716,367 | ||||
For the three months ended June 30, 2021 | For the six months ended June 30, 2021 | |||||||
General and administrative expenses | $ | 561,581 | $ | 2,017,703 | ||||
Loss from operations | (561,581 | ) | (2,017,703 | ) | ||||
Other income (expense) | ||||||||
Unrealized gain on investments held in Trust Account | 6,408 | 59,325 | ||||||
Change in fair value of derivative warrant liabilities | (2,076,920 | ) | (3,135,550 | ) | ||||
Total other income (expense) | (2,070,512 | ) | (3,076,225 | ) | ||||
Net loss | $ | (2,632,093 | ) | $ | (5,093,928 | ) | ||
Basic and diluted weighted average shares outstanding of Class A ordinary shares | 23,000,000 | 23,000,000 | ||||||
Basic and diluted net loss per Class A ordinary share | $ | 0 | $ | 0 | ||||
Basic and diluted weighted average shares outstanding of Class B ordinary shares | 5,750,000 | 5,750,000 | ||||||
Basic and diluted net loss per Class B ordinary share | $ | (0.46 | ) | $ | (0.89 | ) | ||
Ordinary Shares | Additional | Total | ||||||||||||||||||||||||||
Class A | Class B | Paid-in | Accumulated | Shareholders’ | ||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||||||||
Balance — December 31, 2020 | 2,515,251 | $ | 252 | 5,750,000 | $ | 575 | $ | 6,471,389 | $ | (1,472,213 | ) | $ | 5,000,003 | |||||||||||||||
Shares subject to possible redemption | 246,184 | 24 | — | — | 2,461,816 | — | 2,461,840 | |||||||||||||||||||||
Net loss | — | — | — | — | — | (2,461,835 | ) | (2,461,835 | ) | |||||||||||||||||||
Balance — March 31, 2021 (unaudited) | 2,761,435 | $ | 276 | 5,750,000 | $ | 575 | $ | 8,933,205 | $ | (3,934,048 | ) | $ | 5,000,008 | |||||||||||||||
Shares subject to possible redemption | 263,209 | 27 | — | — | 2,632,063 | — | 2,632,090 | |||||||||||||||||||||
Net loss | — | — | — | — | — | (2,632,093 | ) | (2,632,093 | ) | |||||||||||||||||||
Balance — June 30, 2021 (unaudited) | 3,024,644 | $ | 303 | 5,750,000 | $ | 575 | $ | 11,565,268 | $ | (6,566,141 | ) | $ | 5,000,005 | |||||||||||||||
Cash Flows from Operating Activities: | ||||
Net loss | $ | (5,093,928 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||
Unrealized gain on investments held in Trust Account | (59,325 | ) | ||
Change in fair value of derivative warrant liabilities | 3,135,550 | |||
Changes in operating assets and liabilities: | ||||
Prepaid expenses | 274,379 | |||
Accounts payable | 89,189 | |||
Accrued expenses | 735,182 | |||
Due to related party | 323,103 | |||
Net cash used in operating activities | (595,850 | ) | ||
Cash Flows from Investing Activities: | ||||
Cash received from Trust Account | 73,910 | |||
Net cash provided by investing activities | 73,910 | |||
Net decrease in cash | (521,940 | ) | ||
Cash - beginning of the period | 622,985 | |||
Cash - end of the period | $ | 101,045 | ||
Supplemental disclosure of noncash investing and financing activities: | ||||
Change in value of Class A ordinary shares subject to possible redemption | $ | (5,093,930 | ) |
• | Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted). |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; |
• | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and |
• | if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Description | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||
Assets: | ||||||||||||
U.S. Treasury Securities | $ | 230,004,108 | $ | — | $ | — | ||||||
Liabilities: | ||||||||||||
Derivative warrant liabilities — public warrants | $ | 8,318,290 | $ | — | $ | — | ||||||
Derivative warrant liabilities — private warrants | $ | — | $ | — | $ | 8,284,890 |
Description | Quoted Prices in Active Markets (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Other Unobservable Inputs (Level 3) | |||||||||
Assets: | ||||||||||||
U.S. Treasury Fund | $ | 230,017,782 | $ | — | $ | — | ||||||
Liabilities: | ||||||||||||
Derivative warrant liabilities — public warrants | $ | — | $ | — | $ | 6,762,630 | ||||||
Derivative warrant liabilities — private warrants | $ | — | $ | — | $ | 6,705,000 |
As of June 30, 2021 | As of December 31, 2020 | |||||||
Stock price | $ | 9.93 | $ | 9.98 | ||||
Volatility | 25.7 | % | 23.5 | % | ||||
Expected life of the options to convert | 5.10 | 5.47 | ||||||
Risk-free rate | 0.88 | % | 0.43 | % | ||||
Dividend yield | 0 | 0 |
Level 3 – Derivative warrant liabilities at January 1, 2021 | $ | 13,467,630 | ||
Transfer of Public Warrants to Level 1 | (7,285,410 | ) | ||
Change in fair value of derivative warrant liabilities | 2,102,670 | |||
Level 3 – Derivative warrant liabilities at June 30, 2021 | $ | 8,284,890 | ||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Assets | ||||||||
Investments: | ||||||||
Fixed maturities available-for-sale, | $ | 56.0 | $ | 0 | ||||
Short-term investments | 0 | 96.5 | ||||||
Total investments | 56.0 | 96.5 | ||||||
Cash and cash equivalents | 452.3 | 23.3 | ||||||
Restricted cash | 40.1 | 18.7 | ||||||
Accounts receivable, net of allowance of $0.5 and $0, respectively | 37.1 | 3.5 | ||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 134.1 | 0 | ||||||
Deferred policy acquisition costs | 1.9 | 0 | ||||||
Ceding commissions receivable | 21.3 | 0 | ||||||
Prepaid reinsurance premiums | 129.4 | 0 | ||||||
Property and equipment | 0.9 | 0.9 | ||||||
Capitalized internal use software | 14.7 | 7.8 | ||||||
Goodwill | 47.8 | 1.9 | ||||||
Intangible assets | 33.9 | 15.6 | ||||||
Other assets | 9.9 | 2.3 | ||||||
Total assets | $ | 979.4 | $ | 170.5 | ||||
Liabilities, convertible preferred stock, and stockholders’ deficit | ||||||||
Liabilities: | ||||||||
Loss and loss adjustment expense reserve | $ | 105.1 | $ | 0 | ||||
Unearned premiums | 150.3 | 0 | ||||||
Reinsurance premiums payable | 86.1 | 0 | ||||||
Provision for commission | 28.2 | 12.9 | ||||||
Fiduciary liabilities | 17.5 | 10.5 | ||||||
Convertible promissory notes | 273.0 | 0 | ||||||
Derivative liability on notes | 113.3 | 0 | ||||||
Contingent consideration liability | 12.0 | 13.8 | ||||||
Preferred stock warrant liabilities | 22.9 | 6.7 | ||||||
Accrued expenses and other liabilities | 25.7 | 14.6 | ||||||
Total liabilities | 834.1 | 58.5 | ||||||
Commitments and contingencies (Note 14) | ||||||||
Convertible preferred stock: | ||||||||
Preferred stock, $0.000001 par value per share; 46,479,310 and 38,851,220 shares authorized as of December 31, 2020 and 2019, respectively; 43,985,178 and 36,035,688 shares issued and outstanding as of December 31, 2020 and 2019, respectively; Liquidation preferences of $359.4 million and $204.5 million as of December 31, 2020 and 2019, respectively | 344.8 | 190.3 | ||||||
Stockholders’ deficit | ||||||||
Common stock, $0.000001 par value per share; 83,830,000 and 71,000,000 shares authorized as of December 31, 2020 and 2019, respectively; 13,307,826 and 12,069,742 shares issued and outstanding as of December 31, 2020 and 2019, respectively | 0 | 0 | ||||||
Additional paid-in capital | 56.9 | 36.7 | ||||||
Accumulated other comprehensive income | 0.1 | 0.1 | ||||||
Accumulated deficit | (256.6 | ) | (115.1 | ) | ||||
Total Hippo Enterprises Inc. stockholders’ deficit | (199.6 | ) | (78.3 | ) | ||||
Noncontrolling interest | 0.1 | 0 | ||||||
Total stockholders’ deficit | (199.5 | ) | (78.3 | ) | ||||
Total liabilities, convertible preferred stock, and stockholders’ deficit | $ | 979.4 | $ | 170.5 | ||||
Year ended December 31, | ||||||||
2020 | 2019 | |||||||
Revenue: | ||||||||
Net earned premium | $ | 17.1 | $ | 0 | ||||
Commission income, net | 27.1 | 28.9 | ||||||
Service and fee income | 6.3 | 3.6 | ||||||
Net investment income | 1.1 | 2.2 | ||||||
Total revenue | 51.6 | 34.7 | ||||||
Expenses: | ||||||||
Losses and loss adjustment expenses | 25.3 | 0 | ||||||
Insurance related expenses | 19.3 | 7.1 | ||||||
Technology and development | 18.0 | 7.7 | ||||||
Sales and marketing | 69.4 | 66.3 | ||||||
General and administrative | 36.8 | 34.6 | ||||||
Interest and other expense | 26.0 | 2.0 | ||||||
Total expenses | 194.8 | 117.7 | ||||||
Loss before income taxes | (143.2 | ) | (83.0 | ) | ||||
Income taxes (benefit) expense | (1.8 | ) | 0.1 | |||||
Net loss | (141.4 | ) | (83.1 | ) | ||||
Net income attributable to noncontrolling interests, net of tax | 0.1 | 0 | ||||||
Net loss attributable to Hippo Enterprises Inc. | $ | (141.5 | ) | $ | (83.1 | ) | ||
Other comprehensive income: | ||||||||
Change in net unrealized gain on available-for-sale | 0 | 0.1 | ||||||
Comprehensive loss | $ | (141.5 | ) | $ | (83.0 | ) | ||
Per share data: | ||||||||
Net loss attributable to Hippo Enterprises Inc. — basic and diluted | $ | (141.5 | ) | $ | (83.1 | ) | ||
Weighted-average shares used in computing net loss per share attributable to Hippo Enterprises Inc. — basic and diluted | 12,495,509 | 10,652,088 | ||||||
Net loss per share attributable to Hippo Enterprises Inc. — basic and diluted | $ | (11.32 | ) | $ | (7.80 | ) | ||
Convertible Preferred Stock | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income | Accumulated Deficit | Total Hippo Enterprises Inc. Stockholders’ Deficit | Noncontrolling Interests | Total Stockholders’ Deficit | |||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||||||
Balance at January 1, 2019 | 28,627,021 | $ | 87.3 | 8,586,503 | $ | 0 | $ | 13.9 | $ | 0 | $ | (32.0 | ) | $ | (18.1 | ) | $ | 0 | $ | (18.1 | ) | |||||||||||||||||||
Net loss | — | — | — | — | — | 0.1 | (83.1 | ) | (83.0 | ) | — | (83.0 | ) | |||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of Series C preferred stock, net of issuance costs | 1,135,603 | 8.0 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of Series D preferred stock, net of issuance costs | 6,273,064 | 95.0 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of warrants | — | — | 58,500 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | — | — | 1,212,945 | — | 0.9 | — | — | 0.9 | — | 0.9 | ||||||||||||||||||||||||||||||
Vesting of early exercised stock options | — | — | 56,791 | — | 0.1 | — | — | 0.1 | — | 0.1 | ||||||||||||||||||||||||||||||
Vesting of restricted stock awards | — | — | 2,155,003 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Share-based compensation expense | — | — | — | — | 21.8 | — | — | 21.8 | — | 21.8 | ||||||||||||||||||||||||||||||
Balance at December 31, 2019 | 36,035,688 | $ | 190.3 | 12,069,742 | $ | 0 | 36.7 | 0.1 | (115.1 | ) | (78.3 | ) | 0 | $ | (78.3 | ) | ||||||||||||||||||||||||
Net loss | — | $ | — | — | $ | — | $ | — | $ | — | $ | (141.5 | ) | $ | (141.5 | ) | $ | 0.1 | $ | (141.4 | ) | |||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of Series D preferred stock, net of issuance costs | 321,415 | 4.8 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of Series E preferred stock, net of issuance costs | 7,628,075 | 149.7 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | — | — | 1,179,870 | — | 2.5 | — | — | 2.5 | — | 2.5 | ||||||||||||||||||||||||||||||
Vesting of early exercised stock options | — | — | 38,694 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Vesting of restricted stock awards | — | — | 19,520 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Share-based compensation expense | — | — | — | — | 17.7 | — | — | 17.7 | — | 17.7 | ||||||||||||||||||||||||||||||
Balance at December 31, 2020 | 43,985,178 | $ | 344.8 | 13,307,826 | $ | 0 | $ | 56.9 | $ | 0.1 | $ | (256.6 | ) | $ | (199.6 | ) | $ | 0.1 | $ | (199.5 | ) | |||||||||||||||||||
Year ended December 31, | ||||||||
2020 | 2019 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (141.4 | ) | $ | (83.1 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization of property and equipment, intangible assets and capitalized internal use software | 6.7 | 2.9 | ||||||
Share–based compensation expense | 17.2 | 21.6 | ||||||
Change in fair value of preferred stock warrant liabilities | 16.2 | 2.0 | ||||||
Change in fair value of contingent consideration liability | 3.4 | 1.9 | ||||||
Change in fair value of derivative liability on notes | 6.2 | — | ||||||
Other | 1.3 | (0.8 | ) | |||||
Changes in assets and liabilities, net of effect from business acquisitions: | ||||||||
Accounts receivable, net | (14.7 | ) | (1.6 | ) | ||||
Reinsurance recoverable on paid and unpaid losses and LAE | (17.7 | ) | — | |||||
Deferred policy acquisition costs | (0.9 | ) | — | |||||
Ceding commissions receivable | (3.4 | ) | — | |||||
Prepaid reinsurance premiums | 2.5 | — | ||||||
Other assets | (6.9 | ) | (1.7 | ) | ||||
Provision for commission slide and cancellations | 15.3 | 11.2 | ||||||
Fiduciary liabilities | 6.9 | 7.4 | ||||||
Accrued expenses and other liabilities | 4.0 | 11.1 | ||||||
Loss and loss adjustment expense reserves | 11.8 | — | ||||||
Unearned premiums | 18.1 | — | ||||||
Reinsurance premiums payable | 10.0 | — | ||||||
Net cash used in operating activities | (65.4 | ) | (29.1 | ) | ||||
Cash flows from investing activities: | ||||||||
Capitalized internal use software costs | (9.0 | ) | (5.7 | ) | ||||
Purchase of intangible assets | — | (3.7 | ) | |||||
Purchases of property and equipment | (0.4 | ) | (0.9 | ) | ||||
Purchases of investments | (16.7 | ) | (121.2 | ) | ||||
Maturities of investments | 76.8 | 59.8 | ||||||
Sales of investments | 30.7 | — | ||||||
Cash paid for acquisition, net of cash acquired | (83.7 | ) | (0.6 | ) | ||||
Net cash used in investing activities | (2.3 | ) | (72.3 | ) | ||||
Cash flows from financing activities: | ||||||||
Proceeds from Series C preferred stock, net of issuance costs | — | 8.0 | ||||||
Proceeds from Series D preferred stock, net of issuance costs | 4.9 | 95.0 | ||||||
Proceeds from Series E preferred stock, net of issuance costs | 149.7 | — | ||||||
Proceeds from exercise of options | 2.4 | 1.0 | ||||||
Payments of contingent consideration | (3.9 | ) | (2.6 | ) | ||||
Proceeds from promissory notes, net of issuance costs | 365.0 | — | ||||||
Net cash provided by financing activities | 518.1 | 101.4 | ||||||
Net increase in cash, cash equivalents, and restricted cash | 450.4 | 0.0 | ||||||
Cash, cash equivalents, and restricted cash at the beginning of the year | 42.0 | 42.0 | ||||||
Cash, cash equivalents, and restricted cash at the end of the year | $ | 492.4 | $ | 42.0 | ||||
Supplemental disclosures of non-cash financing and investing activities: | ||||||||
Acquisition related contingent consideration | $ | — | $ | 14.9 | ||||
Convertible promissory notes issued for asset acquisition | 12.5 | — | ||||||
Share-based compensation expense capitalized for internal use software | (0.5 | ) | (0.3 | ) | ||||
Purchases of software, accrued but unpaid | (0.4 | ) | — |
• | Level 1 — Quoted prices in active markets for identical assets or liabilities that are publicly accessible at the measurement date. |
• | Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3 — Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability. |
1- | Loss and loss adjustment expense paid for an accident period as of a given evaluation date |
2- | Case reserves for loss and loss adjustment expense for losses for an accident period that have been reported but not yet paid as of a given evaluation date |
3- | IBNR amounts for loss and loss adjustment expense for an accident period are the costs of events or conditions that have not been reported to, or specifically identified by the Company, as of a given date, but have occurred during the period. |
1. | Managing General Agent (“MGA”) Commission: The Company operates as a MGA for multiple insurers. The Company designs and underwrites insurance products on behalf of the insurers culminating in the sale of insurance policies. The Company earns recurring commission and policy fees associated with the policies, they sell. While the Company has underwriting authority and responsibility for administering claims, the Company does not take the risk associated with policies on the consolidated balance sheets. Rather, the Company works with carrier platforms and a diversified panel of highly rated reinsurance companies who pay the Company commission in exchange for the opportunity to take that risk on their balance sheets. The Company’s performance obligation associated with these contracts is the placement of the policy, which is met on the effective data. Upon issuance of a new policy, the Company charge policy fees and inspection fees, retain the share of ceding commission, and remit the balance premium to the respective insurers. Subsequent ceding commission adjustments arising from policy changes such as endorsements, are recognized when the adjustments can be reasonably estimated. |
2. | Agency Commission: The Company also operate licensed insurance agencies that are engaged solely in the sale of policies, including non-Hippo policies. For these policies, the Company earns a recurring agency commission from the carriers whose policies the Company sells, which is recorded in the commission income, net line in the consolidated statements of operations and comprehensive loss. Similar to the MGA business, the performance obligation from the agency contracts is the placement of the insurance policies. For both MGA and insurance agency activities, the Company recognizes commission received from insurers for the sale of insurance contracts as revenue at a point in time on the policy effective dates. |
3. | Ceding Commission: The Company receives revenue based on the premium they cede to third-party reinsurers for the compensation reimbursement for the Company’s acquisition and underwriting services. Excess of ceding commission over the cost of acquisition and underwriting expenses is included in commission income, net line on the consolidated statements of operations and comprehensive loss. For the policies that the Company write on their own carrier as MGA, the Company recognizes the commission as ceding commission on the consolidated statements of operations and comprehensive loss. The Company earns commission on reinsurance premium ceded in a matter consistent with the recognition of the earned premium on the underlying insurance policies, on a pro-rata basis over the terms of the policies reinsured. The Company records the portion of ceding commission income which represents reimbursement of successful direct acquisition costs related to the underlying policies as an offset to the applicable direct acquisition costs. |
4. | Carrier Fronting Fees: Through the Company’s insurance-as-a-service pro-rata basis over the terms of the policies. This revenue is included in the commission income, net line on the consolidated statements of operations and comprehensive loss. |
5. | Claim Processing Fees: As a MGA the Company receives a fee, that is calculated as a percent of the premium, from the insurers in exchange for providing claims adjudication services. The Claims adjudication services are provided over the term of the policy and recognized ratably over the same period. |
Year Ended December 31, | ||||||||
2020 | 2019 | |||||||
Net earned premium | $ | 17.1 | $ | — | ||||
MGA commissions, net | 12.4 | 20.1 | ||||||
Agency commissions, net | 10.0 | 6.6 | ||||||
Policy fees | 4.3 | 2.8 | ||||||
Claims processing fees | 4.7 | 2.2 | ||||||
Other revenue | 2.0 | 0.8 | ||||||
Net investment income | 1.1 | 2.2 | ||||||
Total revenue, net | $ | 51.6 | $ | 34.7 | ||||
As of December 31, 2020 | ||||||||||||||||
Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | $ | 9.5 | $ | 0 | $ | 0 | $ | 9.5 | ||||||||
All other government | 0.6 | 0 | 0 | 0.6 | ||||||||||||
States, and other territories | 5.1 | 0 | 0 | 5.1 | ||||||||||||
Corporate securities | 17.4 | 0 | 0 | 17.4 | ||||||||||||
Foreign securities | 0.8 | 0 | 0 | 0.8 | ||||||||||||
Residential mortgage-backed securities | 12.9 | 0 | 0 | 12.9 | ||||||||||||
Commercial mortgage-backed securities | 5.4 | 0.1 | 0 | 5.5 | ||||||||||||
Asset backed securities | 4.2 | 0 | 0 | 4.2 | ||||||||||||
Total | $ | 55.9 | $ | 0.1 | $ | 0 | $ | 56.0 | ||||||||
As of December 31, 2019 | ||||||||||||||||
Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
Short-term investments: | ||||||||||||||||
U.S. government securities | $ | 96.4 | $ | 0.1 | $ | 0 | $ | 96.5 | ||||||||
Total | $ | 96.4 | $ | 0.1 | $ | 0 | $ | 96.5 | ||||||||
As of December 31, 2020 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 6.4 | $ | 6.4 | ||||
After one year through five years | 21.5 | 21.5 | ||||||
After five years | 5.4 | 5.4 | ||||||
After ten years | 0.1 | 0.1 | ||||||
Residential mortgage-backed securities | 12.9 | 12.9 | ||||||
Commercial mortgage-backed securities | 5.4 | 5.5 | ||||||
Asset backed securities | 4.2 | 4.2 | ||||||
Total fixed maturities available-for-sale | $ | 55.9 | $ | 56.0 | ||||
As of December 31, 2019 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 96.4 | $ | 96.5 | ||||
Total short-term investments | $ | 96.4 | $ | 96.5 | ||||
Year ended December 31, | ||||||||
2020 | 2019 | |||||||
Fixed maturities income | $ | 1.1 | $ | — | ||||
Short-term investment income | — | 2.2 | ||||||
Total gross investment income | 1.1 | 2.2 | ||||||
Investment expenses | 0 | 0 | ||||||
Net investment income | $ | 1.1 | $ | 2.2 | ||||
As of December 31, 2020 | ||||||||
Amortized Cost | Fair Value | |||||||
State | ||||||||
Illinois | $ | 1.6 | $ | 1.6 | ||||
Colorado | 1.5 | 1.5 | ||||||
Nevada | 0.4 | 0.4 | ||||||
North Carolina | 0.3 | 0.3 | ||||||
Virginia | 0.4 | 0.4 | ||||||
New Mexico | 0.4 | 0.4 | ||||||
New York | 3.1 | 3.1 | ||||||
Vermont | 0.3 | 0.3 | ||||||
Massachusetts | 0.1 | 0.1 | ||||||
Florida | 0.3 | 0.3 | ||||||
Total states | $ | 8.4 | $ | 8.4 | ||||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Cash and cash equivalents: | ||||||||
Cash | $ | 56.7 | $ | 19.6 | ||||
Money market funds | 372.1 | 3.7 | ||||||
Treasury bills | 23.5 | — | ||||||
Total cash and cash equivalents | 452.3 | 23.3 | ||||||
Restricted cash: | ||||||||
Fiduciary assets | 12.1 | 12.7 | ||||||
Cash on deposit | 28.0 | 6.0 | ||||||
Total restricted cash | 40.1 | 18.7 | ||||||
Total cash, cash equivalents, and restricted cash | $ | 492.4 | $ | 42.0 | ||||
As of December 31, 2020 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market funds | $ | 372.1 | $ | 0 | $ | 0 | $ | 372.1 | ||||||||
Treasury bills | 23.5 | 0 | 0 | 23.5 | ||||||||||||
Total cash equivalents | $ | 395.6 | $ | 0 | $ | 0 | $ | 395.6 | ||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | $ | 9.5 | $ | 0 | $ | 0 | $ | 9.5 | ||||||||
All other government | 0.6 | 0 | 0 | 0.6 | ||||||||||||
States, and other territories | 0 | 5.1 | 0 | 5.1 | ||||||||||||
Corporate securities | 0 | 17.4 | 0 | 17.4 | ||||||||||||
Foreign securities | 0 | 0.8 | 0 | 0.8 | ||||||||||||
Residential mortgage-backed securities | 0 | 12.9 | 0 | 12.9 | ||||||||||||
Commercial mortgage-backed securities | 0 | 5.5 | 0 | 5.5 | ||||||||||||
Asset backed securities | 0 | 4.2 | 0 | 4.2 | ||||||||||||
Total fixed maturities available-for-sale | $ | 10.1 | $ | 45.9 | $ | 0 | $ | 56.0 | ||||||||
Total financial assets | $ | 405.7 | $ | 45.9 | $ | 0 | $ | 451.6 | ||||||||
Financial liabilities: | ||||||||||||||||
Derivative liability on convertible promissory notes | $ | 0 | $ | 0 | $ | 113.3 | $ | 113.3 | ||||||||
Contingent consideration liability | 0 | 0 | 12.0 | 12.0 | ||||||||||||
Preferred stock warrant liabilities | 0 | 0 | 22.9 | 22.9 | ||||||||||||
Total financial liabilities | $ | 0 | $ | 0 | $ | 148.2 | $ | 148.2 | ||||||||
As of December 31, 2019 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market funds | $ | 3.7 | $ | 0 | $ | 0 | $ | 3.7 | ||||||||
Short-term investments: | ||||||||||||||||
U.S. government securities | 96.5 | 0 | 0 | 96.5 | ||||||||||||
Total financial assets | $ | 100.2 | $ | 0 | $ | 0 | $ | 100.2 | ||||||||
Financial liabilities: | ||||||||||||||||
Contingent consideration liability | $ | 0 | $ | 0 | $ | 13.8 | $ | 13.8 | ||||||||
Preferred stock warrant liabilities | 0 | 0 | 6.7 | 6.7 | ||||||||||||
Total financial liabilities | $ | 0 | $ | 0 | $ | 20.5 | $ | 20.5 | ||||||||
Balance as of January 1, 2019 | $ | 0 | ||
Initial recognition of contingent consideration included | 14.9 | |||
in purchase consideration of acquisition | ||||
Payments of contingent consideration | (3.0 | ) | ||
Changes in fair value | 1.9 | |||
Balance as of December 31, 2019 | $ | 13.8 | ||
Payments of contingent consideration | (5.2 | ) | ||
Changes in fair value | 3.4 | |||
Balance as of December 31, 2020 | $ | 12.0 | ||
Balance as of January 1, 2019 | $ | 4.7 | ||
Changes in fair value | 2.0 | |||
Balance as of December 31, 2019 | 6.7 | |||
Changes in fair value | 16.2 | |||
Balance as of December 31, 2020 | $ | 22.9 | ||
December 31, 2020 | ||||
Deferred policy acquisition costs, net at beginning of year | $ | 0 | ||
Policy acquisition costs deferred during year | 6.4 | |||
Policy acquisition costs amortized during year | (4.5 | ) | ||
Deferred policy acquisition costs, net at end of year | $ | 1.9 | ||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Capitalized internal use software | $ | 18.4 | $ | 8.9 | ||||
Less: accumulated amortization | (3.7 | ) | (1.1 | ) | ||||
Total capitalized internal use software | $ | 14.7 | $ | 7.8 | ||||
As of December 31, | ||||||||||||||||||||||||||||
2020 | 2019 | |||||||||||||||||||||||||||
Weighted- Average Useful Life Remaining (in years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||||
Customer relationships | 4.3 | $ | 13.2 | $ | (3.8 | ) | $ | 9.4 | $ | 13.2 | $ | (1.6 | ) | $ | 11.6 | |||||||||||||
Developed technology | 1.8 | 3.6 | (1.4 | ) | 2.2 | 3.6 | (0.2 | ) | 3.4 | |||||||||||||||||||
Agency and carrier relationships | 7.9 | 13.5 | (0.1 | ) | 13.4 | — | — | — | ||||||||||||||||||||
State licenses | Indefinite | 7.1 | — | 7.1 | — | — | — | |||||||||||||||||||||
VOBA | 1.7 | 0.1 | — | 0.1 | — | — | — | |||||||||||||||||||||
Other | 7.3 | 1.9 | (0.2 | ) | 1.7 | 0.7 | (0.1 | ) | 0.6 | |||||||||||||||||||
Total intangible assets, net | $ | 39.4 | $ | (5.5 | ) | $ | 33.9 | $ | 17.5 | $ | (1.9 | ) | $ | 15.6 | ||||||||||||||
Year ending December 31, | ||||
2021 | $ | 5.4 | ||
2022 | 5.2 | |||
2023 | 4.1 | |||
2024 | 4.1 | |||
2025 | 2.5 | |||
Thereafter | 5.5 | |||
Total | $ | 26.8 | ||
Balance at January 1, 2019 | $ | 0 | ||
Additions from acquisitions | 1.9 | |||
Balance at December 31, 2019 | $ | 1.9 | ||
Additions from acquisitions | 45.9 | |||
Balance at December 31, 2020 | $ | 47.8 | ||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Accrued wages and commissions | $ | 5.0 | $ | 5.3 | ||||
Accounts payable | 0.5 | 3.2 | ||||||
Deferred revenue | 1.7 | 0.8 | ||||||
Advances from customers | 4.4 | 1.5 | ||||||
Accrued license fees and taxes | 2.5 | 0 | ||||||
Other | 11.6 | 3.8 | ||||||
Total accrued expenses and other liabilities | $ | 25.7 | $ | 14.6 | ||||
2020 | ||||
Reserve for losses and LAE, net of reinsurance recoverables as of January 1, 2020 | $ | 0 | ||
Add: Incurred losses and LAE, net of reinsurance, related to: | ||||
Current year | 25.3 | |||
Prior years | 0 | |||
Total incurred | 25.3 | |||
Deduct: Loss and LAE payments, net of reinsurance, related to: | ||||
Current year | (17.0 | ) | ||
Prior year | (0.3 | ) | ||
Total paid | (17.3 | ) | ||
Add: Reserve for losses and LAE, net of reinsurance recoverables acquired from Spinnaker | 5.0 | |||
Reserve for losses and LAE, net of reinsurance recoverables as of December 31, 2020 | 13.0 | |||
Add: Reinsurance recoverables on unpaid losses and LAE as of December 31, 2020 | 92.1 | |||
Reserve for losses and LAE gross of reinsurance recoverables on unpaid losses and LAE as of December 31, 2020 | $ | 105.1 | ||
December 31, | December 31, 2020 | |||||||||||||||||||||||||||||||
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | IBNR | Cumulative Number of Reported Claims | |||||||||||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||||||||||||||||||||||||
Accident Year | ||||||||||||||||||||||||||||||||
2015 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | 7 | |||||||||||||||||
2016 | 0 | 2.5 | 1.9 | 1.9 | 1.8 | 1.8 | 0 | 713 | ||||||||||||||||||||||||
2017 | 0 | 0 | 5.2 | 4.4 | 4.0 | 4.0 | 0 | 3,118 | ||||||||||||||||||||||||
2018 | 0 | 0 | 0 | 7.8 | 7.2 | 7.2 | 0.6 | 6,156 | ||||||||||||||||||||||||
2019 | 0 | 0 | 0 | 0 | 4.8 | 4.9 | 0.3 | 13,676 | ||||||||||||||||||||||||
2020 | 0 | 0 | 0 | 0 | 0 | 28.1 | 6.4 | 26,242 | ||||||||||||||||||||||||
Total incurred Loss and Loss Adjustment Expenses, net | $ | 46.0 | $ | 7.3 | 49,912 | |||||||||||||||||||||||||||
December 31, | ||||||||||||||||||||||||
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |||||||||||||||||||
(unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | ||||||||||||||||||||
Accident Year | ||||||||||||||||||||||||
2015 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||
2016 | 0 | 1.2 | 1.8 | 1.9 | 1.8 | 1.8 | ||||||||||||||||||
2017 | 0 | 0 | 3.0 | 4.0 | 4.0 | 4.0 | ||||||||||||||||||
2018 | 0 | 0 | 0 | 5.3 | 5.7 | 5.7 | ||||||||||||||||||
2019 | 0 | 0 | 0 | 0 | 3.2 | 4.4 | ||||||||||||||||||
2020 | 0 | 0 | 0 | 0 | 0 | 17.1 | ||||||||||||||||||
Total paid losses and LAE, net | $ | 33.0 | ||||||||||||||||||||||
Total unpaid loss and LAE reserves, net | $ | 13.0 | ||||||||||||||||||||||
Ceded unpaid loss and LAE | 92.1 | |||||||||||||||||||||||
Gross unpaid loss and LAE | $ | 105.1 | ||||||||||||||||||||||
Years | 1 | 2 | 3 | 4 | 5 | |||||||||||||||
Property and Casualty | 60 | % | 28 | % | 4 | % | 7 | % | 0 | % |
2020 — Current | ||||||||
Accident Year | ||||||||
Incurred | Paid | |||||||
Rollforward table | $ | 25.3 | $ | 17.0 | ||||
Development table | 28.1 | 17.1 | ||||||
Variance | $ | (2.8 | ) | $ | (0.1 | ) | ||
Unallocated loss adjustment expense | 2.2 | (2.1 | ) | |||||
Loss and LAE of Spinnaker prior to the acquisition | (5.0 | ) | 2.0 |
2020 | ||||
Loss and LAE reserves | ||||
Direct | $ | 102.7 | ||
Assumed | 2.4 | |||
Gross loss and LAE reserves | 105.1 | |||
Ceded | (92.1 | ) | ||
Net loss and LAE reserves | $ | 13.0 | ||
Unearned premiums: | ||||
Direct | $ | 143.7 | ||
Assumed | 6.6 | |||
Gross unearned premiums | 150.3 | |||
Ceded | (129.4 | ) | ||
Net unearned premiums | $ | 20.9 | ||
2020 | ||||
Written premiums: | ||||
Direct | $ | 90.0 | ||
Assumed | 26.1 | |||
Gross written premiums | 116.1 | |||
Ceded | (78.4 | ) | ||
Net written premiums | $ | 37.7 | ||
Earned premiums : | ||||
Direct | $ | 88.7 | ||
Assumed | 9.3 | |||
Gross earned premiums | 98.0 | |||
Ceded | (80.9 | ) | ||
Net earned premiums | $ | 17.1 | ||
Loss and LAE incurred: | ||||
Direct | $ | 93.6 | ||
Assumed | 13.3 | |||
Gross loss and LAE | 106.9 | |||
Ceded | (81.6 | ) | ||
Net loss and LAE | $ | 25.3 | ||
2020 | ||||
Loss — net of reinsurance | $ | 12.5 | ||
LAE — net of reinsurance | 0.5 | |||
Reinsurance recoverables on unpaid loss | 92.1 | |||
Total loss and LAE reserves—gross of reinsurance | $ | 105.1 | ||
2020 | ||||
Reinsurance recoverable on paid loss | $ | 42.0 | ||
Ceded unpaid loss and LAE | 92.1 | |||
Total reinsurance recoverable | $ | 134.1 | ||
AM Best Rating | Reinsurer | 2020 | ||||
A | Validus Reinsurance, Ltd. | $ | 46.9 | |||
A+ | Transatlantic Reinsurance Company | 28.8 | ||||
A | Validus Reinsurance (Switzerland) Ltd. | 22.6 | ||||
A++ | General Reinsurance Corporation | 14.4 | ||||
$ | 112.7 | |||||
Other reinsurers | 73.7 | |||||
$ | 186.4 | |||||
December 31, | ||||||||
2020 | 2019 | |||||||
Statutory net income | $ | 6.6 | $ | 4.3 | ||||
Statutory capital and surplus | 69.6 | 38.0 |
Year Ending December 31, | ||||
2021 | $ | 2.9 | ||
2022 | 4.0 | |||
2023 | 3.5 | |||
2024 | 3.5 | |||
2025 | 3.6 | |||
Thereafter | 7.6 | |||
Total | $ | 25.1 | ||
As of December 31, 2020 | ||||||||||||||||||||
Issuance Price Per Share | Authorized Shares | Shares Issued and Outstanding | Net Carrying Value | Liquidation Preference | ||||||||||||||||
Preferred A-1 Stock | $ | 0.56965 | 5,889,829 | 5,889,829 | $ | 3.4 | $ | 3.4 | ||||||||||||
Preferred A-2 Stock | 1.57432 | 7,015,787 | 6,987,125 | 10.9 | 11.0 | |||||||||||||||
Preferred B Stock | 3.59757 | 6,949,142 | 6,949,142 | 24.9 | 25.0 | |||||||||||||||
Preferred C Stock | 7.04471 | 9,936,529 | 9,936,528 | 56.1 | 70.0 | |||||||||||||||
Preferred C-1 Stock | 11.74119 | 2,465,454 | — | — | — | |||||||||||||||
Preferred D Stock | 15.16420 | 6,594,479 | 6,594,479 | 99.8 | 100.0 | |||||||||||||||
Preferred E Stock | 19.66420 | 7,628,090 | 7,628,075 | 149.7 | 150.0 | |||||||||||||||
Total | 46,479,310 | 43,985,178 | $ | 344.8 | $ | 359.4 | ||||||||||||||
As of December 31, 2019 | ||||||||||||||||||||
Issuance Price Per Share | Authorized Shares | Shares Issued and Outstanding | Net Carrying Value | Liquidation Preference | ||||||||||||||||
Preferred A-1 Stock | $ | 0.56965 | 5,889,829 | 5,889,829 | $ | 3.4 | $ | 3.4 | ||||||||||||
Preferred A-2 Stock | 1.57432 | 7,015,787 | 6,987,125 | 10.9 | 11.0 | |||||||||||||||
Preferred B Stock | 3.59757 | 6,949,142 | 6,949,142 | 24.9 | 25.0 | |||||||||||||||
Preferred C Stock | 7.04471 | 9,936,529 | 9,936,528 | 56.1 | 70.0 | |||||||||||||||
Preferred C-1 Stock | 11.74119 | 2,465,454 | — | — | — | |||||||||||||||
Preferred D Stock | 15.16420 | 6,594,479 | 6,273,064 | 95.0 | 95.1 | |||||||||||||||
Total | 38,851,220 | 36,035,688 | $ | 190.3 | $ | 204.5 | ||||||||||||||
As of December 31, | ||||
2020 | 2019 | |||
Fair value of Series A-2 Preferred Stock | $18.25 | $8.26 | ||
Fair value of Series C-1 Preferred Stock | $20.09 | $12.80 | ||
Exercise price A-2 Preferred Stock | $1.57 | $1.57 | ||
Exercise price C-1 Preferred Stock | $11.74 | $11.74 | ||
Expected term (in years) | 1.8-6.2 | 2.8–7.2 | ||
Expected volatility | 29.0%-40.7% | 21.5%–22.8% | ||
Risk-free interest rate | 0.1%-0.5% | 1.6%–1.8% | ||
Expected dividend yield | — % | — % |
As of December 31, | ||||||||||||||||||||
2020 | 2019 | |||||||||||||||||||
Series | Exercise Price Per Share | Warrant Shares Outstanding | Fair Value | Warrant Shares Outstanding | Fair Value | |||||||||||||||
A-2 | $ | 1.57 | 28,662 | $ | 0.5 | 28,662 | $ | 0.2 | ||||||||||||
C-1 | 11.74 | 2,465,454 | 22.4 | 2,465,454 | 6.5 | |||||||||||||||
Total | 2,494,116 | $ | 22.9 | 2,494,116 | $ | 6.7 | ||||||||||||||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Convertible preferred stock | 43,985,178 | 36,035,688 | ||||||
Warrants to purchase preferred stock | 2,494,116 | 2,494,116 | ||||||
Warrants to purchase common stock | 9,476,102 | 9,476,102 | ||||||
Common stock options outstanding | 10,382,771 | 8,003,108 | ||||||
Shares available for future grant of equity awards | 2,627,921 | 2,324,117 | ||||||
Total | 68,966,088 | 58,333,131 | ||||||
Issue Date | Exercise Price Per Share | Number of Warrants | Expiration Date | Outstanding as of December 31, 2020 | ||||||||||
December 11, 2017 | $ | 0.01 | 4,738,051 | December 31, 2022 | 4,738,051 | |||||||||
February 19, 2018 | $ | 0.01 | 4,738,051 | August 19, 2022 | 4,738,051 |
Options Outstanding | Weighted-Average Remaining Contract Term (In Years) | Aggregate Intrinsic Value (In millions) | ||||||||||||||
Number of Shares | Weighted Average Exercise Price | |||||||||||||||
Outstanding as of January 1, 2020 | 8,003,108 | $ | 3.11 | 9.18 | $ | 20.0 | ||||||||||
Granted | 4,792,500 | 6.94 | ||||||||||||||
Exercised | (1,179,870 | ) | 2.36 | |||||||||||||
Forfeited | (1,181,120 | ) | 3.91 | |||||||||||||
Expired | (51,847 | ) | 1.40 | |||||||||||||
Outstanding as of December 31, 2020 | 10,382,771 | $ | 4.88 | 8.90 | $ | 108.9 | ||||||||||
Vested and exercisable as of December 31, 2020 | 1,425,549 | $ | 3.21 | 8.08 | $ | 17.3 | ||||||||||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Expected term (in years) | 5.63 - 6.12 | 6.02 | ||||||
Expected volatility | 22.6% - 29.9% | 22.7 | % | |||||
Risk-free interest rate | 0.3% - 1.6% | 2.2 | % | |||||
Expected dividend yield | 0 % | 0 | % |
Year ended December 31, | ||||||||
2020 | 2019 | |||||||
Losses and Loss Adjustment Expenses | $ | 0.1 | $ | 0 | ||||
Insurance related expenses | 0.2 | 0.2 | ||||||
Technology and development | 2.4 | 1.7 | ||||||
Sales and marketing | 2.1 | 0.6 | ||||||
General and administrative | 12.4 | 19.1 | ||||||
Total share-based compensation expense | $ | 17.2 | $ | 21.6 | ||||
Fair Value of Consideration Transferred | ||||
Cash Paid | $ | 95.6 | ||
Less: consideration for settlement of pre-existing liabilities due to Spinnaker | (5.1 | ) | ||
Total value of consideration transferred | $ | 90.5 | ||
Acquisition- Date Fair Value | Estimated Useful Life of Finite-Lived Intangible Assets | |||||||
Tangible assets acquired and (liabilities) assumed: | ||||||||
Investments: | ||||||||
Fixed maturities available-for-sale, | $ | 45.7 | ||||||
Short-term investments | 5.0 | |||||||
Total investments | 50.7 | |||||||
Cash and cash equivalents | 16.9 | |||||||
Restricted cash | 2.1 | |||||||
Accounts receivable, net | 18.3 | |||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 116.3 | |||||||
Ceding commissions receivable | 18.7 | |||||||
Prepaid reinsurance premiums | 131.9 | |||||||
Other assets | 0.6 | |||||||
Accrued expenses and other liabilities | (6.6 | ) | ||||||
Loss and loss adjustment expense reserves | (93.3 | ) | ||||||
Unearned premiums | (132.1 | ) | ||||||
Reinsurance premium payable | (76.1 | ) | ||||||
Net tangible assets acquired | 47.4 | |||||||
Intangible assets acquired: | ||||||||
Agency relationships | 3.4 | 8 years | ||||||
VOBA | 0.1 | 2 years | ||||||
State licenses | 7.1 | Indefinite | ||||||
Goodwill | 32.5 | |||||||
Total purchase price | 90.5 | |||||||
Acquisition | ||||||||
Year Ended December 31, | ||||||||
2020 | 2019 | |||||||
Pro forma revenue | 54.1 | 34.9 | ||||||
Pro forma net loss | (136.6 | ) | (75.8 | ) |
Year Ended December 31, | ||||||||
2020 | 2019 | |||||||
Loss before income taxes | $ | (143.2 | ) | $ | (83.0 | ) | ||
Income tax benefit from statutory rate | (30.1 | ) | (17.4 | ) | ||||
Effect of: | ||||||||
Meals, entertainment & parking | 0.1 | 0 | ||||||
Deferred compensation | 8.1 | 4.8 | ||||||
Transaction costs | 0.1 | 0 | ||||||
State taxes | (1.1 | ) | 0.1 | |||||
Increase in valuation allowance | 19.9 | 12.0 | ||||||
Other | 1.2 | 0.6 | ||||||
Income taxes (benefit) expense | $ | (1.8 | ) | $ | 0.1 | |||
Year Ended December 31, | ||||||||
2020 | 2019 | |||||||
Income tax applicable to: | ||||||||
Current | ||||||||
State | $ | 0.2 | $ | 0.1 | ||||
Total current provision | $ | 0.2 | $ | 0.1 | ||||
Deferred | ||||||||
Federal | $ | (1.9 | ) | $ | 0 | |||
State | (0.1 | ) | 0 | |||||
Total deferred provision | $ | (2.0 | ) | $ | 0 | |||
Total provision for income taxes | $ | (1.8 | ) | $ | 0.1 | |||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Deferred tax assets: | ||||||||
Net operating loss carryforward | $ | 35.4 | $ | 18.0 | ||||
Provision for commission | 5.4 | 2.9 | ||||||
Intangible assets | 3.1 | 0.2 | ||||||
Research and development credit | 0.2 | 0.2 | ||||||
Deferred compensation | 0.3 | 0.2 | ||||||
Unearned premium reserve | 1.0 | 0 | ||||||
Loss reserve discount | 0.1 | 0.7 | ||||||
Deferred rent | 0.1 | 0 | ||||||
Accruals | 0.9 | 0 | ||||||
Interest expense limitation | 0.6 | 0 | ||||||
Other | 0 | 0.2 | ||||||
Total deferred tax assets | $ | 47.1 | $ | 22.4 | ||||
Valuation allowance | (39.6 | ) | (19.7 | ) | ||||
Total deferred income tax assets | $ | 7.5 | $ | 2.7 | ||||
Deferred tax liabilities | ||||||||
Property and equipment | $ | 0.1 | $ | 0.1 | ||||
Capitalized software | 3.3 | 1.8 | ||||||
Acquired intangibles | 0.5 | 0.8 | ||||||
Unrealized gains | 0.4 | 0 | ||||||
Spinnaker stepped-up adjustment | 2.9 | 0 | ||||||
Deferred acquisition costs | 0.3 | 0 | ||||||
Total deferred tax liabilities | $ | 7.5 | $ | 2.7 | ||||
Deferred income tax assets, net | $ | 0 | $ | 0 | ||||
20-year Carryforward Expires in 2035 - 2037 | Indefinite Carryforward Period | Total | ||||||||||
U.S. Federal | $ | 9.2 | $ | 145.3 | $ | 154.5 | ||||||
U.S. State | 41.5 | 0 | 41.5 | |||||||||
Balance as of December 31, 2020 | $ | 50.7 | $ | 145.3 | $ | 196.0 | ||||||
Year Ended December 31, | ||||||||
2020 | 2019 | |||||||
Numerator: | ||||||||
Net loss attributable to Hippo Enterprises Inc. — basic and diluted (in millions) | $ | (141.5 | ) | $ | (83.1 | ) | ||
Denominator: | ||||||||
Weighted-average shares used in computing net loss per share attributable to Hippo Enterprises Inc. — basic and diluted | 12,495,509 | 10,652,088 | ||||||
Net loss per share attributable to Hippo Enterprises Inc. — basic and diluted | $ | (11.32 | ) | $ | (7.80 | ) | ||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Convertible preferred stock (on an as if converted basis) | 39,545,082 | 32,546,081 | ||||||
Outstanding options | 8,364,323 | 5,687,268 | ||||||
Warrants to purchase common shares | 4,763,600 | 4,789,980 | ||||||
Warrants to purchase preferred shares | 2,494,116 | 1,784,876 | ||||||
Common stock subject to repurchase | 1,365,948 | 1,691,897 | ||||||
Convertible notes | 2,177,961 | 0 | ||||||
Total | 58,711,030 | 46,500,102 | ||||||
December 31, | ||||||||
2020 | ||||||||
Amount | % of GWP | |||||||
State | ||||||||
Texas | $ | 43.9 | 37.8 | % | ||||
California | 10.4 | 8.9 | % | |||||
Florida | 7.3 | 6.3 | % | |||||
Illinois | 4.9 | 4.3 | % | |||||
Georgia | 4.7 | 4.0 | % | |||||
Missouri | 3.4 | 2.9 | % | |||||
Ohio | 3.0 | 2.6 | % | |||||
Oklahoma | 3.0 | 2.6 | % | |||||
Tennessee | 2.4 | 2.1 | % | |||||
Colorado | 2.5 | 2.1 | % | |||||
Other | 30.6 | 26.4 | % | |||||
Total | $ | 116.1 | 100.0 | % | ||||
As of December 31, | ||||||||
2020 | 2019 | |||||||
Assets | ||||||||
Investments: | ||||||||
Short-term investments | $ | — | $ | 96.5 | ||||
Total investments | — | 96.5 | ||||||
Cash and cash equivalents | 374.8 | 3.8 | ||||||
Intecompany receivable | 151.9 | — | ||||||
Other assets | 0.3 | — | ||||||
Investment in subsidiary | 133.8 | 120.8 | ||||||
Total assets | 660.8 | $ | 221.1 | |||||
Liabilities, convertible preferred stock, and stockholders’ deficit | ||||||||
Liabilities: | ||||||||
Intercompany payables | 100.7 | 100.2 | ||||||
Accrued expenses and other liabilities | 3.6 | — | ||||||
Convertible promissory notes, net of discount | 273.0 | — | ||||||
Derivative liability on notes | 113.3 | �� | — | |||||
Preferred stock warrant liabilities | 22.9 | 6.7 | ||||||
Total liabilities | 513.5 | 106.9 | ||||||
Commitments and contingencies | ||||||||
Convertible preferred stock: | ||||||||
Preferred stock, $0.000001 par value per share; 46,479,310 shares authorized as of December 31, 2020; 43,985,178 shares issued and outstanding as of December 31, 2020; Liquidation preferences of $359.4 million as of December 31, 2020 | 344.8 | 190.3 | ||||||
Stockholders’ deficit | ||||||||
Additional paid-in capital | 56.9 | 36.7 | ||||||
Accumulated other comprehensive income | — | 0.1 | ||||||
Accumulated deficit | (254.4 | ) | (112.9 | ) | ||||
Total stockholders’ deficit | (197.5 | ) | (76.1 | ) | ||||
Total liabilities, convertible preferred stock, and stockholders’ deficit | $ | 660.8 | 221.1 | |||||
Years ended December 31, 2020 | For the period from January 22, 2019 to December 31, 2019 | |||||||
Revenue: | ||||||||
Net investment income | $ | 0.7 | $ | — | ||||
Total revenue | 0.7 | — | ||||||
Expenses: | ||||||||
Losses and Loss Adjustment Expenses | 0.1 | — | ||||||
Technology and development | 3.0 | 0.3 | ||||||
Sales and marketing | 2.1 | 0.1 | ||||||
General and administrative | 13.1 | 0.5 | ||||||
Insurance related expenses | 0.2 | — | ||||||
Interest and other expense | 25.9 | (0.4 | ) | |||||
Total expenses | 44.4 | 0.5 | ||||||
Loss before equity in net loss of subsidiaries | (43.7 | ) | (0.5 | ) | ||||
Equity in net loss of subsidiaries | (97.8 | ) | (80.3 | ) | ||||
Net loss | $ | (141.5 | ) | $ | (80.8 | ) | ||
Year ended December 31, 2020 | For the period January 22, 2019 to December 31, 2019 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net (loss) income | (141.5 | ) | (80.8 | ) | ||||
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||||||||
Share-based compensation expense | 17.7 | 0.9 | ||||||
Change in fair value of preferred stock warrant liabilities | 16.2 | (0.3 | ) | |||||
Change in fair value of derivative liability on notes | 6.2 | — | ||||||
Other | 2.7 | (0.8 | ) | |||||
Equity in net loss of subsidiaries | 97.8 | 80.3 | ||||||
Changes in assets and liabilities: | ||||||||
Intercompany, net | (136.0 | ) | 100.2 | |||||
Other assets | (0.3 | ) | (0.5 | ) | ||||
Accrued expenses and other liabilities | 0.5 | — | ||||||
Net cash (used in) provided by operating activities | (136.7 | ) | 99.0 | |||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Investment in subsidiaries | (105.9 | ) | — | |||||
Purchases of investments | — | (155.4 | ) | |||||
Maturities of investments | 69.6 | 59.8 | ||||||
Sales of investments | 26.8 | — | ||||||
Other | — | — | ||||||
Net cash (used in) provided by investing activities | (9.5 | ) | (95.6 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from issuance of series E preferred stock, net of issuance costs | 149.7 | — | ||||||
Proceeds from exercise of options | 2.5 | 0.4 | ||||||
Proceeds from promissory notes, net of issuance costs | 365.0 | — | ||||||
Net cash provided by financing activities | 517.2 | 0.4 | ||||||
Net increase (decrease) in cash and cash equivalents and restricted cash | 371.0 | 3.8 | ||||||
Cash, cash equivalents and restricted cash at the beginning of the period | 3.8 | — | ||||||
Cash, cash equivalents and restricted cash at the end of the period | 374.8 | 3.8 | ||||||
Non-cash and other disclosures | ||||||||
Convertible promissory notes issued for receivable from subsidiary | $ | 12.5 | $ | — | ||||
Transfer of preferred stock from Hippo Analytics Inc. to Hippo Enterprises Inc. | 4.9 | 190.3 | ||||||
Transfer of preferred stock warrant liability from Hippo Analytics Inc. to Hippo Enterprises Inc. | — | 7.0 | ||||||
Transfer of equity from Hippo Analytics Inc. to Hippo Enterprises Inc. | — | 35.4 |
Additions | ||||||||||||||||||||
($in millions) | Balance at beginning of period | Charged to costs and expenses | Charged to other accounts 1 | Deduction- Amounts Written Off 2 | Balance at end of period | |||||||||||||||
Year Ended December 31, 2019 | ||||||||||||||||||||
Valuation allowance for deferred tax assets | $ | 7.7 | $ | 12.0 | $ | — | $ | — | $ | 19.7 | ||||||||||
Allowance for account receivable | $ | — | $ | — | ||||||||||||||||
Provision for commission | $ | 1.7 | $ | — | $ | 12.2 | $ | (1.0 | ) | $ | 12.9 | |||||||||
Year Ended December 31, 2020 | ||||||||||||||||||||
Valuation allowance for deferred tax assets | $ | 19.7 | $ | 19.9 | $ | — | $ | — | $ | 39.6 | ||||||||||
Allowance for account receivable | $ | — | $ | 0.5 | $ | — | $ | — | $ | 0.5 | ||||||||||
Provision for commission | $ | 12.9 | $ | — | $ | 24.1 | $ | (8.8 | ) | $ | 28.2 |
1 | Additions charged to other accounts are comprised of amounts charged to commission revenue and amounts acquired from Spinnaker. |
2 | Deductions are comprised of refund of cancelled policies and payments of commission slide. |
June 30, 2021 | December 31, 2020 | |||||||
(Unaudited) | ||||||||
Assets | ||||||||
Investments: | ||||||||
Fixed maturities available-for-sale, | $ | 56.6 | $ | 56.0 | ||||
Total investments | 56.6 | 56.0 | ||||||
Cash and cash equivalents | 364.1 | 452.3 | ||||||
Restricted cash | 46.1 | 40.1 | ||||||
Accounts receivable, net of allowance of $0.4 million and $0.5 million, respectively | 54.0 | 37.1 | ||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 242.8 | 134.1 | ||||||
Prepaid reinsurance premiums | 195.3 | 129.4 | ||||||
Ceding commissions receivable | 34.2 | 21.3 | ||||||
Deferred policy acquisition costs | 0 | 1.9 | ||||||
Capitalized internal use software | 18.7 | 14.7 | ||||||
Goodwill | 48.2 | 47.8 | ||||||
Intangible assets | 34.6 | 33.9 | ||||||
Other assets | 27.2 | 10.8 | ||||||
Total assets | $ | 1,121.8 | $ | 979.4 | ||||
Liabilities, convertible preferred stock, and stockholders’ deficit | ||||||||
Liabilities: | ||||||||
Loss and loss adjustment expense reserve | $ | 195.2 | $ | 105.1 | ||||
Unearned premiums | 216.5 | 150.3 | ||||||
Reinsurance premiums payable | 137.0 | 86.1 | ||||||
Provision for commission | 13.0 | 28.2 | ||||||
Fiduciary liabilities | 28.2 | 17.5 | ||||||
Convertible promissory notes | 299.0 | 273.0 | ||||||
Derivative liability on notes | 162.6 | 113.3 | ||||||
Contingent consideration liability | 11.6 | 12.0 | ||||||
Preferred stock warrant liabilities | 137.5 | 22.9 | ||||||
Accrued expenses and other liabilities | 46.0 | 25.7 | ||||||
Total liabilities | 1,246.6 | 834.1 | ||||||
Commitments and contingencies (Note 10) | ||||||||
Convertible preferred stock: | ||||||||
Preferred stock, $0.000001 par value per share; 46,479,310 shares authorized as of June 30, 2021 and December 31, 2020, respectively; 43,985,178 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively; Liquidation preferences of $359.4 million as of June 30, 2021 and December 31, 2020, respectively | 344.8 | 344.8 | ||||||
Stockholder’s deficit | ||||||||
Common stock, $0.000001 par value per share; 83,830,000 shares authorized as of June 30, 2021 and December 31, 2020, respectively; 14,200,750 and 13,307,826 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively | 0 | 0 | ||||||
Additional paid-in capital | 65.8 | 56.9 | ||||||
Accumulated other comprehensive (loss) income | (0.3 | ) | 0.1 | |||||
Accumulated deficit | (536.4 | ) | (256.6 | ) | ||||
Total Hippo stockholders’ deficit | (470.9 | ) | (199.6 | ) | ||||
Noncontrolling interest | 1.3 | 0.1 | ||||||
Total stockholders’ deficit | (469.6 | ) | (199.5 | ) | ||||
Total liabilities, convertible preferred stock, and stockholder’s deficit | $ | 1,121.8 | $ | 979.4 | ||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Revenue: | ||||||||||||||||
Net earned premium | $ | 10.2 | $ | 2.5 | $ | 19.0 | $ | 4.0 | ||||||||
Commission income, net | 6.5 | 8.4 | 11.6 | 15.5 | ||||||||||||
Service and fee income | 4.1 | 0.8 | 7.1 | 2.1 | ||||||||||||
Net investment income | 0.1 | 0.2 | 0.2 | 0.6 | ||||||||||||
Total revenue | 20.9 | 11.9 | 37.9 | 22.2 | ||||||||||||
Expenses: | ||||||||||||||||
Losses and loss adjustment expenses | 21.4 | 3.3 | 38.7 | 5.2 | ||||||||||||
Insurance related expenses | 8.5 | 4.1 | 16.0 | 8.0 | ||||||||||||
Technology and development | 7.5 | 3.7 | 14.5 | 7.3 | ||||||||||||
Sales and marketing | 22.2 | 17.3 | 46.9 | 35.3 | ||||||||||||
General and administrative | 8.8 | 5.5 | 17.1 | 11.1 | ||||||||||||
Interest and other expense | 36.0 | 2.9 | 183.1 | 4.0 | ||||||||||||
Total expenses | 104.4 | 36.8 | 316.3 | 70.9 | ||||||||||||
Loss before income taxes | (83.5 | ) | (24.9 | ) | (278.4 | ) | (48.7 | ) | ||||||||
Income taxes (benefit) expense | 0.2 | — | 0.3 | — | ||||||||||||
Net loss | (83.7 | ) | (24.9 | ) | (278.7 | ) | (48.7 | ) | ||||||||
Net income (loss) attributable to noncontrolling interests, net of tax | 0.8 | (0.1 | ) | 1.1 | 0 | |||||||||||
Net loss attributable to Hippo | $ | (84.5 | ) | $ | (24.8 | ) | $ | (279.8 | ) | $ | (48.7 | ) | ||||
Other comprehensive income: | ||||||||||||||||
Change in net unrealized gain or loss on investments, net of tax | 0.3 | (0.2 | ) | (0.3 | ) | — | ||||||||||
Comprehensive loss attributable to Hippo | $ | (84.2 | ) | $ | (25.0 | ) | $ | (280.1 | ) | $ | (48.7 | ) | ||||
Per share data: | ||||||||||||||||
Net loss attributable to Hippo - basic and diluted | $ | (84.5 | ) | $ | (24.8 | ) | $ | (279.8 | ) | $ | (48.7 | ) | ||||
Weighted-average shares used in computing net loss per share attributable to Hippo - basic and diluted | 14,134,399 | 12,360,596 | 13,968,160 | 12,236,471 | ||||||||||||
Net loss per share attributable to Hippo - basic and diluted | $ | (5.98 | ) | $ | (2.01 | ) | $ | (20.03 | ) | $ | (3.98 | ) | ||||
Convertible Preferred Stock | Common Stock | Additional Paid-in | Accumulated Other Comprehensive | Accumulated | Total Hippo Stockholders’ | Non controlling | Total Stockholders’ | |||||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Income (Loss) | Deficit | Deficit | Interests | Deficit | |||||||||||||||||||||||||||||||
Balance at January 1, 2021 | 43,985,178 | $ | 344.8 | 13,307,826 | $ | 0 | $ | 56.9 | $ | 0.1 | $ | (256.6 | ) | $ | (199.6 | ) | $ | 0.1 | $ | (199.5 | ) | |||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | (195.2 | ) | (195.2 | ) | 0.3 | (194.9 | ) | |||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | (0.6 | ) | — | (0.6 | ) | — | (0.6 | ) | |||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | — | — | 662,101 | — | 1.9 | — | — | 1.9 | — | 1.9 | ||||||||||||||||||||||||||||||
Vesting of early exercised stock options | — | — | 24,689 | — | 0.2 | — | — | 0.2 | — | 0.2 | ||||||||||||||||||||||||||||||
Repurchase of common stock | — | — | (3,125 | ) | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Share-based compensation expense | — | — | — | — | 2.9 | — | — | 2.9 | — | 2.9 | ||||||||||||||||||||||||||||||
Other | — | — | — | — | — | — | (0.1 | ) | (0.1 | ) | 0.1 | — | ||||||||||||||||||||||||||||
Balance at April 1, 2021 | 43,985,178 | $ | 344.8 | 13,991,491 | $ | 0 | $ | 61.9 | $ | (0.5 | ) | $ | (451.9 | ) | $ | (390.5 | ) | $ | 0.5 | $ | (390.0 | ) | ||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | (84.5 | ) | (84.5 | ) | 0.8 | (83.7 | ) | |||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | 0.2 | — | 0.2 | — | 0.2 | ||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | — | — | 184,573 | — | 0.6 | — | — | 0.6 | — | 0.6 | ||||||||||||||||||||||||||||||
Vesting of early exercised stock options | — | — | 24,686 | — | 0.2 | — | — | 0.2 | — | 0.2 | ||||||||||||||||||||||||||||||
Share-based compensation expense | — | — | — | — | 3.1 | — | — | 3.1 | — | 3.1 | ||||||||||||||||||||||||||||||
Other | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Balance at June 30, 2021 | 43,985,178 | 344.8 | 14,200,750 | 0 | 65.8 | (0.3 | ) | (536.4 | ) | (470.9 | ) | 1.3 | $ | (469.6 | ) | |||||||||||||||||||||||||
Balance at January 1, 2020 | 36,035,688 | $ | 190.3 | 12,069,742 | $ | 0 | $ | 36.7 | $ | 0.1 | $ | (115.1 | ) | $ | (78.3 | ) | $ | 0 | $ | (78.3 | ) | |||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | (23.9 | ) | (23.9 | ) | — | (23.9 | ) | |||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | 0.2 | — | 0.2 | — | 0.2 | ||||||||||||||||||||||||||||||
Issuance of Series D preferred stock, net of issuance costs | 321,415 | 4.9 | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | — | — | 82,697 | — | 0.1 | — | — | 0.1 | — | 0.1 | ||||||||||||||||||||||||||||||
Vesting of early exercised stock options | — | — | 38,694 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Vesting of restricted stock awards | — | — | 10,557 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Share-based compensation expense | — | — | — | — | 1.0 | — | — | 1.0 | — | 1.0 | ||||||||||||||||||||||||||||||
Other | — | — | — | — | — | — | — | — | 0.1 | 0.1 | ||||||||||||||||||||||||||||||
Balance at March 31, 2020 | 36,357,103 | $ | 195.2 | 12,201,690 | $ | 0 | $ | 37.8 | $ | 0.3 | $ | (139.0 | ) | $ | (100.9 | ) | $ | 0.1 | $ | (100.8 | ) | |||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | (24.8 | ) | (24.8 | ) | (0.1 | ) | (24.9 | ) | ||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | (0.2 | ) | — | (0.2 | ) | — | (0.2 | ) | |||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options | — | — | 258,673 | — | 0.5 | — | — | 0.5 | — | 0.5 | ||||||||||||||||||||||||||||||
Vesting of restricted stock awards | — | — | 5,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Share-based compensation expense | — | — | — | — | 1.0 | — | — | 1.0 | — | 1.0 | ||||||||||||||||||||||||||||||
Balance at June 30, 2020 | 36,357,103 | 195.2 | 12,465,363 | 0 | 39.3 | 0.1 | (163.8 | ) | (124.4 | ) | 0 | $ | (124.4 | ) | ||||||||||||||||||||||||||
Six Months Ended June 30, 2021 | ||||||||
2021 | 2020 | |||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | (278.7 | ) | $ | (48.7 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | 5.0 | 3.0 | ||||||
Share–based compensation expense | 5.3 | 1.8 | ||||||
Change in fair value of preferred stock warrant liabilities | 114.6 | 4.1 | ||||||
Change in fair value of contingent consideration liability | 1.3 | — | ||||||
Change in fair value of derivative liability on notes | 46.5 | — | ||||||
Amortization of debt discount | 17.1 | — | ||||||
Non-cash service expense | 7.0 | — | ||||||
Other | 5.4 | 0.3 | ||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable, net | (17.0 | ) | (3.8 | ) | ||||
Reinsurance recoverable on paid and unpaid losses and LAE | (108.7 | ) | — | |||||
Deferred policy acquisition costs | 1.9 | (1.8 | ) | |||||
Ceding commissions receivable | (12.9 | ) | — | |||||
Prepaid reinsurance premiums | (65.9 | ) | (1.2 | ) | ||||
Other assets | (12.5 | ) | (3.7 | ) | ||||
Provision for commission slide and cancellations | (15.2 | ) | 3.2 | |||||
Fiduciary liabilities | 10.8 | 8.7 | ||||||
Accrued expenses and other liabilities | 19.6 | 2.0 | ||||||
Loss and loss adjustment expense reserves | 90.1 | 1.9 | ||||||
Unearned premiums | 66.2 | 9.9 | ||||||
Reinsurance premiums payable | 50.9 | 1.4 | ||||||
Net cash used in operating activities | (69.2 | ) | (22.9 | ) | ||||
Cash flows from investing activities: | ||||||||
Capitalized internal use software costs | (5.5 | ) | (4.3 | ) | ||||
Purchase of intangible assets | (3.3 | ) | — | |||||
Purchases of property and equipment | — | (0.2 | ) | |||||
Purchases of investments | (7.1 | ) | — | |||||
Maturities of investments | 2.0 | 42.6 | ||||||
Sales of investments | 3.7 | 26.7 | ||||||
Net cash (used in) provided by investing activities | (10.2 | ) | 64.8 | |||||
Cash flows from financing activities: | ||||||||
Proceeds from Series D preferred stock, net of issuance costs | — | 4.9 | ||||||
Proceeds from exercise of options | 2.6 | 0.5 | ||||||
Payments of contingent consideration | (1.3 | ) | (2.4 | ) | ||||
Payments for reverse recapitalization and transaction costs | (4.1 | ) | — | |||||
Net cash (used in) provided by financing activities | (2.8 | ) | 3.0 | |||||
Net (decrease) increase in cash, cash equivalents, and restricted cash | (82.2 | ) | 44.9 | |||||
Cash, cash equivalents, and restricted cash at the beginning of the period | 492.4 | 42.1 | ||||||
Cash, cash equivalents, and restricted cash at the end of the period | $ | 410.2 | $ | 87.0 | ||||
Supplemental disclosures of non-cash financing and investing activities: | ||||||||
Convertible promissory notes issued for services | 7.0 | — | ||||||
Unpaid transaction costs | 1.1 | — |
June 30, 2021 | ||||||||||||||||
Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | 10.0 | 0 | 0 | 10.0 | ||||||||||||
States, and other territories | 5.9 | 0 | 0 | 5.9 | ||||||||||||
Corporate securities | 18.5 | 0 | (0.1 | ) | 18.4 | |||||||||||
Foreign securities | 0.3 | 0 | 0 | 0.3 | ||||||||||||
Residential mortgage-backed securities | 10.7 | 0 | (0.1 | ) | 10.6 | |||||||||||
Commercial mortgage-backed securities | 5.1 | 0 | (0.1 | ) | 5.0 | |||||||||||
Asset backed securities | 6.4 | 0 | 0 | 6.4 | ||||||||||||
Total | $ | 56.9 | $ | 0 | $ | (0.3 | ) | $ | 56.6 | |||||||
December 31, 2020 | ||||||||||||||||
Amortized Cost | Unrealized Gains | Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | 10.1 | 0 | 0 | 10.1 | ||||||||||||
States, and other territories | 5.1 | 0 | 0 | 5.1 | ||||||||||||
Corporate securities | 17.4 | 0 | 0 | 17.4 | ||||||||||||
Foreign securities | 0.8 | 0 | 0 | 0.8 | ||||||||||||
Residential mortgage-backed securities | 12.9 | 0 | 0 | 12.9 | ||||||||||||
Commercial mortgage-backed securities | 5.4 | 0.1 | 0 | 5.5 | ||||||||||||
Asset backed securities | 4.2 | 0 | 0 | 4.2 | ||||||||||||
Total | $ | 55.9 | $ | 0.1 | �� | $ | 0 | $ | 56.0 | |||||||
June 30, 2021 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 9.3 | $ | 9.3 | ||||
After one year through five years | 21.1 | 21.1 | ||||||
After five years | 4.2 | 4.1 | ||||||
After ten years | 0.1 | 0.1 | ||||||
Residential mortgage-backed securities | 10.7 | 10.6 | ||||||
Commercial mortgage-backed securities | 5.1 | 5.0 | ||||||
Asset backed securities | 6.4 | 6.4 | ||||||
Total fixed maturities available-for-sale | $ | 56.9 | $ | 56.6 | ||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Fixed maturities income | $ | 0.1 | $ | 0.2 | $ | 0.2 | $ | 0.6 | ||||||||
Total gross investment income | 0.1 | 0.2 | 0.2 | 0.6 | ||||||||||||
Investment expenses | 0 | 0 | 0 | 0 | ||||||||||||
Net investment income | $ | 0.1 | $ | 0.2 | $ | 0.2 | $ | 0.6 | ||||||||
June 30, 2021 | ||||||||
Amortized Cost | Fair Value | |||||||
State | ||||||||
Illinois | $ | 1.6 | $ | 1.6 | ||||
Colorado | 1.5 | 1.5 | ||||||
Nevada | 0.2 | 0.2 | ||||||
North Carolina | 0.3 | 0.3 | ||||||
Virginia | 0.3 | 0.4 | ||||||
New Mexico | 0.3 | 0.4 | ||||||
New York | 3.1 | 3.1 | ||||||
Vermont | 0.3 | 0.3 | ||||||
Massachusetts | 0.1 | 0.1 | ||||||
Florida | 0.3 | 0.3 | ||||||
Georgia | 0.1 | 0.1 | ||||||
Total states | $ | 8.1 | $ | 8.3 | ||||
June 30, 2021 | December 31, 2020 | |||||||
Cash and cash equivalents: | ||||||||
Cash | $ | 126.2 | $ | 56.7 | ||||
Money market funds | 237.9 | 372.1 | ||||||
Treasury bills | 0 | 23.5 | ||||||
Total cash and cash equivalents | 364.1 | 452.3 | ||||||
Restricted cash: | ||||||||
Fiduciary assets | 28.0 | 12.1 | ||||||
Letters of credit and cash on deposit | 18.1 | 28.0 | ||||||
Total restricted cash | 46.1 | 40.1 | ||||||
Total cash, cash equivalents, and restricted cash | $ | 410.2 | $ | 492.4 | ||||
June 30, 2021 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market funds | 237.9 | $ | 0 | $ | 0 | $ | 237.9 | |||||||||
Total cash equivalents | $ | 237.9 | $ | 0 | $ | 0 | $ | 237.9 | ||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | $ | 10.0 | $ | 0 | $ | 0 | $ | 10.0 | ||||||||
States, and other territories | 0 | 5.9 | 0 | 5.9 | ||||||||||||
Corporate securities | 0 | 18.4 | 0 | 18.4 | ||||||||||||
Foreign securities | 0 | 0.3 | 0 | 0.3 | ||||||||||||
Residential mortgage-backed securities | 0 | 10.6 | 0 | 10.6 | ||||||||||||
Commercial mortgage-backed securities | 0 | 5.0 | 0 | 5.0 | ||||||||||||
Asset backed securities | 0 | 6.4 | 0 | 6.4 | ||||||||||||
Total fixed maturities available-for-sale | 10.0 | 46.6 | 0 | 56.6 | ||||||||||||
Total financial assets | $ | 247.9 | $ | 46.6 | $ | 0 | $ | 294.5 | ||||||||
Financial liabilities: | ||||||||||||||||
Derivative liability on convertible promissory notes | $ | 0 | $ | 0 | $ | 162.6 | $ | 162.6 | ||||||||
Contingent consideration liability | 0 | 0 | 11.6 | 11.6 | ||||||||||||
Preferred stock warrant liabilities | 0 | 0 | 137.5 | 137.5 | ||||||||||||
Total financial liabilities | $ | 0 | $ | 0 | $ | 311.7 | $ | 311.7 | ||||||||
December 31, 2020 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Financial assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market funds | $ | 372.1 | $ | 0 | $ | 0 | $ | 372.1 | ||||||||
Treasury Bills | 23.5 | 0 | 0 | 23.5 | ||||||||||||
Total cash equivalents | $ | 395.6 | $ | 0 | $ | 0 | $ | 395.6 | ||||||||
Fixed maturities available-for-sale: | ||||||||||||||||
U.S. government and agencies | $ | 10.1 | $ | 0 | $ | 0 | $ | 10.1 | ||||||||
States, and other territories | 0 | 5.1 | 0 | 5.1 | ||||||||||||
Corporate securities | 0 | 17.4 | 0 | 17.4 | ||||||||||||
Foreign securities | 0 | 0.8 | 0 | 0.8 | ||||||||||||
Residential mortgage-backed securities | 0 | 12.9 | 0 | 12.9 | ||||||||||||
Commercial mortgage-backed securities | 0 | 5.5 | 0 | 5.5 | ||||||||||||
Asset backed securities | 0 | 4.2 | 0 | 4.2 | ||||||||||||
Total fixed maturities available-for-sale | $ | 10.1 | $ | 45.9 | $ | 0 | $ | 56.0 | ||||||||
Total financial assets | $ | 405.7 | $ | 45.9 | $ | 0 | $ | 451.6 | ||||||||
Financial liabilities: | ||||||||||||||||
Derivative liability on convertible promissory notes | $ | 0 | $ | 0 | $ | 113.3 | $ | 113.3 | ||||||||
Contingent consideration liability | 0 | 0 | 12.0 | 12.0 | ||||||||||||
Preferred stock warrant liabilities | 0 | 0 | 22.9 | 22.9 | ||||||||||||
Total financial liabilities | $ | 0 | $ | 0 | $ | 148.2 | $ | 148.2 | ||||||||
2021 | 2020 | |||||||
Balance as of January 1, | $ | 22.9 | $ | 6.7 | ||||
Changes in fair value | 114.6 | 4.1 | ||||||
Balance as of June 30, | $ | 137.5 | $ | 10.8 | ||||
2021 | 2020 | |||||||
Balance as of January 1, | $ | 12.0 | $ | 13.8 | ||||
Payments of contingent consideration | (1.7 | ) | (3.2 | ) | ||||
Changes in fair value | 1.3 | 0 | ||||||
Balance as of June 30, | $ | 11.6 | $ | 10.6 | ||||
2021 | ||||
Balance as of January 1, | $ | 113.3 | ||
Initial measurement of new derivative | 2.8 | |||
Changes in fair value | 46.5 | |||
Balance as of June 30, | $ | 162.6 | ||
June 30, 2021 | December 31, 2020 | |||||||||||||||||||||||||||
Weighted- Average Useful Life Remaining (in years) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | ||||||||||||||||||||||
(in millions) | (in millions) | |||||||||||||||||||||||||||
Agency and carrier | 7.9 | $ | 13.5 | $ | (0.9 | ) | $ | 12.6 | $ | 13.5 | $ | (0.1 | ) | $ | 13.4 | |||||||||||||
State licenses and domain name | Indefinite | 10.5 | 0 | 10.5 | 7.1 | 0 | 7.1 | |||||||||||||||||||||
Customer relationships | 3.8 | 13.2 | (4.9 | ) | 8.3 | 13.2 | (3.8 | ) | 9.4 | |||||||||||||||||||
Developed technology | 1.3 | 3.6 | (2.0 | ) | 1.6 | 3.6 | (1.4 | ) | 2.2 | |||||||||||||||||||
VOBA | 1.2 | 0.1 | 0 | 0.1 | 0.1 | 0 | 0.1 | |||||||||||||||||||||
Other | 7.1 | 1.9 | (0.4 | ) | 1.5 | 1.9 | (0.2 | ) | 1.7 | |||||||||||||||||||
Total intangible assets, net | $ | 42.8 | $ | (8.2 | ) | $ | 34.6 | $ | 39.4 | $ | (5.5 | ) | $ | 33.9 | ||||||||||||||
June 30, 2021 | December 31, 2020 | |||||||
(in millions) | ||||||||
Accrued wages and commissions | $ | 7.0 | $ | 5.0 | ||||
Deferred revenue | 7.2 | 1.7 | ||||||
Advances from customers | 9.6 | 4.4 | ||||||
Accrued licenses and taxes | 3.0 | 2.5 | ||||||
Accrued transaction cost | 1.1 | 0 | ||||||
Accrued interest | 0.9 | 0.8 | ||||||
Other | 17.2 | 11.3 | ||||||
Total accrued expenses and other liabilities | $ | 46.0 | $ | 25.7 | ||||
2021 | 2020 | |||||||
Reserve for losses and LAE gross of reinsurance recoverables on unpaid losses and LAE as of beginning of the period | $ | 105.1 | $ | 0 | ||||
Reinsurance recoverables on unpaid losses | (92.1 | ) | 0 | |||||
Reserve for losses and LAE, net of reinsurance recoverables as of beginning of the period | 13.0 | 0 | ||||||
Add: Incurred losses and LAE, net of reinsurance, related to: | ||||||||
Current year | 39.0 | 5.3 | ||||||
Prior years | (0.3 | ) | (0.1 | ) | ||||
Total incurred | 38.7 | 5.2 | ||||||
Deduct: Loss and LAE payments, net of reinsurance, related to: | ||||||||
Current year | (19.5 | ) | (3.3 | ) | ||||
Prior year | (5.1 | ) | 0 | |||||
Total paid | (24.6 | ) | (3.3 | ) | ||||
Reserve for losses and LAE, net of reinsurance recoverables at end of period | 27.1 | 1.9 | ||||||
Add: Reinsurance recoverables on unpaid losses and LAE at end of period | 168.1 | 0 | ||||||
Reserve for losses and LAE gross of reinsurance recoverables on unpaid losses and LAE as of end of the period | $ | 195.2 | $ | 1.9 | ||||
For the Three Months Ended June 30, | ||||||||||||||||||||||||
2021 | 2020 | |||||||||||||||||||||||
Written premiums | Earned premiums | Loss and LAE incurred | Written premiums | Earned premiums | Loss and LAE incurred | |||||||||||||||||||
Direct | $ | 129.3 | $ | 83.9 | $ | 135.7 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||
Assumed | (0.7 | ) | 3.2 | 4.8 | 5.5 | 3.1 | 3.3 | |||||||||||||||||
Gross | 128.6 | 87.1 | 140.5 | 5.5 | 3.1 | 3.3 | ||||||||||||||||||
Ceded | (116.4 | ) | (76.9 | ) | (119.1 | ) | 0 | (0.6 | ) | 0 | ||||||||||||||
Net | $ | 12.2 | $ | 10.2 | $ | 21.4 | $ | 5.5 | $ | 2.5 | $ | 3.3 | ||||||||||||
For the Six Months Ended June 30, | ||||||||||||||||||||||||
2021 | 2020 | |||||||||||||||||||||||
Written premiums | Earned premiums | Loss and LAE incurred | Written premiums | Earned premiums | Loss and LAE incurred | |||||||||||||||||||
Direct | $ | 224.3 | $ | 154.9 | $ | 276.1 | $ | 0 | $ | 0 | $ | 0 | ||||||||||||
Assumed | 3.4 | 6.6 | 10.1 | 14.7 | 4.8 | 5.2 | ||||||||||||||||||
Gross | 227.7 | 161.5 | 286.2 | 14.7 | 4.8 | 5.2 | ||||||||||||||||||
Ceded | (208.4 | ) | (142.5 | ) | (247.5 | ) | (2.0 | ) | (0.8 | ) | 0 | |||||||||||||
Net | $ | 19.3 | $ | 19.0 | $ | 38.7 | $ | 12.7 | $ | 4.0 | $ | 5.2 | ||||||||||||
June 30, 2021 | ||||||||||||||||||||
Issuance Price Per Share | Authorized Shares | Shares Issued and Outstanding | Net Carrying Value | Liquidation Preference | ||||||||||||||||
Preferred A-1 Stock | $ | 0.56965 | 5,889,829 | 5,889,829 | $ | 3.4 | $ | 3.4 | ||||||||||||
Preferred A-2 Stock | 1.57432 | 7,015,787 | 6,987,125 | 10.9 | 11.0 | |||||||||||||||
Preferred B Stock | 3.59757 | 6,949,142 | 6,949,142 | 24.9 | 25.0 | |||||||||||||||
Preferred C Stock | 7.04471 | 9,936,529 | 9,936,528 | 56.1 | 70.0 | |||||||||||||||
Preferred C-1 Stock | 11.74119 | 2,465,454 | 0 | 0 | 0 | |||||||||||||||
Preferred D Stock | 15.16420 | 6,594,479 | 6,594,479 | 99.8 | 100.0 | |||||||||||||||
Preferred E Stock | 19.66420 | 7,628,090 | 7,628,075 | 149.7 | 150.0 | |||||||||||||||
Total | 46,479,310 | 43,985,178 | $ | 344.8 | $ | 359.4 | ||||||||||||||
June 30, 2021 | December 31, 2020 | |||||||
Fair value of Series A-2 Preferred Stock | $ | 66.64 | $ | 18.25 | ||||
Fair value of Series C-1 Preferred Stock | $ | 66.74 | $ | 20.09 | ||||
Exercise price A-2 Preferred Stock | $ | 1.57 | $ | 1.57 | ||||
Exercise price C-1 Preferred Stock | $ | 11.74 | $ | 11.74 | ||||
Expected term (in years) | 1.3-5.7 | 1.8-6.2 | ||||||
Expected volatility | 26.6%-29.1% | 29.0%-40.7% | ||||||
Risk-free interest rate | 0.1%-1.1% | 0.1%-0.5% | ||||||
Expected dividend yield | 0% | 0% |
June 30, 2021 | December 31, 2020 | |||||||||||||||||||
Series | Exercise Price Per Share | Warrant Shares Outstanding | Fair Value | Warrant Shares Outstanding | Fair Value | |||||||||||||||
A-2 | $ | 1.57 | 28,662 | $ | 1.9 | 28,662 | $ | 0.5 | ||||||||||||
C-1 | 11.74 | 2,465,454 | 135.6 | 2,465,454 | 22.4 | |||||||||||||||
Total | 2,494,116 | $ | 137.5 | 2,494,116 | $ | 22.9 | ||||||||||||||
June 30, 2021 | December 31, 2020 | |||||||
Convertible preferred stock | 43,985,178 | 43,985,178 | ||||||
Warrants to purchase preferred stock | 2,494,116 | 2,494,116 | ||||||
Warrants to purchase common stock | 9,476,102 | 9,476,102 | ||||||
Common stock options outstanding | 9,449,400 | 10,382,771 | ||||||
Shares available for future grant of equity awards | 2,617,273 | 2,627,921 | ||||||
Total | 68,022,069 | 68,966,088 | ||||||
Issue Date | Exercise Price Per Share | Number of Warrants | Expiration Date | Outstanding as of June 30, 2021 | ||||||||||||
December 11, 2017 | $ | 0.01 | 4,738,051 | December 31, 2022 | 4,738,051 | |||||||||||
February 19, 2018 | $ | 0.01 | 4,738,051 | August 19, 2022 | 4,738,051 |
Options Outstanding | Weighted-Average Remaining | Aggregate Intrinsic | ||||||||||||||
Number of Shares | Weighted Average Exercise Price | Contract Term (In Years) | Value (In Millions) | |||||||||||||
Outstanding as of January 1, 2021 | 10,382,771 | $ | 4.88 | 8.90 | $ | 108.9 | ||||||||||
Granted | 569,350 | 25.44 | ||||||||||||||
Exercised | (846,674 | ) | 2.56 | |||||||||||||
Forfeited | (649,324 | ) | 6.67 | |||||||||||||
Expired | (6,723 | ) | 3.95 | |||||||||||||
Outstanding as of June 30, 2021 | 9,449,400 | $ | 6.20 | 8.55 | $ | 547.0 | ||||||||||
Vested and exercisable as of June 30, 2021 | 1,555,878 | $ | 4.27 | 8.01 | $ | 93.0 | ||||||||||
June 30, 2021 | December 31, 2020 | |||||||
Expected term (in years) | 5.8 - 6.1 | 5.6 - 6.1 | ||||||
Expected volatility | 29.7% - 30.1% | 22.6% - 29.9% | ||||||
Risk-free interest rate | 0.6% - 1.0% | 0.3% - 1.6% | ||||||
Expected dividend yield | —% | —% |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Losses and loss adjustment expenses | $ | 0.1 | $ | 0 | $ | 0.1 | $ | 0 | ||||||||
Insurance related expenses | 0 | 0 | 0.1 | 0.1 | ||||||||||||
Technology and development | 0.5 | 0.2 | 1.0 | 0.4 | ||||||||||||
Sales and marketing | 1.2 | 0.2 | 2.1 | 0.4 | ||||||||||||
General and administrative | 1.0 | 0.5 | 2.0 | 0.9 | ||||||||||||
Total share-based compensation expense | $ | 2.8 | $ | 0.9 | $ | 5.3 | $ | 1.8 | ||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Numerator: | ||||||||||||||||
Net loss attributable to Hippo - basic and diluted (in millions) | $ | (84.5 | ) | $ | (24.8 | ) | $ | (279.8 | ) | $ | (48.7 | ) | ||||
Denominator: | ||||||||||||||||
Weighted-average shares used in computing net loss per share attributable to Hippo — basic and diluted | 14,134,399 | 12,360,596 | 13,968,160 | 12,236,471 | ||||||||||||
Net loss per share attributable to Hippo — basic and diluted | $ | (5.98 | ) | $ | (2.01 | ) | $ | (20.03 | ) | $ | (3.98 | ) | ||||
As of June 30, | ||||||||
2021 | 2020 | |||||||
Convertible preferred stock (on an as if converted basis) | 43,985,178 | 36,330,613 | ||||||
Outstanding options | 9,741,833 | 8,141,970 | ||||||
Warrants to purchase common shares | 4,800,551 | 4,738,051 | ||||||
Warrants to purchase preferred shares | 2,494,116 | 2,494,116 | ||||||
Common stock subject to repurchase | 1,713,658 | 1,366,513 | ||||||
Convertible notes | 21,603,512 | 0 | ||||||
Total | 84,338,848 | 53,071,263 | ||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||||||||
Amount | % of GWP | Amount | % of GWP | Amount | % of GWP | Amount | % of GWP | |||||||||||||||||||||||||
State | ||||||||||||||||||||||||||||||||
Texas | $ | 39.9 | 31.0 | % | $ | 4.0 | 72.7 | % | $ | 72.9 | 32.0 | % | $ | 10.9 | 74.1 | % | ||||||||||||||||
California | 22.8 | 17.7 | % | 0 | 0 | % | 41.6 | 18.3 | % | 0 | 0 | % | ||||||||||||||||||||
Florida | 8.6 | 6.7 | % | 0 | 0 | % | 14.4 | 6.3 | % | 0 | 0 | % | ||||||||||||||||||||
Georgia | 5.6 | 4.4 | % | 0.2 | 3.6 | % | 9.8 | 4.3 | % | 0.4 | 2.7 | % | ||||||||||||||||||||
Illinois | 4.5 | 3.5 | % | 0.3 | 5.5 | % | 7.6 | 3.3 | % | 0.7 | 4.8 | % | ||||||||||||||||||||
Missouri | 3.5 | 2.7 | % | 0.2 | 3.6 | % | 5.9 | 2.6 | % | 0.5 | 3.4 | % | ||||||||||||||||||||
Colorado | 3.1 | 2.4 | % | 0 | 0 | % | 5.7 | 2.5 | % | 0 | 0 | % | ||||||||||||||||||||
Arizona | 2.9 | 2.3 | % | 0 | 0 | % | 5.3 | 2.3 | % | 0 | 0 | % | ||||||||||||||||||||
New Jersey | 2.3 | 1.8 | % | 0 | 0 | % | 4.5 | 2.0 | % | 0 | 0 | % | ||||||||||||||||||||
Ohio | 2.8 | 2.2 | % | 0.2 | 3.6 | % | 4.8 | 2.1 | % | 0.5 | 3.4 | % | ||||||||||||||||||||
Other | 32.6 | 25.3 | % | 0.6 | 10.9 | % | 55.2 | 24.2 | % | 1.7 | 11.6 | % | ||||||||||||||||||||
Total | $ | 128.6 | 100 | % | $ | 5.5 | 100 | % | $ | 227.7 | 100 | % | $ | 14.7 | 100 | % | ||||||||||||||||
2019 | 2018 | |||||||
Assets | ||||||||
Cash, cash equivalents, and short term investments | $ | 25,364 | $ | 18,460 | ||||
Fixed maturities, at fair value | 44,077 | 30,638 | ||||||
Total cash, cash equivalents, and investments | 69,441 | 49,098 | ||||||
Accrued interest and dividends | 240 | 163 | ||||||
Premium and agents’ balances (net of allowance for doubtful accounts) | ||||||||
amount of $0 and $0 in 2019 and 2018, respectively) | 31,169 | 19,726 | ||||||
Deferred policy acquisition costs | 2,462 | 1,921 | ||||||
Ceded unearned premium | 110,139 | 44,968 | ||||||
Ceding commissions receivable | 9,776 | 14,156 | ||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 42,475 | 15,295 | ||||||
Deferred income taxes, net | 820 | — | ||||||
Other assets | 118 | 41 | ||||||
Property, plant, & equipment | 258 | 16 | ||||||
Total assets | $ | 266,898 | $ | 145,384 | ||||
Liabilities | ||||||||
Unpaid losses and loss expenses | $ | 36,457 | $ | 13,072 | ||||
Unearned premiums | 113,177 | 47,880 | ||||||
Commissions payable and contingent commissions | 3,340 | 6,566 | ||||||
Advanced premium | 690 | 535 | ||||||
Reinsurance payable | 58,560 | 34,539 | ||||||
Federal income taxes payable | 664 | — | ||||||
Accrued expenses and other liabilities | 5,308 | 2,902 | ||||||
Other amounts due to reinsurers | 22 | 1,825 | ||||||
Deferred ceding fees | 7,436 | 3,369 | ||||||
Total liabilities | 225,654 | 110,688 | ||||||
Stockholder’s Equity | ||||||||
Common stock | 4,200 | 4,200 | ||||||
Additional paid in capital | 29,910 | 29,910 | ||||||
Retained earnings | 6,736 | 889 | ||||||
Accumulated other comprehensive income (loss): | ||||||||
Net unrealized gains (losses) on securities, net of tax expense (benefit) of $106 and ($81) in 2019 and 2018, respectively | 398 | (303 | ) | |||||
Total stockholder’s equity | 41,244 | 34,696 | ||||||
Total liabilities and stockholder’s equity | $ | 266,898 | $ | 145,384 | ||||
2019 | 2018 | |||||||
Revenues: | ||||||||
Premiums earned | $ | 143,098 | $ | 51,441 | ||||
Premiums ceded | (135,641 | ) | (32,684 | ) | ||||
Net premiums earned | 7,457 | 18,757 | ||||||
Net investment income | 1,166 | 726 | ||||||
Net realized capital gain on investments | — | 5 | ||||||
Other income | 15 | 1 | ||||||
Total revenues | 8,638 | 19,489 | ||||||
Expenses: | ||||||||
Loss and Loss Adjustment Expenses | 3,795 | 6,932 | ||||||
Commission expense | (9,155 | ) | 4,742 | |||||
Underwriting and general expenses | 8,217 | 4,639 | ||||||
Total expenses | 2,857 | 16,313 | ||||||
Income from operations before income taxes | 5,781 | 3,176 | ||||||
Provision for income taxes | (66 | ) | 62 | |||||
Net income | 5,847 | 3,114 | ||||||
Other comprehensive income (loss), before tax: | ||||||||
Unrealized holding gains (losses) on securities | 887 | (283 | ) | |||||
Reclassification adjustment for net realized capital gains | — | (5 | ) | |||||
Income tax (expense) benefit related to items of other comprehensive income (loss) | (186 | ) | 60 | |||||
Other comprehensive income (loss), net of tax | 701 | (228 | ) | |||||
Comprehensive income | $ | 6,548 | $ | 2,886 | ||||
Common Stock | Total Paid-in Capital | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Income (Loss) | Total Stockholder’s Equity | ||||||||||||||||||||
Shares | Par Value | |||||||||||||||||||||||
Balance at December 31, 2017 | 1,000 | $ | 4,200 | $ | 29,910 | $ | (2,225 | ) | $ | (75 | ) | $ | 31,810 | |||||||||||
Net income | — | — | — | 3,114 | — | 3,114 | ||||||||||||||||||
Other comprehensive (loss), net of tax | — | — | — | — | (228 | ) | (228 | ) | ||||||||||||||||
Balance at December 31, 2018 | 1,000 | 4,200 | $ | 29,910 | $ | 889 | $ | (303 | ) | $ | 34,696 | |||||||||||||
Net income | — | — | — | 5,847 | — | 5,847 | ||||||||||||||||||
Other comprehensive income, net of tax | — | — | — | — | 701 | 701 | ||||||||||||||||||
Balance at December 31, 2019 | 1,000 | $ | 4,200 | $ | 29,910 | $ | 6,736 | $ | 398 | $ | 41,244 | |||||||||||||
2019 | 2018 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 5,847 | $ | 3,114 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Deferred income taxes | (1,007 | ) | 63 | |||||
Net realized capital gain on investment | — | (5 | ) | |||||
Depreciation of fixed assets | 5 | — | ||||||
Amortization of right-of-use | 32 | — | ||||||
Net amortization of premiums and discounts on investments | 105 | 106 | ||||||
Amortization of deferred policy acquisition costs | 3,696 | 7,944 | ||||||
Amortization of deferred ceding fees | (8,546 | ) | (2,594 | ) | ||||
Changes in assets and liabilities: | ||||||||
Accrued interest and dividends | (77 | ) | (35 | ) | ||||
Premium and agents’ balances | (11,443 | ) | (8,866 | ) | ||||
Deferred policy acquisition costs | (4,237 | ) | (6,007 | ) | ||||
Ceded unearned premium | (65,171 | ) | (34,594 | ) | ||||
Ceding commissions receivable | 4,380 | (11,440 | ) | |||||
Reinsurance recoverable on paid and unpaid losses and LAE | (27,180 | ) | (13,404 | ) | ||||
Other assets | (72 | ) | (26 | ) | ||||
Unpaid losses and loss expenses | 23,385 | 9,322 | ||||||
Unearned premiums | 65,297 | 28,518 | ||||||
Commissions payable and contingent commissions | (3,226 | ) | 4,056 | |||||
Advanced premium | 155 | 298 | ||||||
Reinsurance payable | 24,021 | 27,036 | ||||||
Federal income taxes payable | 664 | — | ||||||
Operating lease right-of-use-office | (259 | ) | — | |||||
Accrued expenses and other liabilities | 2,406 | 1,923 | ||||||
Other amounts due to reinsurers | (1,803 | ) | 1,825 | |||||
Deferred ceding fees | 12,613 | 5,118 | ||||||
Net cash provided by operating activities | 19,585 | 12,352 | ||||||
Cash flows from investing activities: | ||||||||
Proceeds from sales of investments | 7,231 | 8,719 | ||||||
Purchases of investments | (19,892 | ) | (8,916 | ) | ||||
Fixed assets acquired | (20 | ) | (16 | ) | ||||
Net cash used in investing activities | (12,681 | ) | (213 | ) | ||||
Net increase in cash | 6,904 | 12,139 | ||||||
Cash, cash equivalents, and short term investments at beginning of year | 18,460 | 6,321 | ||||||
Cash, cash equivalents, and short term investments at end of year | $ | 25,364 | $ | 18,460 | ||||
1. | Nature of Operations and Summary of Significant Accounting Policies: |
2. | Investments |
2019 | ||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities: | ||||||||||||||||
U.S. Government and agencies | $ | 7,854 | $ | 35 | $ | — | $ | 7,889 | ||||||||
All Other Government | 500 | — | — | 500 | ||||||||||||
States, territories and possessions and political subdivisions | 2,662 | 69 | (3 | ) | 2,728 | |||||||||||
Corporate securities | 16,455 | 243 | (10 | ) | 16,688 | |||||||||||
Foreign securities | 3,002 | 53 | — | 3,055 | ||||||||||||
Residential mortgage-backed securities | 7,347 | 61 | (10 | ) | 7,398 | |||||||||||
Commercial mortgage-backed securities | 2,753 | 42 | (19 | ) | 2,776 | |||||||||||
Asset backed securities | 3,000 | 44 | (1 | ) | 3,043 | |||||||||||
Total investments | $ | 43,573 | $ | 547 | $ | (43 | ) | $ | 44,077 | |||||||
2018 | ||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities: | ||||||||||||||||
U.S. Government and agencies | $ | 7,800 | $ | 2 | $ | (72 | ) | $ | 7,730 | |||||||
States, territories and possessions and political subdivisions | 203 | — | (3 | ) | 200 | |||||||||||
Corporate securities | 10,664 | 8 | (106 | ) | 10,566 | |||||||||||
Foreign securities | 1,801 | — | (17 | ) | 1,784 | |||||||||||
Residential mortgage-backed securities | 6,716 | — | (176 | ) | 6,540 | |||||||||||
Commercial mortgage-backed securities | 1,388 | — | (23 | ) | 1,365 | |||||||||||
Asset backed securities | 2,449 | 9 | (5 | ) | 2,453 | |||||||||||
Total investments | $ | 31,021 | $ | 19 | $ | (402 | ) | $ | 30,638 | |||||||
Preferred stocks | ||||||||||||||||
Industrial miscellaneous | — | — | — | — | ||||||||||||
Common stocks | ||||||||||||||||
Finance and banking | — | — | — | — | ||||||||||||
Total investments | $ | 31,021 | $ | 19 | $ | (402 | ) | $ | 30,638 | |||||||
December 31, 2019 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 9,096 | $ | 9,120 | ||||
After one year through five years | 17,672 | 17,935 | ||||||
After five years | 3,598 | 3,699 | ||||||
After ten years | 107 | 106 | ||||||
Residential mortgage-backed securities | 7,347 | 7,398 | ||||||
Commercial mortgage-backed securities | 2,753 | 2,776 | ||||||
Asset backed securities | 3,000 | 3,043 | ||||||
Total fixed maturities | $ | 43,573 | $ | 44,077 | ||||
December 31, 2018 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 3,600 | $ | 3,575 | ||||
After one year through five years | 14,917 | 14,781 | ||||||
After five years | 1,240 | 1,232 | ||||||
After ten years | 711 | 692 | ||||||
Residential mortgage-backed securities | 6,716 | 6,540 | ||||||
Commercial mortgage-backed securities | 1,388 | 1,365 | ||||||
Asset backed securities | 2,449 | 2,453 | ||||||
Total fixed maturities | $ | 31,021 | $ | 30,638 | ||||
2019 | 2018 | |||||||
Fixed income | $ | 944 | $ | 690 | ||||
Cash and cash equivalents | 362 | 170 | ||||||
Total gross investment income | 1,306 | 860 | ||||||
Investment expenses | 140 | 134 | ||||||
Net investment income | $ | 1,166 | $ | 726 | ||||
December 31, 2019 | ||||||||||||||||||||||||
Less than 12 months | Greater than 12 months | Total | ||||||||||||||||||||||
Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||
U.S. Government and agencies | $ | 998 | $ | — | $ | — | $ | — | $ | 998 | $ | — | ||||||||||||
States, territories and possessions and political subdivisions | 743 | (3 | ) | 107 | — | 850 | (3 | ) | ||||||||||||||||
Corporate securities | 1,567 | (10 | ) | — | — | 1,567 | (10 | ) | ||||||||||||||||
Residential mortgage-backed securities | 1,957 | (6 | ) | 991 | (4 | ) | 2,948 | (10 | ) | |||||||||||||||
Commercial mortgage-backed securities | 1,022 | (17 | ) | 159 | (2 | ) | 1,181 | (19 | ) | |||||||||||||||
Asset-backed securities | 749 | (1 | ) | — | — | 749 | (1 | ) | ||||||||||||||||
Total investments | $ | 7,036 | $ | (37 | ) | $ | 1,257 | $ | (6 | ) | $ | 8,293 | $ | (43 | ) | |||||||||
December 31, 2018 | ||||||||||||||||||||||||
Less than 12 months | Greater than 12 months | Total | ||||||||||||||||||||||
Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||
U.S. Government and agencies | $ | 2,583 | $ | (1 | ) | $ | 4,845 | $ | (71 | ) | $ | 7,428 | $ | (72 | ) | |||||||||
States, territories and possessions and political subdivisions | — | — | 201 | (3 | ) | 201 | (3 | ) | ||||||||||||||||
Corporate securities | 5,478 | (65 | ) | 3,333 | (41 | ) | 8,811 | (106 | ) | |||||||||||||||
Foreign securities | 1,784 | (17 | ) | — | — | 1,784 | (17 | ) | ||||||||||||||||
Residential mortgage-backed securities | 606 | (9 | ) | 5,442 | (167 | ) | 6,048 | (176 | ) | |||||||||||||||
Commercial mortgage-backed securities | 255 | — | 1,109 | (23 | ) | 1,364 | (23 | ) | ||||||||||||||||
Asset-backed securities | — | — | 944 | (5 | ) | 944 | (5 | ) | ||||||||||||||||
Total investments | $ | 10,706 | $ | (92 | ) | $ | 15,874 | $ | (310 | ) | $ | 26,580 | $ | (402 | ) | |||||||||
3. | Fair Value Measurements |
Fair Value Measurement at December 31, 2019 | ||||||||||||||||
Total | Level I | Level II | Level III | |||||||||||||
Assets: | ||||||||||||||||
Fixed maturity securities: | ||||||||||||||||
U.S. Government and agencies | $ | 7,889 | $ | 7,889 | $ | — | $ | — | ||||||||
All Other Government | 500 | — | 500 | |||||||||||||
States, territories and possessions and political subdivisions | 2,728 | — | 2,728 | — | ||||||||||||
Corporate securities | 16,688 | — | 16,688 | — | ||||||||||||
Foreign securities | 3,055 | — | 3,055 | — | ||||||||||||
Residential mortgage-backed securities | 7,398 | — | 7,398 | — | ||||||||||||
Commercial mortgage-backed securities | 2,776 | — | 2,776 | — | ||||||||||||
Asset backed securities | 3,043 | — | 3,043 | — | ||||||||||||
Total fixed maturity securities | 44,077 | 7,889 | 36,188 | — | ||||||||||||
Cash equivalents | 25,481 | 3,726 | 21,755 | — | ||||||||||||
Total assets at fair value | $ | 69,558 | $ | 11,615 | $ | 57,943 | $ | — | ||||||||
Fair Value Measurement at December 31, 2018 | ||||||||||||||||
Total | Level I | Level II | Level III | |||||||||||||
Assets: | ||||||||||||||||
Fixed maturity securities: | ||||||||||||||||
U.S. Government and agencies | $ | 7,730 | $ | 7,730 | $ | — | $ | — | ||||||||
States, territories and possessions and political subdivisions | 200 | — | 200 | — | ||||||||||||
Corporate securities | 10,566 | — | 10,566 | — | ||||||||||||
Foreign securities | 1,784 | — | 1,784 | — | ||||||||||||
Residential mortgage-backed securities | 6,540 | — | 6,540 | — | ||||||||||||
Commercial mortgage-backed securities | 1,365 | — | 1,365 | — | ||||||||||||
Asset backed securities | 2,453 | — | 2,453 | — | ||||||||||||
Total fixed maturity securities | 30,638 | 7,730 | 22,908 | — | ||||||||||||
Cash equivalents | 18,576 | 3,269 | 15,307 | — | ||||||||||||
Total assets at fair value | $ | 49,214 | $ | 10,999 | $ | 38,215 | $ | — | ||||||||
4. | Insurance and Reinsurance Activity |
2019 | 2018 | |||||||||||||||
Premiums Written | Premiums Earned | Premiums Written | Premiums Earned | |||||||||||||
Direct premium | $ | 208,395 | $ | 143,098 | $ | 79,960 | $ | 51,441 | ||||||||
Ceded premium — nonaffiliated | (200,812 | ) | (135,641 | ) | (67,278 | ) | (32,684 | ) | ||||||||
Net premiums | $ | 7,583 | $ | 7,457 | $ | 12,682 | $ | 18,757 | ||||||||
2019 | 2018 | |||||||
Direct losses and loss adjustment expenses | $ | 109,900 | $ | 34,414 | ||||
Ceded losses and loss adjustment expenses | (106,105 | ) | (27,482 | ) | ||||
Net losses and loss adjustment expenses | $ | 3,795 | $ | 6,932 | ||||
2019 | 2018 | |||||||
Balance at beginning of period: | ||||||||
Liability for unpaid losses and loss adjustment expense | $ | 13,072 | $ | 3,750 | ||||
Reinsurance ceded | 10,223 | 1,537 | ||||||
Net balance at beginning of year | 2,849 | 2,213 | ||||||
Incurred related to: | ||||||||
Current year | 4,780 | 7,794 | ||||||
Prior years | (985 | ) | (862 | ) | ||||
Total incurred | 3,795 | 6,932 | ||||||
Paid related to: | ||||||||
Current year | (3,249 | ) | (5,317 | ) | ||||
Prior years | (365 | ) | (979 | ) | ||||
Total paid | (3,614 | ) | (6,296 | ) | ||||
Balance at end of year: | ||||||||
Liability for unpaid losses and loss adjustment expense | 36,457 | 13,072 | ||||||
Reinsurance ceded | 33,427 | 10,223 | ||||||
Net balance at end of year | $ | 3,030 | $ | 2,849 | ||||
Property and Casualty | At December 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||
Incurred Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance For the Year Ended December 31, 2019 | Total IBNR Plus Expected Development on Reported Claims | |||||||||||||||||||||||||||||||||||||||||||||||
Cumulative Number of Reported Claims | ||||||||||||||||||||||||||||||||||||||||||||||||
Accident Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | ||||||||||||||||||||||||||||||||||||||
unaudited | ||||||||||||||||||||||||||||||||||||||||||||||||
(in thousands, except claim counts) | ||||||||||||||||||||||||||||||||||||||||||||||||
2010 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | — | |||||||||||||||||||||||||
2011 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
2012 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
2013 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
2014 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
2015 | — | — | — | — | — | 24 | 25 | 25 | 25 | 25 | — | 7 | ||||||||||||||||||||||||||||||||||||
2016 | — | — | — | — | — | — | 2,457 | 1,858 | 1,859 | 1,770 | — | 713 | ||||||||||||||||||||||||||||||||||||
2017 | — | — | — | — | — | — | — | 5,219 | 4,354 | 4,034 | 10 | 3,118 | ||||||||||||||||||||||||||||||||||||
2018 | — | — | — | — | — | — | — | — | 7,793 | 7,184 | 952 | 6,133 | ||||||||||||||||||||||||||||||||||||
2019 | — | — | — | — | — | — | — | — | — | 4,780 | 946 | 12,421 | ||||||||||||||||||||||||||||||||||||
Total | $ | 17,793 | ||||||||||||||||||||||||||||||||||||||||||||||
Property and Casualty | ||||||||||||||||||||||||||||||||||||||
Paid Claims and Allocated Claim Adjustment Expenses, Net of Reinsurance For the Year Ended December 31, | ||||||||||||||||||||||||||||||||||||||
Accident Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | ||||||||||||||||||||||||||||
unaudited | ||||||||||||||||||||||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||||||||||||||||
2010 | $— | $— | $— | $— | $— | $— | $— | $— | $— | $— | ||||||||||||||||||||||||||||
2011 | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
2012 | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
2013 | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
2014 | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||
2015 | — | — | — | — | — | 8 | 25 | 25 | 25 | 25 | ||||||||||||||||||||||||||||
2016 | — | — | — | — | — | — | 1,244 | 1,846 | 1,858 | 1,770 | ||||||||||||||||||||||||||||
2017 | — | — | — | — | — | — | — | 3,019 | 3,983 | 4,021 | ||||||||||||||||||||||||||||
2018 | — | — | — | — | — | — | — | — | 5,317 | 5,698 | ||||||||||||||||||||||||||||
2019 | — | — | — | — | — | — | — | — | — | 3,249 | ||||||||||||||||||||||||||||
Total | $ | 14,763 | ||||||||||||||||||||||||||||||||||||
All outstanding liabilities prior to 2009, net of reinsurance | $ | — | ||||||||||||||||||||||||||||||||||||
| Liabilities for Claims and Claim adjustment expenses, net of reinsurance | | $ | 3,030 |
Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance | ||||||||||||||||||||||||||||||||||||||||
Years | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||||||||||||||||||||||||||||||
Property and Casualty | 63.8 | % | 32.8 | % | 0.5 | % | -2.5 | % | — | % | — | % | — | % | — | % | — | % | — | % |
5. | Operating Leases |
2019 | 2018 | |||||||
Operating lease right-of-use-office | $ | 259 | $ | — | ||||
Accumulated amortization | (32 | ) | — | |||||
Operating lease included in property, plant, & equipment | $ | 227 | $ | — �� | ||||
Opiating lease liability included in included in accrued expenses and other liabilities | $ | (246 | ) | $ | — | |||
Year Ending December 31: | Operating | |||
2020 | $ | 62 | ||
2021 | 63 | |||
2022 | 66 | |||
2023 | 66 | |||
2024 | 38 | |||
Total lease Payments | 295 | |||
Less: interest | (49 | ) | ||
Present value of the lease liability | $ | 246 | ||
2019 | 2018 | |||||||
Operating lease included in underwriting and general expenses | $ | 55 | $ | 27 |
2019 | 2018 | |||||||
Cash paid for amounts included in the measurement of the lease liabilities: | ||||||||
Operating cash flows from operating leases | $ | 26 | $ | 27 | ||||
Lease assets obtained in exchange for the lease obligation: | ||||||||
Operating leases | 259 | — |
6. | Contingencies |
7. | Debt |
8. | Benefit Plans |
9. | Income Taxes |
2019 | 2018 | |||||||
Current | $ | 940 | $ | — | ||||
Deferred | (1,006 | ) | 62 | |||||
$ | (66 | ) | $ | 62 | ||||
2019 | % of Pre-Tax Income | 2018 | % of Pre-Tax Income | |||||||||||||
Expected provision computed at statutory rate | $ | 1,216 | 21.0 | % | $ | 667 | 21.0 | % | ||||||||
Effect of permanent differences | 5 | 0.1 | % | 3 | 0.1 | % | ||||||||||
Change in valuation allowance | (1,284 | ) | -22.2 | % | (607 | ) | -19.1 | % | ||||||||
Other items | (8 | ) | -0.1 | % | (1 | ) | 0.0 | % | ||||||||
Prior year over accrual | 5 | 0.1 | % | — | 0.0 | % | ||||||||||
Total | $ | (66 | ) | (1.1 | )% | $ | 62 | 2.0 | % | |||||||
2019 | 2018 | |||||||
Deferred income tax assets: | ||||||||
Unearned premium | $ | 132 | $ | 122 | ||||
Unpaid Loss and Loss Adjustment Expenses | 37 | 30 | ||||||
Advanced premium | 28 | 22 | ||||||
Net operation loss carryovers | — | 282 | ||||||
Intangible Assets | 1,038 | 1,106 | ||||||
Other | 249 | 142 | ||||||
Total gross deferred income tax assets | 1,484 | 1,704 | ||||||
Deferred income tax liabilities: | ||||||||
Deferred policy acquisition costs | 530 | 403 | ||||||
Other | 134 | 17 | ||||||
Total gross deferred income tax liabilities | 664 | 420 | ||||||
Net deferred income tax assets | 820 | 1,284 | ||||||
Valuation allowance | — | (1,284 | ) | |||||
Deferred income tax assets, net | $ | 820 | $ | — | ||||
10. | Stockholder’s Equity |
11. | Statutory Net Earnings and Stockholder’s Equity |
2019 | 2018 | |||||||
Total stockholder’s equity | $ | 41,244 | $ | 34,696 | ||||
Non-admitted assets | (788 | ) | (53 | ) | ||||
Deferred acquisition costs | (2,462 | ) | (1,921 | ) | ||||
Deferred taxes | 615 | — | ||||||
Book Value of Bonds (PGAAP) | (70 | ) | (81 | ) | ||||
Market Value of Bonds | (504 | ) | 383 | |||||
Provision for reinsurance | (38 | ) | 9 | |||||
Miscellaneous differences | (1 | ) | (16 | ) | ||||
Aggregate statutory surplus of insurance subsidiaries | $ | 37,996 | $ | 33,017 | ||||
Net income | $ | 5,847 | $ | 3,114 | ||||
Deferred acquisition costs | (541 | ) | 1,937 | |||||
Deferred taxes | (1,005 | ) | 60 | |||||
GAAP to STAT bond amortization difference | 7 | 8 | ||||||
Miscellaneous differences | — | 16 | ||||||
Aggregate statutory net earnings | $ | 4,308 | $ | 5,135 | ||||
12. | Related Parties |
13. | Subsequent Events |
June 30, 2020 | December 31, 2019 | |||||||
Assets | ||||||||
Cash and cash equivalents | $ | 17,461 | $ | 24,560 | ||||
Restricted cash | 1,886 | 804 | ||||||
Short-term investments | 4,998 | — | ||||||
Fixed maturities, at fair value | 47,159 | 44,077 | ||||||
Accrued interest and dividends | 239 | 240 | ||||||
Premium and agents’ balances | 31,259 | 31,169 | ||||||
Deferred policy acquisition costs | 2,403 | 2,462 | ||||||
Ceded unearned premium | 134,419 | 110,139 | ||||||
Ceding commissions receivable | 22,160 | 9,776 | ||||||
Reinsurance recoverable on paid and unpaid losses and LAE | 85,602 | 42,475 | ||||||
Deferred income taxes, net | 501 | 820 | ||||||
Property and equipment, net | 238 | 258 | ||||||
Other assets | 398 | 118 | ||||||
Total assets | $ | 348,723 | $ | 266,898 | ||||
Liabilities | ||||||||
Unpaid losses and loss expenses | 57,138 | $ | 36,457 | |||||
Unearned premiums | 134,987 | 113,177 | ||||||
Commissions payable and contingent commissions | 825 | 3340 | ||||||
Advanced premium | 1,691 | 690 | ||||||
Reinsurance payable | 94,745 | 58,560 | ||||||
Federal income taxes payable | 1,354 | 664 | ||||||
Accrued expenses and other liabilities | 3,531 | 5,308 | ||||||
Other amounts due to reinsurers | — | 22 | ||||||
Deferred ceding fees | 8,683 | 7,436 | ||||||
Total liabilities | 302,954 | 225,654 | ||||||
Commitments and contingencies (Note 6) | ||||||||
Stockholder’s Equity | ||||||||
Common Stock | 4,200 | 4,200 | ||||||
Additional paid-in-capital | 29,910 | 29,910 | ||||||
Retained earnings | 10,329 | 6,736 | ||||||
Accumulated other comprehensive income | ||||||||
Net unrealized gains on securities, net of tax expense of $354 and $106 during the periods ended June 30, 2020 and December 31, 2019 respectively | 1,330 | 398 | ||||||
Total stockholder’s equity | 45,769 | 41,244 | ||||||
Total liabilities and stockholder’s equity | $ | 348,723 | $ | 266,898 | ||||
Six Months Ended | ||||||||
June 30, 2020 | June 30, 2019 | |||||||
Revenues: | ||||||||
Premiums earned | $ | 111, 223 | $ | 53,531 | ||||
Premiums ceded | (107,146 | ) | (49,812 | ) | ||||
Net premiums earned | 4,077 | 3,719 | ||||||
Net investment income | 556 | 557 | ||||||
Net realized capital gain on investments | 39 | — | ||||||
Other income | 9 | 6 | ||||||
Total revenues | 4,681 | 4,282 | ||||||
Expenses: | ||||||||
Loss and Loss Adjustment Expenses | 2,695 | 2,118 | ||||||
Commission income | (8,548 | ) | (4,011 | ) | ||||
Underwriting and general expenses | 5,933 | 4,347 | ||||||
Total expenses | 80 | 2,454 | ||||||
Income from operations before income taxes | 4,601 | 1,828 | ||||||
(Benefit) provision for income taxes | 1,008 | (123 | ) | |||||
Net income | 3,593 | 1,951 | ||||||
Other comprehensive income, before tax: | ||||||||
Unrealized holding gains on securities | 1,180 | 783 | ||||||
Income tax expense related to items of other comprehensive income | (248 | ) | (164 | ) | ||||
Other comprehensive income, net of tax: | 932 | 619 | ||||||
Comprehensive income | $ | 4,525 | $ | 2,570 | ||||
Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Total Stockholder’s Equity | ||||||||||||||||||||
Shares | Amount | |||||||||||||||||||||||
Balance at December 31, 2018 | 1,000 | $ | 4,200 | $ | 29,910 | $ | 889 | $ | (303 | ) | $ | 34,696 | ||||||||||||
Net income | — | — | — | 1,951 | — | 1,951 | ||||||||||||||||||
Other comprehensive income, net of tax | — | — | — | — | 619 | 619 | ||||||||||||||||||
Balance at June 30, 2019 | 1,000 | $ | 4,200 | $ | 29,910 | $ | 2,840 | $ | 316 | $ | 37,266 | |||||||||||||
Balance at December 31, 2019 | 1,000 | $ | 4,200 | $ | 29,910 | $ | 6,736 | $ | 398 | $ | 41,244 | |||||||||||||
Net income | — | — | — | 3,593 | — | 3,593 | ||||||||||||||||||
Other comprehensive income, net of tax | — | — | — | — | 932 | 932 | ||||||||||||||||||
Balance at June 30, 2020 | 1,000 | $ | 4,200 | $ | 29,910 | $ | 10,329 | $ | 1,330 | $ | 45,769 | |||||||||||||
Six Months Ended. | ||||||||
June 30, 2020 | June 30, 2019 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 3,593 | $ | 1,951 | ||||
Adjustments to reconcile net income to net cash used in operating activities: Net realized capital loss (gain) on investment | (39 | ) | — | |||||
Depreciation of fixed assets | 4 | 2 | ||||||
Amortization of right-of-use | 21 | 12 | ||||||
Net amortization of premiums and discounts on investments | 72 | 37 | ||||||
Amortization of deferred policy acquisition costs | 2,017 | 1,709 | ||||||
Amortization of deferred ceding fees | (7,261 | ) | (3,341 | ) | ||||
Changes in assets and liabilities: | ||||||||
Accrued interest and dividends | 1 | (31 | ) | |||||
Premium and agents’ balances | (90 | ) | (11,122 | ) | ||||
Deferred policy acquisition costs | (1,958 | ) | (2,170 | ) | ||||
Deferred income taxes, net | 72 | (164 | ) | |||||
Ceded unearned premium | (24,280 | ) | (39,892 | ) | ||||
Ceding commissions receivable | (12,384 | ) | (7,307 | ) | ||||
Reinsurance recoverable on paid and unpaid losses and LAE | (43,127 | ) | (20,889 | ) | ||||
Other assets | (280 | ) | (81 | ) | ||||
Unpaid losses and loss expenses | 20,681 | 16,212 | ||||||
Unearned premiums | 21,810 | 39,499 | ||||||
Commissions and contingencies (Note 6) | (2,515 | ) | 3,348 | |||||
Advanced premium | 1,001 | 1,059 | ||||||
Reinsurance payable | 36,185 | 31,869 | ||||||
Federal income taxes payable | 690 | 10 | ||||||
Operating lease right-of-use-office | — | (259 | ) | |||||
Accrued expenses and other liabilities | 5,484 | 3,639 | ||||||
Other amounts due to reinsurers | (22 | ) | (1,825 | ) | ||||
Deferred ceding fees | 1,247 | 2,071 | ||||||
Net cash provided by operating activities | 922 | 14,337 | ||||||
Cash flows from investing activities: | ||||||||
Proceeds from sales of investments with fixed maturities | 6,071 | 2,372 | ||||||
Purchases of short-term investments | (4,998 | ) | — | |||||
Purchases of investments with fixed maturities | (8,007 | ) | (7,245 | ) | ||||
Fixed assets acquired | (5 | ) | (16 | ) | ||||
Net cash used in investing activities | (6,939 | ) | (4,889 | ) | ||||
�� | ||||||||
Net (decrease) increase in cash | (6,017 | ) | 9,448 | |||||
Cash, cash equivalents and restricted cash, beginning of year | 25,364 | 18,460 | ||||||
Cash, cash equivalents and restricted cash, end of period | $ | 19,347 | $ | 27,908 | ||||
Supplemental disclosures of cash flow information Cash paid for income taxes | $ | 238 | $ | 261 | ||||
June 30, 2020 | December 31, 2019 | |||||||
Cash and cash equivalents | $ | 17,461 | $ | 24,560 | ||||
Restricted cash | 1,886 | 804 | ||||||
Total cash, cash equivalents, and restricted cash | $ | 19,347 | $ | 25,364 | ||||
June 30.2020 | ||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||
Short-term investments | ||||||||||||||||
Treasury bills | $ | 4,998 | — | — | $ | 4,998 | ||||||||||
Total short-term investments | 4,998 | — | — | 4,998 | ||||||||||||
Fixed maturities: | ||||||||||||||||
U.S. government and agencies | $ | 6307 | $ | 89 | $ | — | $ | 6,396 | ||||||||
All other government | 489 | 145 | — | 634 | ||||||||||||
States, territories and possessions and political subdivisions | 3,149 | 221 | — | 3,370 | ||||||||||||
Corporate securities | 18,491 | 667 | (1 | ) | 19,157 | |||||||||||
Foreign securities | 1,802 | 90 | — | 1,892 | ||||||||||||
Residential mortgage-backed securities | 6,227 | 195 | — | 6,422 | ||||||||||||
Commercial mortgage-backed securities | 5,250 | 234 | — | 5,484 | ||||||||||||
Asset backed securities | 3,691 | 113 | — | 3,804 | ||||||||||||
Total fixed maturities | $ | 45,406 | $ | 1,754 | $ | (1 | ) | $ | 47,159 | |||||||
Total investments | $ | 50,404 | $ | 1,754 | $ | (1 | ) | $ | 52,157 | |||||||
December 31, 2019 | ||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||
Fixed maturities: | ||||||||||||||||
U.S. government and agencies | $ | 7,854 | $ | 35 | $ | — | $ | 7,889 | ||||||||
All other government | 500 | — | — | 500 | ||||||||||||
States ; territories and possessions and political subdivisions | 2,662 | 69 | (3 | ) | 2,728 | |||||||||||
Corporate securities | 16,455 | 243 | (10 | ) | 16,688 | |||||||||||
Foreign securities | 3,002 | 53 | — | 3,055 | ||||||||||||
Residential mortgage-backed securities | 7,347 | 61 | (10 | ) | 7,398 | |||||||||||
Commercial mortgage-backed securities | 2,753 | 42 | (19 | ) | 2,776 | |||||||||||
Asset backed securities | 3,000 | 44 | (1 | ) | 3,043 | |||||||||||
Total investments | $ | 43,573 | $ | 547 | $ | (43 | ) | $ | 44,077 | |||||||
June 31, 2020 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 12,783 | $ | 12,819 | ||||
After one year through five years | 18,045 | 18,785 | ||||||
After five years | 4,321 | 4,756 | ||||||
After ten years | 87 | 87 | ||||||
Residential mortgage-backed securities | 6,227 | 6,422 | ||||||
Commercial mortgage-backed securities | 5,250 | 5,484 | ||||||
Asset backed securities | 3,691 | 3,804 | ||||||
Total investments | $ | 50,404 | $ | 52,157 | ||||
December 31, 2019 | ||||||||
Amortized Cost | Fair Value | |||||||
Due to mature: | ||||||||
One year or less | $ | 9,096 | $ | 9,120 | ||||
After one year through five years | 17,672 | 17,935 | ||||||
After five years | 3,598 | 3,699 | ||||||
After ten years | 107 | 106 | ||||||
Residential mortgage-backed securities | 7,347 | 7,398 | ||||||
Commercial mortgage-backed securities | 2,753 | 2,776 | ||||||
Asset backed securities | 3,000 | 3,043 | ||||||
Total investments | $ | 43,573 | $ | 44,077 | ||||
Six months ended. | ||||||||
June 30, 2020 | June 30, 2019 | |||||||
Fixed income | $ | 562 | $ | 445 | ||||
Cash and cash equivalents | 68 | 178 | ||||||
Total gross investment income | 630 | 623 | ||||||
Investment expenses | 74 | 66 | ||||||
Net investment income | $ | 556 | $ | 557 | ||||
June 30. 2020 | ||||||||||||||||||||||||
Less than 12 months | Greater than 12 months | Total | ||||||||||||||||||||||
Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Short-term investments | ||||||||||||||||||||||||
Treasury bills | $ | 4,998 | $ | — | $ | — | $ | — | $ | 4,998 | $ | — | ||||||||||||
Total short-tenn investments | 4,998 | — | — | — | 4,998 | — | ||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||
U.S. government and agencies | $ | 1,011 | $ | — | $ | — | $ | — | $ | 1,011 | $ | — | ||||||||||||
Corporate securities | — | — | 504 | (1 | ) | 504 | (1 | ) | ||||||||||||||||
Commercial mortgage- backed securities | — | — | 118 | — | 118 | — | ||||||||||||||||||
Total fixed maturities | 1,011 | 622 | (1 | ) | 1,633 | (1 | ) | |||||||||||||||||
Total investments | $ | 6,009 | $ | — | $ | 622 | $ | (1 | ) | $ | 6,631 | $ | (1 | ) | ||||||||||
December 31.2019 | ||||||||||||||||||||||||
Less than 12 months | Greater than 12 months | Total | ||||||||||||||||||||||
Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | Fair Value | Unrealized Losses | |||||||||||||||||||
Fixed matunties: | ||||||||||||||||||||||||
U.S. government and agencies | $ | 998 | $ | — | $ | — | $ | — | $ | 998 | $ | — | ||||||||||||
States, territories and possessions and political subdivisions | 743 | (3 | ) | 107 | — | 850 | (3 | ) | ||||||||||||||||
Corporate securities | 1,567 | (10 | ) | — | — | 1,567 | (10 | ) | ||||||||||||||||
Residential mortgage-backed securities | 1,957 | (6 | ) | 991 | (4 | ) | 2,948 | (10 | ) | |||||||||||||||
Commercial mortgage- backed securities | 1,022 | (17 | ) | 159 | (2 | ) | 1,181 | (19 | ) | |||||||||||||||
Asset-backed secunties | 749 | (1 | ) | — | — | 749 | (1 | ) | ||||||||||||||||
Total investments | $ | 7,036 | $ | (37 | ) | $ | 1,257 | $ | (6 | ) | $ | 8,293 | $ | (43 | ) | |||||||||
Fair Valve Measurement at June 30. 2020 | ||||||||||||||||
Total | Level I | Level II | Level III | |||||||||||||
Assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Money market fund | $ | 296 | $ | 296 | $ | — | $ | — | ||||||||
Treasury bill | 8,499 | 8,499 | — | — | ||||||||||||
Total Cash equivalents | 8,795 | 8,795 | — | — | ||||||||||||
Short-term investments: | ||||||||||||||||
Treasury bills | 4,998 | 4,998 | — | |||||||||||||
Total short-term investments | 4,998 | 4,998 | — | — | ||||||||||||
Fixed maturity securities: | ||||||||||||||||
U.S. government and agencies | 6,396 | 6,396 | — | — | ||||||||||||
All other government | 634 | — | 634 | — | ||||||||||||
States, territories and possessions | — | — | ||||||||||||||
and political subdivisions | 3,370 | — | 3,370 | — | ||||||||||||
Corporate securities | 19,157 | — | 19,157 | — | ||||||||||||
Foreign securities | 1,892 | — | 1,892 | — | ||||||||||||
Residential mortgage-backed securities | 6,422 | — | 6,422 | — | ||||||||||||
Commercial mortgage-backed securities | 5,484 | — | 5,484 | — | ||||||||||||
Asset backed securities | 3,804 | — | 3,804 | — | ||||||||||||
Total fixed maturity securities | 47,159 | 6,396 | 40,763 | — | ||||||||||||
Total assets at fair value | $ | 60,952 | $ | 20,189 | $ | 40,763 | $ | — | ||||||||
Fair Value Measurement at December 31. 2019 | ||||||||||||||||
Total | Level I Level II | Level HI | ||||||||||||||
Assets: | ||||||||||||||||
Cash equivalents: | ||||||||||||||||
Treasury bills | $ | 21,755 | $ | 21,755 | $ | — | $ | — | ||||||||
Total Cash equivalents | 21,755 | 21,755 | — | — | ||||||||||||
Fixed maturity securities: | ||||||||||||||||
U.S. government and agencies | 7,889 | 7,889 | — | — | ||||||||||||
All other government | 500 | — | 500 | |||||||||||||
States, territories and possessions and political subdivisions | 2,728 | — | 2,728 | — | ||||||||||||
Corporate securities | 16,688 | — | 16,688 | — | ||||||||||||
Foreign securities | 3,055 | — | 3,055 | — | ||||||||||||
Residential mortgage-backed securities | 7,398 | — | 7,398 | — | ||||||||||||
Commercial mortgage-backed securities | 2,776 | — | 2,776 | — | ||||||||||||
Asset backed securities | 3,043 | — | 3,043 | — | ||||||||||||
Total fixed maturity securities | 44,077 | 7,889 | 36,188 | |||||||||||||
Total assets at fair value | $ | 65,832 | $ | 29,644 | $ | 36,188 | $ | — | ||||||||
Six Months Ended June 30, 2020 | Six Months Ended June 30, 2019 | |||||||||||||||
Premiums Written | Premiums Earned | Premiums Written | Premiums Earned | |||||||||||||
Direct premium | $ | 133,033 | $ | 111,223 | $ | 93,030 | $ | 53,531 | ||||||||
Ceded premium — nonaffiliated | (131,425 | ) | (107,146 | ) | (89,704 | ) | (49,812 | ) | ||||||||
Net premiums | $ | 1,608 | $ | 4,077 | $ | 3,326 | $ | 3,719 | ||||||||
Six Months Ended, | ||||||||
June 30, 2020 | June 30. 2019 | |||||||
Direct Loss and Loss Adjustment Expenses | $ | 93,942 | $ | 48,574 | ||||
Ceded Loss and Loss Adjustment Expenses | (91,247 | ) | (46,456 | ) | ||||
Net Loss and Loss Adjustment Expenses | $ | 2,695 | $ | 2,118 | ||||
Six Months Ended. | ||||||||
June 30, 2020 | June 30, 2019 | |||||||
Balance at beginning of period: | ||||||||
Liability for unpaid Loss and Loss Adjustment Expense | $ | 36,457 | $ | 13,072 | ||||
Reinsurance recoverable | 33,427 | $ | 10,223 | |||||
Net balance at beginning of period | 3,030 | 2,849 | ||||||
Incurred related to: | ||||||||
Current year | 2,739 | 2,107 | ||||||
Prior years | (40 | ) | 13 | |||||
Total incurred | 2,699 | 2.120 | ||||||
Paid related to: | ||||||||
Current year | 1,412 | 1,016 | ||||||
Prior years | 646 | (756 | ) | |||||
Total paid | 2,058 | 260 | ||||||
Balance at end of period: | ||||||||
Liability for unpaid Loss and Loss Adjustment Expense | 57,138 | 29,284 | ||||||
Reinsurance recoverable | 53,467 | 24,576 | ||||||
Net balance at end of period | $ | 3,671 | $ | 4,708 | ||||
June 30, 2020 | December 31, 2019 | |||||||
Operating lease right-of-use-office | $ | 259 | $ | 259 | ||||
Accumulated amortization | (53 | ) | (32 | ) | ||||
Operating lease included in property, plant & equipment | 206 | 227 | ||||||
Operating lease liability included in included in accrued expenses and other liabilities | $ | (225 | ) | $ | (246 | ) | ||
Remaining fiscal 2020 | $ | 31 | ||
Fiscal year 2021 | 63 | |||
Fiscal year 2022 | 66 | |||
Fiscal year 2023 | 66 | |||
Fiscal year 2024 | 38 | |||
Total lease Payments | 264 | |||
Less: interest | (39 | ) | ||
Present value of the lease liability | $ | 225 | ||
Six Months Ended, | ||||||||
June 30, 2020 | June 30, 2019 | |||||||
Operating lease included in underwriting and general expenses | $ | 32 | $ | 23 |
Six Months Ended, | ||||||||
2020 | 2019 | |||||||
Cash paid for amounts included in the measurement of the lease liabilities: Operating cash flows from operating leases | $ | 31 | $ | 8 | ||||
Lease assets obtained in exchange for the lease obligation: Operating leases | $ | — | $ | 259 |
June 30, 2020 | June 30, 2019 | |||||||
Total shareholder’s equity | $ | 45,769 | $ | 37,266 | ||||
Non-admitted assets | (859 | ) | (132 | ) | ||||
Deferred policy acquisition costs | (2,403 | ) | (2,382 | ) | ||||
Deferred taxes | 879 | — | ||||||
Book value of bonds (PGAAP) | (70 | ) | (77 | ) | ||||
Market value of bonds | (1,684 | ) | (400 | ) | ||||
Aggregate statutory surplus of insurance subsidiaries | $ | 41,632 | $ | 34,275 | ||||
June 30, 2020 | June 30, 2019 | |||||||
Net Income | $ | 3,593 | $ | 1,951 | ||||
Deferred policy acquisition costs | 58 | (462 | ) | |||||
Deferred taxes | 70 | (164 | ) | |||||
GAAP to STAT bond amortization difference | 4 | 4 | ||||||
Other differences | 1 | — | ||||||
Aggregate statutory net earnings | $ | 3,726 | $ | 1,329 | ||||
Securities and Exchange Commission registration fee | $ | 183,510.65 | ||
Accounting fees and expenses | $ | 35,000.00 | ||
Legal fees and expenses | $ | 75,000.00 | ||
Financial printing and miscellaneous expenses | $ | 115,000.00 | ||
Total | $ | 408,510.65 |
• | On October 7, 2020, RTPZ issued an aggregate of 5,750,000 RTPZ Class B ordinary shares to the Sponsor for an aggregate gross proceeds of $25,000; |
• | On November 23, 2020, RTPZ issued 4,400,000 warrants to purchase an equivalent number of RTPZ Class A ordinary shares to the Sponsor for aggregate gross proceeds of $6,600,000; and |
• | On August 2, 2021, Hippo Holdings issued 55,000,000 shares of Hippo Holdings common stock to certain qualified institutional buyers and accredited investors that agreed to purchase such shares in connection with the Business Combination for aggregate gross proceeds of $550,000,000. |
† | The schedules, and certain exhibits to this Exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Registrant hereby agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. |
+ | Indicates a management contract or compensatory plan. |
(a) | To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement: |
(i) | To include any prospectus required by section 10(a)(3) of the Securities Act of 1933; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement; and |
(b) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment that contains a form of prospectus will be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to be the initial bona fide offering thereof. |
(c) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(d) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, will be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
(e) | That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
2. | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by them is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. |
3. | The undersigned registrant hereby undertakes as follows: that prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable registration form with |
respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. |
4. | The registrant undertakes that every prospectus: (1) that is filed pursuant to the immediately preceding paragraph, or (2) that purports to meet the requirements of Section 10(a)(3) of the Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment will be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to be the initial bona fide offering thereof. |
5. | The undersigned Registrant hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus pursuant to Items 4, 10(b), 11, or 13 of this Form S-4, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the Registration Statement through the date of responding to the request. |
6. | The undersigned Registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in the Registration Statement when it became effective. |
HIPPO HOLDINGS INC. | ||
By: | /s/ Assaf Wand | |
Name: Assaf Wand Title: Chief Executive Officer |
Signature | Title | |
/s/ Assaf Wand Assaf Wand | Director, Co-Founder and Chief Executive Officer(Principal Executive Officer) | |
/s/ Stewart Ellis Stewart Ellis | Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | |
/s/ Amy Errett Amy Errett | Director | |
/s/ Eric Feder Eric Feder | Director | |
/s/ Lori Dickerson Fouché Lori Dickerson Fouché | Director | |
/s/ Hugh R. Frater Hugh R. Frater | Director | |
/s/ Noah Knauf Noah Knauf | Director | |
/s/ Sam Landman Sam Landman | Director | |
/s/ Sandra Wijnberg Sandra Wijnberg | Director |